Stockwinners Market Radar for February 08, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
HOOD | Hot Stocks20:07 EST Cathie Wood's ARK Investment bought 771K shares of Robinhood today
|
SE | Hot Stocks20:06 EST Cathie Wood's ARK Investment bought 124K shares of Sea Limited today
|
QNGY CCAC | Hot Stocks19:56 EST Quanergy Systems closes business combination with CITIC Capital Acquisition - Quanergy Systems (QNGY) "announced the closing of its previously announced business combination with CITIC Capital Acquisition Corp (CCAC). The transaction gives the company access to approximately $175M in available liquidity on top of its existing balance sheet, before transaction expenses and debt paydown, consisting of approximately $50M in cash proceeds from the PIPE and SPAC Trust, as well as up to $125M in committed funding from a previously announced share subscription facility from Global Emerging Markets Group, a Luxembourg-based private alternative investment group. Under the GEM facility, the Company can draw on a $25 million advance from the total $125M following effectiveness of a resale S-1 Registration Statement. Proceeds from the transaction will be used for working capital, repayment of $35 million of secured notes, and transaction expenses, positioning the Company to fund future growth and continue investing in its leading portfolio of smart LiDAR and 3D perception solutions. CCAC shareholders approved the transaction at its shareholders meeting held on January 31, 2022. The combined company has been renamed "Quanergy Systems, Inc." and is expected to begin trading on the New York Stock Exchange at market open tomorrow, February 9, 2022, under the ticker "QNGY" for Quanergy common stock and "QNGY.WS" for Quanergy publicly traded warrants. "
|
UBSFY | Hot Stocks19:18 EST Ubisoft partners with blockchain-based metaverse game The Sandbox - The Sandbox, an upcoming blockchain-based 3D open world metaverse game, said in a blog post that it is partnering with Ubisoft to introduce Ubisoft game IP elements to The Sandbox metaverse. Ubisoft will have its own ESTATE with interactive experiences. Voxel characters and items will also be available for players and creators to incorporate into their own experiences using The Sandbox's free VoxEdit and Game Maker creation tools. "We're excited to bring the Rabbids to The Sandbox community and to empower players to create their own original experiences incorporating elements of our gaming IP. We can't wait to see how they make the Rabbids' world their own. The Sandbox is an obvious new fun playground addition to the long list of Rabbids world invasions, and a great opportunity for Ubisoft to experiment a metaverse experience for its brands," said Guillaume Mammi, Senior Manager of New Business and Partnerships at Ubisoft. Reference Link
|
MRSN | Hot Stocks19:07 EST Mersana Therapeutics director buys $5.0M in common stock - In a regulatory filing, Mersana Therapeutics disclosed that its director Andrew Hack bought 1.1M shares of common stock on February 7th in a total transaction size of $5.0M.
|
NTDOY MSFT | Hot Stocks18:55 EST Microsoft's 'Minecraft Dungeons' reaches 15M players - Microsoft (MSFT) video game "Minecraft Dungeons," which is playable on PC, Xbox consoles, and the Nintendo Switch (NTDOY), has reached 15M players, according to the "Minecraft Dungeons" Twitter account. The game originally released in May of 2020. Reference Link
|
LBRT | Hot Stocks18:16 EST Liberty Oilfield Services expects Q1 high single digit sequential revenue growth - The company said, "The transformative work our team accomplished in 2021 positions us well as our industry begins an upcycle driven by rapidly tightening markets for oil & gas. Seven years of subdued global investment in upstream oil and gas production is now colliding with record global demand for natural gas and natural gas liquids today, and likely record global demand for oil later this year. Oil and gas are central to the global economy which is well along the way of recovering from the global pandemic. The severe energy crisis that has wracked Europe over the last several months demonstrates the danger of underinvestment in our industry. E&P operators are responding to oil and gas price signals. The public operators are maintaining discipline and will show only modest production growth this year, while the private operators are reacting more robustly to strong commodity prices. Within the frac market, two years of supply attrition and cannibalization plus constraints from labor shortages, and a secular shift towards next generation frac fleet technologies has led to tightness in the frac space. Liberty has focused on finding the right long-term partnerships for the coming years and has been very disciplined in holding our active frac fleet count steady until returns are strong." "In the Q1, we expect high single digit sequential revenue growth and strong improvement in our margins as integration costs start to fade away. We are benefiting from increased pricing in 2022, driven by a pass-through of inflationary costs and higher net service pricing. We expect continued modest rises in frac pricing in subsequent quarters. We also expect margin growth as our new strategic efforts begin to pay dividends in lowering our cost of operations and increasing efficiency," commented CEO, Chris Wright. "We are excited for the opportunity ahead and are investing to build truly differential competitive advantages in frac fleet technology, digital systems, and logistics optimization bolstered by the PropX acquisition. We expect that our investments today will lead to strong returns in the coming years," continued Wright.
|
MNDT MSFT | Hot Stocks17:30 EST Mandiant says 'no comment' on reports of potential merger with Microsoft
|
MNDT | Hot Stocks17:29 EST Mandiant sees FY22 ARR growth 30% - Sees FY22 gross margin 61.5%-62.5%. Expects to deliver non-GAAP profitability in 2023.
|
MNDT | Hot Stocks17:21 EST Mandiant sees Q1 ending ARR $291M-$297M, subscription revenue up 3%-5% - Sees Q1 gross margin 59%-60%.
|
MNDT | Hot Stocks17:18 EST Mandiant says achieved record billings, revenue in Q4 - Expects to have "exceptional leverage" going forward. Says continues to have great success attracting talent. Says has several qualified candidates for CFO position. Says had significant increase in contract length and higher mix of renewals. Comments taken from Q4 earnings conference call.
|
MMM | Hot Stocks17:17 EST 3M increases quarterly dividend to $1.49 per share - 3M declared a dividend on the company's common stock of $1.49 per share for Q1. The dividend is payable March 12 to shareholders of record at the close of business on February 18.
|
BA | Hot Stocks17:15 EST Boeing awarded $94.9M Navy contract - Boeing was awarded a $94.9M cost-plus-fixed-fee, indefinite-delivery/indefinite-quantity contract. This contract provides engineering services and supplies, to include capability defect package fixes and acoustic software improvement efforts in support of the continued development and sustainment of the P-8A Acoustic Operational Flight Program. Work is expected to be completed in January 2027. No funds will be obligated at the time of award; funds will be obligated on individual orders as they are issued. This contract was not competitively procured pursuant to 10 U.S. Code 2304. The Naval Air System Command is the contracting activity.
|
AZEK | Hot Stocks17:10 EST Azek director Nagel buys 5K shares of company stock - Azek director Vernon Nagel disclosed in a regulatory filing that he had purchased 5,000 shares of company stock at $30.41 per share for a total transaction amount of $152,050.
|
SVM | Hot Stocks17:09 EST Silvercorp Metals sees FY23 production 1,040,000-1,140,000 tonnes of ores - In FY23 expects to mine and process approximately 1,040,000-1,140,000 tonnes of ores, yielding 6,300 to 7,900 ounces of gold, 7.0M-7.3M ounces of silver, 68.4M-71.3M pounds of lead, and 32.0M-34.5M pounds of zinc. The guidance represents a production increase of approximately 9% in ores, 100% in gold, 11% in silver, 3% in lead, and 12% to 21% in zinc compared to the FY22 guidance. The increased production guidance is made possible by over 629,000 metres of exploration and resource upgrade drilling completed at the mines from 2020 to 2021. During 2021 alone, over 409,000 metres of drilling were completed.
|
SVM | Hot Stocks17:07 EST Silvercorp Metals reports Q3 adjusted EPS 8c, consensus 8c - Reports Q3 revenue $59.1M, consensus $59.67M. Reports 292,072 tonnes of ore and milled 304,772 tonnes of ore mined in Q3, up 5% and 17% compared to the prior year quarter.
|
GES | Hot Stocks17:04 EST Guess refutes Legion claims against Paul Marciano - Guess issued a statement in response to a letter released by Legion Partners. "In its letter, Legion Partners commends the Company on its positive strategic moves and improvement in a number of important areas. We remain committed to acting in the best interests of all shareholders, and our Board and management will continue to engage with Legion Partners and evaluate all opportunities to create value for all shareholders. Since 2019, under the leadership of Chief Executive Officer Carlos Alberini, Co-Founder and Chief Creative Officer Paul Marciano and the Guess? senior management team, we have been executing on a clear strategic plan to elevate the Guess? and Marciano brands, redefine the Company's global e-commerce strategy, optimize store footprint, enhance supply chain and drive efficiencies across the business. As part of our focus on brand elevation and customer-centric initiatives, we have taken steps to launch our first global product line, elevate the quality and sustainability of our product, upgrade our marketing and visual merchandising, optimize full-price selling and remodel our store fleet. While our business transformation remains ongoing, the Company is today supported by a strong balance sheet and solid cash flow generation to propel our growth, while also returning cash to shareholders. Our strategy is working, our team is executing and our Company is on the right path forward. From 2019 through the third quarter of fiscal year 2022, the Company repurchased $327 million, or approximately 25%, of Guess? outstanding shares. In 2021 alone, we announced a significant expansion of the Company's share repurchase program to $200 million and a 100% increase to the quarterly dividend. Furthermore, we delivered strong third quarter 2022 results and, as demonstrated by our full-year guidance, we expect to report the Company's best full-year results of the last decade. Specifically, we anticipate reaching an operating margin of 11%, which is double the level of our pre-pandemic performance. This reflects our team's successful management of the business under the substantial and evolving challenges presented by today's operating environment, particularly for a company that serves diverse global markets. As we look ahead, we are confident that our highly-engaged Board and leadership team will continue to deliver on our strategic priorities and to build on Guess?'s strong momentum." The company noted that Legion Partners has resurfaced information related to one of its co-founders, Paul Marciano, the details of which come from public information, including the company's own disclosure on these matters. As previously disclosed in 2018, the Guess? Board established a Special Committee to investigate, with the assistance of independent outside legal counsel, allegations of improper conduct by Mr. Marciano. The Special Committee, composed of independent directors, conducted a comprehensive investigation, the findings of which were made public in June 2018. Regarding subsequent allegations against Mr. Marciano, the company has strongly refuted these claims and is contesting them vigorously.
|
LUV | Hot Stocks17:01 EST Southwest reaches tentative agreement with TWU 550 - Southwest and the Transport Workers Union Local 550, or TWU 550, have reached a tentative agreement for the more than 400 Southwest Airlines dispatch employees. This tentative agreement covers all Southwest Airlines flight dispatchers, assistant dispatchers, flight superintendents, dispatch specialists, and dispatch ATC specialists. The TWU 550 will share details directly with their members about the agreement and the voting process.
|
PGC | Hot Stocks16:44 EST Peapack-Gladstone appoints Heidi Smith as general counsel - Peapack-Gladstone announced the appointment of Heidi Smith as senior VP, general counsel and corporate secretary at Peapack-Gladstone Bank. Working out of the bank's Headquarters in Bedminster, New Jersey, Smith is responsible for overseeing all legal affairs of the company in addition to providing advice to the bank's executive team on all matters of law and policy. Smith previously served as assistant general counsel at the bank, focusing primarily on providing legal support to Peapack Capital, the Bank's equipment finance subsidiary.
|
FMC | Hot Stocks16:40 EST FMC Corporation board authorizes new $1B share repurchase program - FMC's Board of Directors authorized a new $1B share repurchase program confirming confidence in the company's ability to sustainably generate strong cash flow in 2022 and beyond. This further confirms the company's commitment to return to shareholders cash in excess of that needed to support growth of the business, FMC said.
|
NEWR | Hot Stocks16:39 EST New Relic down 19% at $88.25 after Q3 earnings miss
|
AAT | Hot Stocks16:39 EST American Assets Trust increases quarterly dividend 7% to 32c per share - In addition, the company has declared a dividend on its common stock of $0.32 per share for the first quarter of 2022. The dividend will be paid in cash on March 24, 2022 to stockholders of record on March 10, 2022.
|
LYFT | Hot Stocks16:38 EST Lyft falls about 4% to $39.69 after Q4 results
|
BWMX | Hot Stocks16:37 EST Betterware de Mexico announces new leadership appointments - Betterware de Mexico announced a new corporate leadership structure to support the ongoing growth of its business, including the operation of Jafra Cosmetics International and Jafra Mexico Holding Company, which were recently acquired, subject to certain conditions yet to be fulfilled. All executives will report directly to Luis G. Campos, Betterware's Executive Chairman of the Board. Juan Luis Toscano is joining Betterware as Corporate Chief Talent Officer and will be in charge of overseeing all human resources activities in Betterware and JAFRA, to allow the Chief Executive Officers of each company to focus on business strategy and growth. Toscano has over 25 years of experience in Human Resources and, in particular, with building and managing multicultural and multifunctional teams. Carlos Doormann is joining Betterware as Corporate CFO and will ensure the correct functioning of all financial areas of Betterware and JAFRA. Doormann's activities will include strategic and financial planning, investor relations and relations with banks and external auditors. Doormann has significant experience in execution of financial and business strategies, investor relations, risk management, financial reporting, among other areas of expertise. Mauricio Alvarez Chief Information Officer of Betterware since August 2020, has been promoted to the new position of Corporate Chief Information Officer and will be in charge of deploying and overseeing all technology developments in Betterware and JAFRA to support future growth. Rebeca Figueroa New Business Director of Betterware since July 2021, has been promoted to Chief Commercial Model Officer, and will be in charge of replicating Betterware's commercial model and three strategic pillars in JAFRA. Andres Campos continues as CEO of Betterware.
|
PEAK | Hot Stocks16:35 EST Healthpeak announces full lease-up of Nexus on Grand project - Healthpeak Properties announced the execution of long-term leases with Graphite Bio, Inc. and another leading biotech company at its life science development, Nexus on Grand, bringing the project to 100% pre-leased. Prominently located on East Grand Avenue in the heart of South San Francisco, Nexus on Grand will feature 148,000 square feet of state-of-the-art laboratory and office space and a first-class amenities center to include a cafe, fitness center, and several indoor and outdoor meeting areas within its entry plaza. Nexus on Grand is one of Healthpeak's three active development projects in the South San Francisco market. The project is currently under construction with an anticipated completion in the second quarter of 2023.
|
YUMC | Hot Stocks16:33 EST Yum China sees FY22 CapEx $800M-$1B - Which includes stepped-up investments in supply chain, infrastructure and digital. Sees approximately 1,000-1,200 net new stores.
|
YUMC | Hot Stocks16:31 EST Yum China reports Q4 sames store sales down 11%, total system sales down 3% - In Q4: Total system sales decreased 3% year over year, with decreases of 3% at KFC and 2% at Pizza Hut, excluding F/X. Same-store sales decreased 11% year over year, with decreases of 12% at KFC and 8% at Pizza Hut, excluding F/X. Opened 563 gross new stores, or 373 net new stores. Restaurant margin was 7.5%, compared with 15.1% in the prior year period, primarily due to sales deleveraging as a result of worsened COVID-19 conditions.
|
FUBO | Hot Stocks16:31 EST Cleveland Cavaliers, Fubo Gaming announce Ohio market access agreement - The Cleveland Cavaliers and Fubo Gaming, a subsidiary of fuboTV Inc., announced a market access agreement, making Fubo Sportsbook an Official Mobile Sports Betting Partner of the team when the sportsbook launches in Ohio, pending requisite regulatory approvals. Fubo Gaming launched Fubo Sportsbook in the fourth quarter 2021 and is live in two states: Iowa and Arizona.
|
ASR | Hot Stocks16:31 EST Asur reports January traffic up 3.3% from 2019 level - ASUR announced passenger traffic for January 2022 reached a total of 4.8 million passengers, 3.3% above the levels reported in January 2019, "reflecting a continued overall recovery in travel demand and the rollout of vaccination campaigns in the US and gradual advances in Mexico, despite restrictions and requirements in certain countries of the world to contain the spread of the virus, as well as the impact of the new Omicron variant mainly in Mexico and Puerto Rico."
|
SNDL | Hot Stocks16:28 EST Sundial Growers granted 180-day extension to regain Nasdaq compliance - Sundial Growers announced that it has received an extension of 180 calendar days to regain compliance with Nasdaq's minimum bid price requirement. As previously reported, the company was notified by Nasdaq on August 9, 2021 that the bid price for its common shares was not in compliance with the Nasdaq minimum bid price requirement. At that time, the company was required to regain compliance by February 7. The extension will allow the company to regain compliance if the bid price for the company's common shares closes at or above $1.00 per share for a minimum of 10 consecutive trading days before August 8. The company intends to monitor the closing bid price of its common shares and has given written assurance to Nasdaq that it will, if necessary, implement available options to regain compliance with the minimum bid price requirement, including a reverse stock split.
|
XPO | Hot Stocks16:26 EST XPO Logistics sees double-digit volume growth in North American truck brokerage - "Our North American truck brokerage business is continuing to far outpace industry growth, propelled by our XPO Connect digital brokerage platform. This technology was a major tailwind behind the 29% load growth we achieved in 2021 year-over-year, including 35% load growth from our top 20 customers. In the fourth quarter, 70% of our brokerage orders were created or covered digitally. We expect to continue to deliver double-digit volume growth in North American truck brokerage in 2022 and going forward."
|
CMG | Hot Stocks16:25 EST Chipotle jumps 7% to $1,559 after Q4 results beat estimates
|
PRI | Hot Stocks16:25 EST Primerica raises quarterly dividend 17% to 55c per share - Primerica announced that the Board of Directors has approved a 17% increase in stockholder dividends to 55c per share. The dividend is payable on March 14, 2022, to stockholders of record on February 22, 2022.
|
SGMS | Hot Stocks16:24 EST Scientific Games expands sports betting, lottery operations in Azerbaijan - Scientific Games has launched large-scale retail and digital sports betting and lottery operations in Azerbaijan. The national lottery, Azerlotereya, launched sports betting in mid-January with Scientific Games' technology as part of a 10-year agreement for the exclusive supplier of retail and digital lottery instant games, draw games, sports, and an omni-channel lottery gaming system. The Azerbaijan sports launch expands Scientific Games' global leadership in sports betting and its ongoing, successful partnership with Demiroren, the operator of the national lottery, Azerloterya.
|
NEWR | Hot Stocks16:21 EST New Relic reports Q3 active customer accounts 14.6K vs. 14.3K q/q - Reports Q3 Active Customer Accounts above $100,000: 1,064 vs, 1,011 q/q and Net Revenue Retention rate 116% vs. 112% q/q.
|
ERYP | Hot Stocks16:21 EST Erytech Pharma expands patent portfolio for rare metabolic diseases - ERYTECH Pharma announced the allowance of a US patent application covering arginine deiminase ADI encapsulated into red blood cells for the treatment of arginase-1 deficiency A1D , a debilitating rare metabolic disease. The claims will also cover methods of treating other indications, including arginine-dependent cancers, septic shock, and angiogenesis-associated diseases. In addition to their potential in cancer metabolism, ERYTECH's red blood cell-encapsulated therapeutics can be deployed to reduce pathological levels of various metabolites, that can occur in certain inborn errors of metabolism disorders. And while some enzyme replacement therapies ERT are commercially available, the clinical benefits of these enzymes are often outweighed by hypersensitivity and rapid clearance. Therefore, there is a high need for better tolerated and longer-acting ERT approaches.
|
CNS | Hot Stocks16:20 EST Cohen & Steers reports preliminary AUM $102.1B as of January 31 - A decrease of $4.6B from assets under management at December 31, 2021.
|
AIZ | Hot Stocks16:18 EST Assurant sees FY22 adjusted EBITDA growth 8%-10% - In 2022, the company expects 8%-10% growth in Adjusted EBITDA, excluding reportable catastrophes, driven by expansion across Global Lifestyle and Global Housing.
|
NVGS | Hot Stocks16:17 EST Navigator Holdings provides preliminary unaudited results for Q4 and 2021 - Navigator Holdings provided a trading update ahead of its preliminary unaudited results for the fourth quarter and year ended 2021, which the Company expects to publish in March. Oeyvind Lindeman, Navigator's Chief Commercial Officer commented: "2021 was a landmark year for Navigator. Not only did we complete the most significant M&A transaction in this Company's history, strengthening the foundations of our business and adding new opportunities to generate value, but we also began to see the value of our investments to date, particularly starting in Q3 2021, where we saw increased revenue and net income compared to prior quarters. "With these foundations, we continued our strong operational performance in Q4 2021, during which our fleet utilization remained at a high 91.4%, and we achieved throughput volumes at our Houston Ethylene Export Terminal joint venture of 234,000 tons. "As we look ahead to 2022, Navigator finds itself in a robust position from which it can grow. We look forward to driving further operationally strong performance and finding new ways to drive shareholder value." Q4 2021 Operational Highlights: Based on the Company's preliminary estimates, the following are specific Q4 2021 operational highlights: Strong operational performance across the business in Q4 2021, increasing the results achieved in prior quarters. Fleet utilization of 91.4% during the three months ended December 31, 2021, compared to fleet utilization of 84.0% for the three months ended September 30, 2021. Houston Ethylene Export Terminal throughput volumes of 234,000 tons for the three months ended December 31, 2021, compared to 128,000 tons for three months ended September 30.
|
KAMN | Hot Stocks16:16 EST Kaman Composites expands part 145 capabilities with FAA approvals - Kaman Composites announced that its FAA Part 145 Repair Station in Wichita, Kansas has earned FAA approval of two new composite repair capabilities, to include ATR and ERJ airframes. "We aligned our strategic plan last year to assure composite repair capabilities on platforms where there were immediate needs. Specifically, we focused on the regional aircraft market, due to the amount of demand that we see," said Malissa Nesmith, Senior Director of Business Development. "Kaman has historically performed most of the repair services of the Part 145 station for military support programs. As part of our on-going growth strategy, we have extended those repair services to include the commercial aftermarket. With the most recent FAA approvals, we are now offering composite repairs for structures on the ATR and ERJ aircrafts."
|
CMG | Hot Stocks16:14 EST Chipotle raises long-term restaurant goal for North America to 7,000 from 6,000 - The company said, "Based on the success of small-town locations that are delivering unit economics at or better than traditional Chipotle locations, we provide the following update to our long-term development opportunity: Over time, we believe there can be at least 7,000 Chipotle restaurants in North America, up from the prior goal of 6,000 restaurants. Given the healthy and improving cash on cash returns, we are building a real estate pipeline that will allow us to accelerate unit growth to be in the range of 8% to 10% per year, with greater than 80% of new restaurants having a Chipotlane."
|
CMG | Hot Stocks16:13 EST Chipotle reports Q4 digital sales grew 3.8% and accounted for 41.6% of sales - Q4 operating margin was 8.1%, an increase from 7.3%. Restaurant level operating margin was 20.2%, an increase of 70 basis points.
|
ARGO | Hot Stocks16:12 EST Argo Group Q4 'negatively affected by adverse prior year reserve development' - The company states: "Argo expects net adverse prior year reserve development to be in the range of $130M to $140M for the 2021 fourth quarter. Prior year adverse development was the result of the recently concluded fourth quarter 2021 reserve review. The largest reserve increases were related to construction defect claims within Argo's U.S. Operations, in addition to reserve increases in the Run-off segment. The prior year reserve increase for construction defect primarily related to the 2017 and prior underwriting years in business lines that have either been significantly remediated or discontinued. Additionally, several non-operating charges are anticipated to be reflected in Argo's fourth quarter 2021 results. As part of an ongoing strategic review and recent operating results, an impairment of goodwill and intangible assets is expected to be in the range of $40M to $45M related to Argo's Syndicate 1200 business unit, and Non-operating expense charges expected to be in the range of $20M to $25M primarily related to the reduction in Argo's real estate footprint in the UK and the impairment of certain information technology assets."
|
CMG | Hot Stocks16:11 EST Chipotle sees Q1 comparable restaurant sales growth mid to high single digits - For 2022, management is anticipating the following: First quarter comparable restaurant sales growth in the mid to high single digits range; Between 235 to 250 new restaurant openings (including 5 to 10 relocations to add a Chipotlane), which assumes construction and permit delays related to COVID-19 don't worsen; An estimated underlying effective full year tax rate between 25% and 27% before discrete items.
|
LYFT | Hot Stocks16:08 EST Lyft reports Q4 Active Riders up 49.2% y/y at 18.7M - Reports Q4 Revenue per Active Rider up 14.1% at $51.79.
|
NCR | Hot Stocks16:07 EST NCR Corp. to commence strategic review process - The NCR board of directors has unanimously approved commencing a comprehensive strategic review process, with the assistance of outside advisors, which will evaluate a full range of strategic alternatives available to NCR to enhance value for all shareholders. Those strategic alternatives could include a disposition of a material business or assets of the Company, a spin-off, merger or sale of the Company, other structural changes, changes to branding or geographic footprint or other transactions or alternatives. The board has not set a timetable for the conclusion of its review of strategic alternatives. NCR does not intend to comment further on the strategic review process unless and until NCR has determined that further disclosure is beneficial or required by law. Shareholders are advised that there can be no certainty that the strategic review will result in a transaction, or if a transaction is pursued that such a transaction will be completed.
|
DOCS | Hot Stocks16:07 EST Doximity to acquire Amion, terms not disclosed - Doximity announced that it has acquired Amion, an on-call physician scheduling site. Amion manages nearly 200,000 physician schedules at thousands of hospitals, including 18 of the top 20. The transaction is expected to close April 1.
|
FLR | Hot Stocks16:04 EST Alan Boeckmann to retire as Executive Chairman of Fluor - Fluor announced that Alan Boeckmann, the company's current executive chairman, will not stand for re-election at the annual shareholders meeting on May 5, 2022. Fluor's CEO David Constable has been appointed by the board of directors to succeed Boeckmann as chairman in addition to his CEO role.
|
MNDT S | Hot Stocks16:03 EST Mandiant, SentinelOne create strategic cybersecurity alliance - Mandiant (MNDT) and SentinelOne (S) announced a new strategic alliance to help organizations reduce the risk of data breaches and strengthen their ability to mitigate cyber threats. The alliance enables Mandiant's renowned incident responders' use of SentinelOne's Singularity XDR platform to investigate and remediate breaches. "Evolving threats and IT environments have resulted in a perfect storm for security practitioners, making it more difficult than ever to keep environments secure. In partnering with cyber security leaders such as SentinelOne, we are better empowering organizations to protect their environments and mitigate future risk through unparalleled threat detection and response capabilities," said Marshall Heilman, EVP and Global CTO at Mandiant. "Mandiant Advantage was purposely designed to support strategic partnerships such as this, and we look forward to extending this capability as we continue to make every organization more secure from cyber threats." Through the strategic alliance, Mandiant will provide consulting engagements that span the Mandiant Advantage and Singularity XDR platforms. In addition, the Mandiant Managed Defense practice plans to introduce managed detection and response for SentinelOne customers in the second half of 2022.
|
SONY | Hot Stocks15:50 EST Sony beta testing PS5 voice command feature in U.S., U.K. - Sony said that its second PlayStation 5 system beta is kicking off Wednesday with new personalization features across party chat, Game Base and accessibility settings. "We're also rolling out a PS4 system software beta tomorrow for players to try out the community-requested Open Parties feature, which is also coming in the PS5 beta," the company said. "In addition, for PS5 beta participants in the U.S. and U.K, we're previewing a feature that enables voice commands for finding and opening games and apps, as well as controlling media playback (English language setting only). While access to the PS5 and PS4 betas will be open to selected participants in applicable countries, the final system software updates will be available globally later this year. If you're selected to participate in the betas, you'll receive an email invitation when the updates are available to download tomorrow. As with previous system software betas, some features available during this phase may not make it into the final version or may see significant changes." Reference Link
|
H | Hot Stocks15:40 EST Hyatt announces plans for Magma Resort Santorini - Hyatt Hotels announced that a Hyatt affiliate has entered into a franchise agreement with Thera Island Suites S.A., owners of Magma Resort Santorini, and Athens-based SWOT Hospitality will operate the hotel. Expected to open in 2022 in time for the summer season, the hotel will join The Unbound Collection by Hyatt portfolio as the first Hyatt-affiliated resort in the Greek islands, featuring 59 guestrooms, including 24 suites. The signing underscores Hyatt's strategy to grow its brand footprint in the leisure and independent collection segments across key European leisure destinations. "We are thrilled to work with SWOT Hospitality and are excited to announce The Unbound Collection by Hyatt brand's upcoming entry into the Greek Islands with Magma Resort Santorini," said Peter Norman, senior vice president of development for EAME & SWA, Hyatt. "The expansion of our luxury and independent collection brands in popular leisure destinations in Europe plays a central role in our growth strategy as we aim to satisfy the increasing leisure demand from travelers looking for story-worthy experiences."
|
MNDT MSFT | Hot Stocks14:52 EST Mandiant up 17% on resuming trade after report of possible Microsoft interest - Shares of Mandiant (MNDT) are up $2.59, or 17%, to $17.65 after Bloomberg said Microsoft (MSFT) has weighed a possible takeover bid.
|
MNDT | Hot Stocks14:49 EST Mandiant trading resumes
|
MNDT | Hot Stocks14:39 EST Mandiant trading halted, volatility trading pause
|
SKY | Hot Stocks14:13 EST Skyline Champion disloses $200.3M FEMA order for manufactured housing - Skyline Champion disclosed that on February 7, Champion Home Builders, its wholly owned subsidiary, entered into a Delivery Disaster Relief Order pursuant to a December 30, 2020, contract for the production, shipment, and delivery of NextGen Manufactured Housing Units with FEMA-Community Survivor Assistance Federal Emergency Management Agency. FEMA invoked the Defense Protection Act in awarding the contract. The contract calls for a base year and four option years. Skyline previously performed under FEMA's first article order during the base year in December 2021. The first article order was the first order under the contract and deemed immaterial. The order was received during option year one and has been deemed material by the company. The order totals $200.3M and will be completed by September. There are three option years remaining under the contract, collectively ending December 29, 2025.
|
ENTA | Hot Stocks13:56 EST Enanta to begin dosing in first-in-human COVID study of EDP-235 this month - Enanta said in its earnings press release: "Enanta is on track to begin dosing subjects this month in a Phase 1 study of EDP-235, its oral, coronavirus 3CL protease inhibitor - also known as Mpro or main protease - specifically designed for the treatment of COVID-19. Preclinical data demonstrate that EDP-235 potently blocks the replication of SARS-CoV-2 in multiple cellular models, including primary human airway epithelial cells with an EC90 of 33 nanomolar, positioning EDP-235 among the most potent direct-acting antivirals currently in development for SARS-CoV-2 infection, with the potential for convenient once-daily dosing. Importantly, EDP-235 has shown good exposure after oral administration without ritonavir boosting and favorable distribution into lung cells as well as other key target tissues. EDP-235 has demonstrated potent antiviral activity across a range of currently circulating SARS-CoV-2 variants, including Omicron and Delta. Additionally, EDP-235 is active against all other known human coronaviruses, providing the potential for a pan-coronavirus treatment."
|
FB | Hot Stocks13:45 EST Meta says 'absolutely not threatening to leave Europe' - Markus Reinisch, Vice President, Public Policy Europe at Meta, stated in a blog post: "There has been reporting in the press that we are "threatening" to leave Europe because of the uncertainty over EU-US data transfers mechanisms. This is not true. Like all publicly-traded companies, we are legally required to disclose material risks to our investors. Last week, as we have done in our previous four financial quarters, we disclosed that continuing uncertainty over EU-US data transfers mechanisms poses a threat to our ability to serve European consumers and operate our business in Europe. We have absolutely no desire to withdraw from Europe; of course we don't. But the simple reality is that Meta, like many other businesses, organisations and services, relies on data transfers between the EU and the US in order to operate our global services. We're not alone. At least 70 other companies across a wide range of industries, including ten European businesses, have also raised the risks around data transfers in their earnings filings... Businesses need clear, global rules to protect transatlantic data flows over the long term and, like other companies across a wide range of industries, we are closely monitoring the potential impact to the millions of people and businesses who use our services as these developments progress. Like other international and European businesses, brands and trade organisations, we hope to see continued progress in negotiations for a Privacy Shield replacement to protect transatlantic data transfers, ensure robust privacy protections and keep global communities, economies, businesses and families connected." Reference Link
|
CCOEY... | Hot Stocks13:12 EST Capcom says 'Resident Evil 3' remake has sold over 5M units worldwide - Capcom (CCOEY) announced that its 2020 remake of "Resident Evil 3" for PlayStation 4 (SONY), Xbox One (MSFT) and PC has shipped over 5M units worldwide. Reference Link
|
F | Hot Stocks13:00 EST Ford says now shipping E-Transit, working to boost production - Ford E-Transit, the first of two all-electric vehicles "purpose-built" for Ford Pro commercial customers, is now shipping across the U.S., Ford Motor announced. "The popular E-Transit already has more than 10,000 orders from businesses of all sizes and Ford is working on ways to increase production. The all-new E-Transit is produced at Kansas City Assembly Plant - Ford's first U.S. plant to assemble both batteries and all-electric vehicles in-house," the company stated in a press release. "E-Transit is part of Ford's more than $30 billion investment in electrification through 2025. It is Ford's most recent electric vehicle, following Mustang Mach-E. F-150 Lightning and F-150 Lightning Pro deliveries begin this spring. By the end of next year, Ford will have the global capacity to produce 600,000 battery electric vehicles annually, which includes 200,000-plus Mustang Mach-E SUVs and 150,000 F-150 Lightning trucks. Ford is now working on ways to increase E-Transit production. Demand is strong, with more than 300 customers placing orders for 10,000-plus E-Transit vans," Ford added. Reference Link
|
SCHW | Hot Stocks13:00 EST Charles Schwab chairman sells 119,280 common shares - In a regulatory filing, Charles Schwab chairman Charles Schwab disclosed the sale of 119,280 common shares of the company on February 7 at a price of $92.5878 per share.
|
TROW | Hot Stocks12:44 EST T. Rowe Price raises quarterly dividend 11.1% to $1.20 per share - T. Rowe Price announced that its Board of Directors has declared a quarterly dividend of $1.20 per share payable March 30, 2022, to stockholders of record as of the close of business on March 15, 2022. The quarterly dividend rate represents an 11.1% increase over the previous quarterly dividend rate of $1.08 per share. This will mark the 36th consecutive year since the firm's initial public offering that the company will have increased its regular annual dividend.
|
PYPL | Hot Stocks12:10 EST PayPal establishes advisory council on blockchain, digital currencies - PayPal said that to "support not only our current and future products in the space but our broader mission of leading the way towards a more affordable, efficient and inclusive digital financial system," it has established an advisory council on blockchain, crypto and digital currencies. Reference Link
|
SHW | Hot Stocks12:07 EST Sherwin-Williams to expand manufacturing capabilities in Statesville, NC - The Sherwin-Williams Company announced that it signed an agreement today with the state of North Carolina, Iredell County and the city of Statesville to significantly expand its architectural paint and coatings manufacturing capacity and establish a larger distribution facility in Statesville, North Carolina. Sherwin-Williams plans to invest a minimum of $300M in the project and add more than 180 full-time jobs at the site over the next three years, which would essentially double the existing workforce. The project will include a 36,000-square-foot extension of its existing 200,000-square-foot manufacturing facility, the addition of four new rail spurs, as well as the construction of a new 800,000-square-foot distribution and fleet transportation center, which has another 200,000 square feet available for future expansion, the company said in a statement, adding that the facility upgrades will add millions of gallons of annual manufacturing capacity and sizable pallet storage capacity to support the company in meeting increasing demand for its architectural paint and coatings products.
|
ARW | Hot Stocks12:03 EST Arrow names Gretchen Zech chief governance, sustainability, and HR officer - Arrow Electronics announced that Gretchen K. Zech will expand her current role and has been named chief governance, sustainability, and human resources officer of the company. Zech, who joined Arrow in 2011 in her current position, will now also lead the company's environmental, social, and governance strategy, and oversee the company's legal and compliance and real estate functions.
|
FB | Hot Stocks12:02 EST Oversight Board urges Meta to update privacy standard to crack down on 'doxing' - The Meta Oversight Board published its first policy advisory opinion. In its policy advisory opinion, the Board recommends that Meta remove the exception to the Privacy Violations Community Standard that allows the sharing of private residential information when it is considered "publicly available." This would help Meta better protect people's private residential information. Last year, Meta requested a policy advisory opinion from the Board on the sharing of private residential addresses and images, and the contexts in which this information may be published on Facebook and Instagram. Meta considers this to be a difficult question as while access to such information can be relevant to journalism and civic activism, "exposing this information without consent can create a risk to residents' safety and infringe on an individual's privacy." Meta's request noted several potential harms linked to releasing personal information, including residential addresses and images. These include "doxing," where information which can identify someone is revealed online. Meta noted that doxing can have negative real-world consequences, such as harassment or stalking. Reference Link
|
ESGC | Hot Stocks12:01 EST Eros STX Global falls -19.2% - Eros STX Global is down -19.2%, or -78c to $3.25.
|
GHM | Hot Stocks12:01 EST Graham falls -29.1% - Graham is down -29.1%, or -$3.43 to $8.34.
|
SLQT | Hot Stocks12:01 EST SelectQuote falls -51.9% - SelectQuote is down -51.9%, or -$3.39 to $3.14.
|
RKLY | Hot Stocks12:00 EST Rockley Photonics rises 15.1% - Rockley Photonics is up 15.1%, or 53c to $4.05.
|
HAE | Hot Stocks12:00 EST Haemonetics rises 15.8% - Haemonetics is up 15.8%, or $7.43 to $54.40.
|
TDC | Hot Stocks12:00 EST Teradata rises 23.9% - Teradata is up 23.9%, or $9.64 to $49.92.
|
NMRK | Hot Stocks11:49 EST Newmark appoints Roger Anscher as CAO - Newmark Group announced that Roger Anscher has joined the Company as Chief Administrative Officer of Newmark's operating businesses. In his role, Anscher will be responsible for overseeing services, budgets, key performance indicators and staffing across the Company's global operations platform, including the Technology Infrastructure, Human Resources, Research, Marketing and Communications Departments. Reporting to Newmark CEO Barry Gosin, Anscher will be based in the Company's New York City headquarters. Anscher will join the Company's other senior leaders on the Executive Committee. Most recently, Anscher spent four and a half years as COO of a New York City-based commercial real estate brokerage company.
|
SIRI | Hot Stocks11:37 EST Sirius XM appoints Faye Tylee as CHRO - Sirius XM Holdings announced that Faye Tylee is joining the company as Chief Human Resources Officer, effective March 1, 2022. Tylee succeeds Dara Altman, SiriusXM's Chief Administrative Officer, who will be retiring after serving in senior management positions with the company since 2006. Altman will work with Tylee until the end of May 2022 to ensure a seamless transition. Tylee will report directly to SiriusXM CEO Jennifer Witz, and will lead the teams that support SiriusXM's Human Resources, including Talent Acquisition, Culture and Employee Experience, Total Rewards, HR Business Partners and Employee Relations, Learning and Development, HR People Services and Analytics, as well as the company's Diversity, Equity and Inclusion efforts, and social impact programs/ She comes to SiriusXM from Avaya Holdings Corp., where she was Chief Human Resources Officer for a global leader in digital communications software, services and devices.
|
MRNA | Hot Stocks11:12 EST Moderna enters supply agreement wiith Colombia for 10.8M COVID-19 vaccine doses - Moderna announced a new supply agreement with the government of Colombia for 10.8 million doses of Moderna's COVID-19 vaccine. These doses are in addition to 10 million doses supplied to Colombia in 2021. Under the terms of the agreement, Moderna expects to deliver one million doses in the first quarter of 2022, six million doses in the second quarter of 2022, and 3.8 million doses in the third quarter of 2022. In Latin America, Moderna recently announced a new supply agreement with the government of Chile for two million doses of Moderna's COVID-19 booster vaccine or an updated booster vaccine candidate, if authorized. Under the terms of the agreement, Moderna expects to start delivering doses in February 2022, pending obtaining local emergency use authorization.
|
AMZN | Hot Stocks10:47 EST Amazon Care virtual health services now available nationwide - The company said, "In-person care services are expanding to more than 20 new cities in 2022, bringing even more care options to Amazon Care's growing customer base. Amazon Care launched in September 2019 to bring the most patient-centric health care to customers when and where they need it. Amazon Care combines the best of virtual care and in-person services, and as more and more organizations look for convenient, comprehensive, high-quality health care solutions, we're seeing growing demand and excitement for Amazon Care's unique hybrid care offering. Amazon Care's virtual health services are now available nationwide-and in-person services will be rolled out in more than 20 new cities this year. The expansion comes as we continue to invest in growing our clinical care team and our in-person care services to bring convenient, quality care to more customers across the U.S...Working in lockstep with our customers to address their growing needs, Amazon Care is on track to rapidly expand in-person care locations throughout 2022. The service is already available in Seattle, Baltimore, Boston, Dallas, Austin, Los Angeles, Washington, D.C., and Arlington. In 2022, we plan to bring in-person care services to more than 20 additional cities-including major metropolitan areas like San Francisco, Miami, Chicago, and New York City-so customers can access care where and when they need it most." Reference Link
|
SYY | Hot Stocks10:39 EST Sysco says needs to find ways to bring down protein inflation
|
AMGN | Hot Stocks10:26 EST Amgen targeting carbon neutrality by 2027
|
AMGN | Hot Stocks10:25 EST Amgen CEO: Company has 'all pieces in place that we need to succeed' - CFO Peter Griffith indicated it is the company's plan to return, on average, approximately 60 percent of non-GAAP net income to shareholders through 2030, through a combination of dividends and share repurchases. Griffith highlighted how the company has grown the dividend meaningfully each year since 2011 and plans for continued dividend growth over the long term. Griffith also discussed the company's 2022 share repurchase plans of between $6B-$7B including its plans to buy back up to $6B of its shares during the first quarter of 2022.
|
SYY | Hot Stocks10:23 EST Sysco seeing 'green shoots of progress' in February from volume perspective
|
PLSE | Hot Stocks10:23 EST Pulse Biosciences down after FDA sees insufficient evidence to expand indication - Shares of Pulse Biosciences are down $3.65, or 34%, to $7.21 in early Tuesday trading after the company announced an update to its recent U.S. Food and Drug Administration 510(k) submission to add the specific indication for treatment of sebaceous hyperplasia to expand the current labeling for the CellFX System powered by Nano-Pulse Stimulation technology. The company noted that it submitted a 510(k) in December 2021 to add the treatment of sebaceous hyperplasia to the CellFX System's indications for use in the United States. On February 5, the company received an Additional Information, or "AI," letter from the FDA in response to the 510(k) submitted. In the AI letter, the FDA stated it did not believe the company provided sufficient clinical evidence at this time to support the expanded indication for use, and that the company had not met the primary endpoints of the sebaceous hyperplasia FDA-approved IDE study. "The company anticipates meeting with the FDA to discuss the contents of the AI letter and potential next steps, which may require additional clinical data and potentially a new 510(k) submission. The AI letter is a standard part of the 510(k) review process and places the review on hold until the company responds within 180 days of the request in the AI letter. Based on FDA guidance, the company believes its meeting with the FDA will take place in Q1 2022," Pulse stated.
|
DCFC | Hot Stocks10:20 EST Tritium Dcfc Ltd trading resumes
|
DCFC | Hot Stocks10:09 EST Tritium Dcfc Ltd trading halted, volatility trading pause
|
SYY | Hot Stocks10:08 EST Sysco sees topline impact from omicron continuing in Q3
|
SYY | Hot Stocks10:07 EST Sysco: 10% of U.S. workforce tested positive for Covid during January
|
SYY | Hot Stocks10:05 EST Sysco: Covid negatively impacting supply chains around the world
|
AAPL | Hot Stocks10:03 EST Apple announces feature allowing payment with tap of iPhone - Apple announced plans to introduce Tap to Pay on iPhone. "The new capability will empower millions of merchants across the US, from small businesses to large retailers, to use their iPhone to seamlessly and securely accept Apple Pay, contactless credit and debit cards, and other digital wallets through a simple tap to their iPhone - no additional hardware or payment terminals needed," the company said in a statement. Tap to Pay on iPhone will be available for payment platforms and app developers to integrate into their iOS apps and offer as a payment option to their business customers. Stripe will be the first payment platform to offer Tap to Pay on iPhone to their business customers, including the Shopify Point of Sale app this spring. Additional payment platforms and apps will follow later this year, Apple added. The company said that once Tap to Pay on iPhone becomes available, merchants "will be able to unlock contactless payment acceptance through a supporting iOS app on an iPhone XS or later device."
|
ALKT | Hot Stocks10:02 EST First Community Bank implements Alkami Credit Card Origination System - Alkami Technology announced that First Community Bank will implement Alkami's Credit Card Origination System. The new system will help simplify, shorten and improve the bank's online credit card application process for its customers.
|
SYY | Hot Stocks10:02 EST Sysco reaffirms long-term guidance, 'confident' in long-term trajectory
|
SYY | Hot Stocks10:01 EST Sysco sees snap-back investments improving in 2H22
|
ESGC | Hot Stocks10:01 EST Eros STX Global falls -11.9% - Eros STX Global is down -11.9%, or -48c to $3.55.
|
SYY | Hot Stocks10:01 EST Sysco sees exceeding prior view of growth of 1.2x industry in FY22 - Comments taken from Q2 earnings conference call.
|
MFGP | Hot Stocks10:00 EST Micro Focus falls -12.0% - Micro Focus is down -12.0%, or -73c to $5.37.
|
GHM | Hot Stocks10:00 EST Graham falls -25.7% - Graham is down -25.7%, or -$3.02 to $8.75.
|
HAE | Hot Stocks10:00 EST Haemonetics rises 11.3% - Haemonetics is up 11.3%, or $5.30 to $52.27.
|
CEIX | Hot Stocks10:00 EST Consol Energy rises 12.8% - Consol Energy is up 12.8%, or $3.08 to $27.23.
|
TDC | Hot Stocks10:00 EST Teradata rises 17.8% - Teradata is up 17.8%, or $7.16 to $47.44.
|
DCFC | Hot Stocks09:48 EST Tritium announces location of new US manufacturing facility in Tennessee - Earlier today, Tritium DCFC announced plans to expand its footprint in America with a new manufacturing facility in Lebanon, Tennessee. The location is expected to house up to six production lines for Tritium's DC fast chargers, including the Company's award-winning RTM and all-new PKM150 models. All chargers produced at the facility are expected to comply with applicable Buy America Act provisions under Federal Highway Administration, FHWA, requirements for domestic sourcing. The Infrastructure Investment and Jobs Act is expected to provide $7.5B of investment for deploying a network of 500,000 EV chargers along highway corridors in the United States. This network is intended to facilitate long-distance travel, as well as shorter distance travel within communities.
|
BKKT | Hot Stocks09:47 EST Bakkt falls -8.3% - Bakkt is down -8.3%, or -48c to $5.32.
|
EPC | Hot Stocks09:47 EST Edgewell Personal Care falls -9.0% - Edgewell Personal Care is down -9.0%, or -$3.86 to $38.99.
|
MFGP | Hot Stocks09:47 EST Micro Focus falls -11.3% - Micro Focus is down -11.3%, or -69c to $5.41.
|
HAE | Hot Stocks09:47 EST Haemonetics rises 11.2% - Haemonetics is up 11.2%, or $5.27 to $52.24.
|
CEIX | Hot Stocks09:47 EST Consol Energy rises 11.8% - Consol Energy is up 11.8%, or $2.85 to $27.00.
|
TDC | Hot Stocks09:47 EST Teradata rises 13.0% - Teradata is up 13.0%, or $5.22 to $45.50.
|
HOG | Hot Stocks09:43 EST Harley-Davidson says moving to global vs. U.S. pricing mechanism in 2022
|
TFC | Hot Stocks09:40 EST Truist Insurance to acquire Kensingon Vanguard National Land Services - Truist Insurance Holdings announced that it has signed a definitive agreement to acquire Kensington Vanguard National Land Services, one of the country's largest independent full-service national title insurance agencies. The transaction significantly expands Truist Insurance Holdings' presence in the title insurance market. Truist's existing title operation, BridgeTrust Title, will be integrated into the Kensington Vanguard platform. The transaction is expected to close later in the first quarter. The terms of the sale were not disclosed.
|
NVCT | Hot Stocks09:38 EST Nuvectis Pharma Inc trading resumes
|
AMGN | Hot Stocks09:38 EST Amgen sees 2022-2030 revenue growth CAGR in the mid-single digits - Amgen earlier forecast high single to low double digit CAGR for adjusted EPS and non-GAAP operating margin as a percentage of product sales of approximately 50% for the 2022-2030 period.
|
PLSE | Hot Stocks09:37 EST Pulse Biosciences trading resumes
|
NVCT | Hot Stocks09:33 EST Nuvectis Pharma Inc trading halted, volatility trading pause
|
PLSE | Hot Stocks09:32 EST Pulse Biosciences trading halted, volatility trading pause
|
VRS | Hot Stocks09:32 EST Verso files proxy statement in connection with BillerudKorsnas merger agreement - Verso Corporation announced the filing of a definitive proxy statement for a special meeting of stockholders, at which Verso stockholders will consider and vote upon various items related to the proposed and previously announced transaction with BillerudKorsnas AB. If approved, all Verso stockholders will receive $27.00 per share in cash upon closing of the transaction, representing immediate and certain value at a significant premium. The consideration corresponds to a premium of approximately 57% compared to the unaffected closing price of Verso's shares on July 9, 2021, the day prior to the submission of an unsolicited, non-binding proposal to acquire Verso for $20.00 per share in cash, and a 35% premium over that unsolicited proposal. Verso said: "As outlined in the definitive proxy and previously announced, this agreement follows careful consideration and multiple rounds of negotiation led by the Special Committee of our Board which was formed following receipt of the unsolicited proposal. The Board and the Special Committee determined that the BillerudKorsnas offer was clearly superior to any alternative transaction or the risk-adjusted value that could reasonably be achieved through continued execution of Verso's standalone plan and is confident that the proposed transaction is in the best interests of all Verso stockholders."
|
CNHI | Hot Stocks09:31 EST CNH Industrial's Raven Industries awarded $3.6B radar subcontract - Raven Industries announced that Aerostar Technical Solutions has secured a subcontract with a value of $3.6M for products to TCOM L.P. for the KSA Modified Persistent Surveillance Systems - Tethered Large Systems in Saudi Arabia under a Foreign Military Sales program with the U.S. Army. The Sioux Falls, South Dakota-based company will provide its Vista F25 radar systems for the PSS-T system throughout a five-year period of performance with a work completion date of March 23, 2027. A subsequent task order award is anticipated to supply spares, integration support, reach-back support, training and sustainment, the company said in a statement. Raven is a subsidiary of CNH Industrial.
|
MTTR | Hot Stocks09:30 EST Matterport introduces Axis hands-free motor mount - Matterport announced Matterport Axis, a revolutionary motorized mount that works with a smartphone to capture 3D digital twins of any physical space with increased speed, precision, and consistency. This convenient, hands-free solution produces reliable high-fidelity results with just a click of a button. From homes to offices, hotels, rentals, retail locations, even a factory floor, Matterport Axis is the most affordable way to supercharge 3D capture using just the phone in your pocket. With Axis, the company aims to accelerate the digital transformation of the built world by making it effortless for anyone with a smartphone to digitize any kind of space with a new level of precision and ease of use. Starting today, Matterport Axis is available with special pre-launch pricing of just $59, by securing a place on the Axis waitlist at Matterport.com. The official launch date is April 1 when general availability pricing will start at $79. All waitlist sign-ups received by March 31 will qualify for pre-launch pricing, subject to terms and conditions. Matterport has also enlisted its premier e-commerce partners, Adorama and B&H, to bring Matterport Axis to market. The special pre-launch pricing will also be available at both of these websites starting today.
|
HOG | Hot Stocks09:26 EST Harley-Davidson raises quarterly dividend to 15.75c from 15c per share - Yesterday, The Harley-Davidson Board of Directors announced it approved a cash dividend of 15.75c per share for the first quarter of 2022. The dividend is payable March 18 to the shareholders of record of the company's common stock as of February 28.
|
TYL | Hot Stocks09:24 EST Tyler Technologies acquires outdoor technology solutions firm US eDirect - Tyler Technologies announced it has acquired US eDirect, Through this acquisition, Tyler will add US eDirect's Recreation Dynamics product to its digital government and payment services. Recreation Dynamics is a large-scale, enterprise-grade cloud transaction management system focused on the government recreation and tourism industry. Powered by Amazon Web Services , the solution manages transactions related to campground accommodations, tours and events, passes and memberships, recreation rentals, outdoor licenses, and parking and entry. "The acquisition of US eDirect augments our current outdoor solution portfolio, allowing us to offer an extensive 'all in one' outdoor recreation solution that will seamlessly integrate with our NIC payments platform," said Elizabeth Proudfit, president of Tyler's NIC Division. "We look forward to welcoming the US eDirect team into the NIC and Tyler family and building on our 20 years of experience in outdoor recreation with a new comprehensive and scalable solution for our public sector clients." In addition to integrating Recreation Dynamics with Tyler's NIC payments platform, Tyler plans to integrate its Data & Insights platform into the solution. This will bring advanced analytics to the solution, allowing clients to easily digest information and better understand customers' transactions.
|
HOG | Hot Stocks09:24 EST Harley-Davidson anticipates 'strong 2021 momentum' to continue in 2022 - Says remains committed to being at the forefront of electronic motorcycle technology. Says parts and accessories business now a growth driver. Says seeing strong pricing dynamics for new and used cycles. Says expects to execute discretionary share repurchases in 2022. Comments taken from Q4 earnings conference call.
|
MYMD | Hot Stocks09:24 EST MyMD Pharmaceuticals announces MYMD-1 trial data - MyMD Pharmaceuticals announced Phase 1 clinical trial data demonstrating MYMD-1's reduction of tumor necrosis factor-alpha, or TNF-a, the molecules that are the root cause of aging, in the blood of healthy human subjects. In the Phase 1 study, subjects were treated with MYMD-1 or placebo and TNF-a levels were measured pre and post treatment. There was a statistically significant decrease in TNF-alpha levels found in MYMD-1 treated subjects, but no change in the levels in subjects given placebo. While consistent with all of the preclinical studies of MYMD-1, this is the first demonstration in humans of the ability of MYMD-1 to decrease TNF-a levels. MYMD-1's Phase 1 aging data is consistent with outcomes from pre-clinical models pointing to the drug's potential role in reducing both frailty and inflammatory cytokines.
|
VVPR | Hot Stocks09:21 EST VivoPower announces expanded Tembo e-LV development, assembly facility - VivoPower International is pleased to announce that its wholly-owned subsidiary in the Netherlands, Tembo e-LV B.V. will move to an expanded electric light vehicle development and assembly facility in Eindhoven in May 2022. Currently based in Bergeijk, Tembo's e-LV conversion kits transform diesel-powered vehicles into customized and/or ruggedized e-LVs for use in sectors such as mining, resources, infrastructure, construction, and defense. In the past year, Tembo has made significant progress despite COVID disruptions, including signing agreements with distribution partners for e-LV kits across six continents. To accommodate these developments and enable the necessary e-LV development and assembly growth to service its customer base, Tembo will move to an expanded facility located in Eindhoven, the hub of the Dutch automotive industry, on May 1st. This new facility is conveniently located within the Eindhoven international airport precinct and comprises 29,795 square feet of space, a significant increase on Tembo's current facilities of 13,993 square feet. The Eindhoven area features numerous automotive OEMs and related manufacturing businesses. It is home to over 50 percent of the Dutch automotive industry.
|
TURN | Hot Stocks09:19 EST 180 Degree Capital provides update on legacy private portfolio monetization - "Five years ago, we started an effort to remake 180 through the transition from venture capital investments to public company investments," said Kevin M. Rendino, Chief Executive Officer of 180. "Judging from the current asset mix on our balance sheet, our business today has almost no resemblance to the one we inherited and is predominantly cash and public equities. Over the last nine months we have become increasingly optimistic about our ability to monetize our private portfolio, and are pleased with today's announcement by D-Wave and XPOA. This announcement comes shortly after our press release on January 27, 2022, that provided an update on our potential to receive milestone payments from the acquisition of Petra Pharma Corporation by Eli Lilly and Company. If the merger of D-Wave with XPOA is completed, it would be a very significant milestone for 180 and would materially advance our strategy to have 100% of our portfolio in cash and public and public-related equities. Between D-Wave/XPOA, the potential for the $6.8 million milestone payment from the acquisition of Petra, as well as other developments in our legacy private portfolio, we are currently optimistic that we have the potential to see material monetization events from these holdings in 2022."
|
TURN... | Hot Stocks09:19 EST 180 Degree Capital's D-Wave to become public company through DPCM merger - 180 Degree Capital (TURN) noted that D-Wave Systems announced its intent to become a publicly traded company through a merger with DPCM Capital, (XPOA), a special purpose acquisition company. If the transaction is completed as currently agreed to by each party, 180 would hold approximately 900,000 shares of common stock of the merged company. According to D-Wave and XPOA, the transaction is expected to enhance D-Wave's leadership in commercial quantum computing and accelerate quantum use cases into significant customer segments, including manufacturing, logistics, pharmaceuticals, finance, and government. Upon closing of the transaction, shares of D-Wave Quantum Inc., a newly formed parent company of D-Wave and XPOA, are expected to trade on the NYSE under the symbol "QBTS." D-Wave and XPOA stated the transaction values D-Wave at an equity value of approximately $1.2 billion USD. The transaction also includes an innovative incentive structure, whereby a bonus pool of 5 million shares will be allocated pro rata to non-redeeming public stockholders of XPOA, effectively reducing their cost basis. A similar bonus pool of up to 1.8 million shares has been established for Private Investment in Public Equity investors to ensure the same effective cost basis for PIPE investors as for public stockholders of XPOA. D-Wave and XPOA further noted that the transaction, which has been unanimously approved by the Board of Directors of D-Wave as well as the Board of Directors of XPOA, is expected to close in the second quarter of 2022, subject to the satisfaction of customary closing conditions, including the approval of the stockholders of XPOA.
|
EZFL | Hot Stocks09:16 EST EzFill announces new fleet, employment agreement with Florida high school - EzFill announced the signing of a new fleet and employee agreement with Monsignor Edward Pace High School in Miami Gardens, Florida. This agreement adds educational facilities to the growing list of fleet types partnering with EzFill. Furthermore, EzFill will offer gas fueling for teachers and administrators while they are working at the school. "The transportation of students has become increasingly stressful and complicated for school administrators and workers amid the ongoing pandemic. Relying on EzFill to fuel their vehicles will result in one less thing for them to worry about. In a world where we have to be extremely careful about what we touch, we pride ourselves on providing a service that can help drivers as well as consumers add hands-free fueling to their routines," said Mike McConnell, CEO of EzFill. "We plan to partner with additional educational institutions in the near future, allowing their drivers and staff to operate more efficiently by eliminating the downtime associated with refueling."
|
NVCN | Hot Stocks09:13 EST Neovasc announces German reimbursement renewal, commercial progress - Neovasc announced the German Institute for the Hospital Remuneration System has awarded the Neovasc Reducer, a CE-Marked medical device for the treatment of refractory angina, NUB Status 1 designation yet again for 2022. Additionally, the Company announced the 500th patient has been treated in Germany. New examination and treatment methods, NUBs, are comprised of novel and innovative medicines, medical products and procedures that can be utilized by hospitals before reaching full reimbursement eligibility. Reducer has been granted Status 1 - the highest priority designation available. The NUB decision is valid for one year and can be renewed annually. For 2022, 256 German hospitals applied for the Reducer NUB, and they can now negotiate full reimbursement coverage for the Reducer therapy. "Our team has been focused on securing broad reimbursement coverage for Reducer so more patients can benefit from the therapy," commented Fred Colen, Chief Executive Officer of Neovasc. "Obtaining NUB Status 1 for 2022 from the German reimbursement authorities is a vital component of our overall strategy. In the past several quarters, we have had significant reimbursement wins in Germany, France, the U.K., and the United States. These reimbursement expansions are a testament to the profound impact that the Reducer can have on patients."
|
FLYW | Hot Stocks09:11 EST Flywire partners with Ascensus to digitize 529 college savings plan payments - Flywire and Ascensus announced a partnership to digitize and streamline tuition payments from 529 college savings plans to higher education institutions throughout the United States. Through the partnership, families saving in a 529 plan on the Ascensus platform can leverage Flywire to disburse funds to pay tuition-related expenses directly to the school from their 529 account. This Ascensus-Flywire solution takes aim at the complexity of 529 payments to schools via checks, which can be difficult for institutions to process and reconcile.The partnership between Flywire and Ascensus eliminates these legacy inefficiencies and provides a completely digital path to payment and reconciliation for 529 plan withdrawals. "As 529 plans continue to rise in popularity, our clients have been asking us for a solution that would take away so many of the current pain points related to the disbursement of payments," said Sharon Butler, EVP of Education, Flywire. "We couldn't ask for a better partner than Ascensus, who manages 529 programs for 25 states and the District of Columbia, and we're thrilled to partner with them to roll out an innovative solution that will help both families and institutions."
|
EXPI | Hot Stocks09:10 EST eXp World's eXp Realty opens brokerage operations in Dominican Republic - eXp Realty, the core subsidiary of eXp World Holdings, has expanded into the Dominican Republic. eXp Realty now operates in 19 countries with over 73,000 agents around the world. eXp's real estate brokerage operations in the Dominican Republic will be led by Marbel Lugo. "As we continue to gain traction in the Caribbean and Latin American markets, we have had significant interest from agents in the Dominican Republic and feel it's a perfect next step in expanding our footprint," said Michael Valdes, President of eXp Global who is responsible for eXp Realty's worldwide expansion. "With a strong residential property market driven by tourism, easy international access and attractive incentives for foreign investment, the Dominican Republic is an ideal market to expand our growing brand." The Dominican Republic represents the first of three markets that eXp Global has identified for expansion in the first quarter of 2022. Greece and New Zealand are slated to open later in the quarter.
|
NWVCF | Hot Stocks09:10 EST EnWave announces U.S. patent for cannabis drying process - EnWave Corporation announced that the U.S. Patent and Trademark Office has granted the Company a new method and apparatus patent for the drying and decontamination of cannabis using its Radiant Energy Vacuum advanced dehydration technology. This new patent further strengthens EnWave's intellectual property protection of its method of reducing bioburden in cannabis while concurrently achieving fast, uniform drying. EnWave's newly patented process uses proven parameters, including power density and vacuum conditions that vary throughout the process, to optimize terpene and cannabinoid retention and materially reduce bioburden. The original patent application was filed in 2017. EnWave has successfully commercialized its proprietary drying technology with large cannabis operators in the United States and Canada, with three large-scale machines being sold to multi-state and single state operators in the U.S. within the past year. EnWave collaborates closely with cannabis producers to optimize drying protocols and programs to maximize the quality of finished dried products and optimize the return on investment achieved using REV technology. In contrast to the traditional drying methods, EnWave's proprietary REV process allows for the drying of cannabis in the absence of oxygen, at low and controlled temperatures, resulting in a fresh-to-dry processing time of less than 2 hours. Since REV rapidly dries cannabis in a controlled environment the plants can be dried before bioburden and microbes can propagate. REV technology offers an improved method for reducing the bioburden of cannabis and avoids the drawbacks of traditional decontamination methods. EnWave's proprietary processing methods allow cannabis cultivators to rapidly process high volumes of plant material and eliminate unnecessary costs and time associated with traditional drying methods. EnWave's vacuum-microwave dehydration technology is protected by a portfolio of 18 various apparatus and process patents.
|
PTON | Hot Stocks09:09 EST Peloton: Marketing 'critical to success going forward'
|
HUM | Hot Stocks09:08 EST Humana expands access to new cancer treatment options - Humana Specialty Pharmacy has announced two significant additions to its comprehensive, personalized and targeted oncology therapies. Patients can now receive the following drugs, delivered to their front doors in a fast and meaningful way, while Humana Specialty Pharmacy supports them along their journey: TAGRISSO, osimertinib, a drug that helps certain patients with epidermal growth factor receptor-mutated EGFRm non-small cell lung cancer NSCLC manage their disease. LENVIMA, lenvatinib, a drug that helps patients with different forms of cancer, including certain types of thyroid, liver and kidney cancers. Patients who receive TAGRISSO and LENVIMA from Humana Specialty Pharmacy also benefit from its Oncology Center of Excellence where Humana Specialty Pharmacy patient advocates and specialty pharmacists are available to provide invaluable treatment guidance, including help with managing daily symptoms, assistance on how and when to take medications, and any other questions they may have with respect to staying on their therapy.
|
MRCY | Hot Stocks09:07 EST Mercury Systems board of directors implements equity retention plan - Mercury Systems announced the implementation of an equity retention plan for certain Mercury employees whose continuing efforts are critical to the Company's success. The plan is intended to recognize the recipients' substantial contributions, to retain and motivate the recipients in the current challenging industry environment and labor market, and to reinforce the alignment of the recipients' interests with the Company's shareholders. Mercury's Board of Directors approved the equity retention plan at the recommendation of the Company's Human Capital and Compensation Committee, after consultation with its independent compensation consultant, on February 7, 2022. "Mercury is exceptionally well-positioned at the intersection of the high-tech and defense industries, and our Board and management team have great confidence in Mercury's ability to deliver enhanced value to our stakeholders," said William O'Brien, Chairman of Mercury's Board of Directors. "After careful consideration of a range of retention options for our executive leadership team and over 100 additional leaders, the Board approved this plan as a key element in our ongoing efforts to build on Mercury's strong foundation and drive the next phase of value creation at a greater scale. The Board believes that implementing this plan is in the best interests of all shareholders."
|
COCO | Hot Stocks09:06 EST Vita Coco announces pilot launch of The Hangover Shop - Vita Coco is here to tackle your Monday morning hangover the day after the Big Game with the pilot launch of The Hangover Shop on all major delivery platforms in New York City, Los Angeles and Miami. On February 14, Vita Coco is teaming up with REEF Kitchens to launch The Hangover Shop, your one-stop-shop for everything you need to remedy your hangover and get back on track. Consumers can shop for their go-to hangover recovery items, including Advil, DiGiorno frozen pizza, Vita Coco and more, from the comfort of their couch and expect deliveries to their doorstep within minutes. To order from The Hangover Shop, residents within the set delivery radius in New York City, Los Angeles and Miami can open any major delivery app, including DoorDash, Postmates, UberEats and GrubHub, on iOS or Android, and search The Hangover Shop, or visit thehangover.shop. For a limited time, customers will receive $5 off their purchase of $25 or more. Vita Coco's first-of-its-kind The Hangover Subscription is also available nationwide, giving consumers the ability to enroll in automatic deliveries of coconut water ten days prior to the Big Game and all major holidays. The customized plan gives you a choice of coconut water and provides you with a free gift based on your hangover mood with your first shipment.
|
FBMS | Hot Stocks09:06 EST First Bancshares announces renewal of share repurchase plan - The First Bancshares announced the renewal of its share repurchase program that previously expired on December 31. Under the program, the Company may, but is not required to, from time to time repurchase up to $30M of shares of its common stock in any manner determined appropriate by the Company's management. The actual timing and method of any purchases, the target number of shares and the maximum price under the program, will be determined by management at its discretion and will depend on a number of factors, including the market price of the Company's common stock, general market and economic conditions, and applicable legal and regulatory requirements. The renewed share repurchase program has an expiration date of December 31.
|
DPDW | Hot Stocks09:06 EST Deep Down receives $1.7M equipment, services order - Deep Down announced the receipt of an order for installation equipment and services valued at more than $1.7M. All activities are currently scheduled to be complete by the end of 2022. The project includes the installation of Deep Down built equipment whose final destination is the Gulf of Mexico. "This award highlights the continued confidence our customers place in our team's ability to provide integrated solutions that span the design, engineering, manufacturing and installation of subsea production equipment," said Charles Njuguna, president and CEO of Deep Down, Inc. "With the easing of travel restrictions across the globe, we maintain the ability to deploy our highly experienced teams anywhere in the world in support of our customers' projects," he added.
|
PTON | Hot Stocks09:05 EST Peloton expects to see considerably stronger cash flow tailwind in FY23
|
TBLA | Hot Stocks09:05 EST Taboola signs AP to three-year deal to power recommendations, reader insights - Taboola announced a new deal with The Associated Press, AP, an independent global news organization dedicated. This new agreement marks seven years that Taboola and AP have worked together. "The AP is one of the world's fastest and most accurate news sources," said Adam Singolda, CEO at Taboola. "Their journalism approach has high standards and we are grateful to mutually grow together over the past seven years. We are also grateful for their trust in our ability to keep audiences engaged and in our data to power nearly every aspect of their high caliber journalism-from ideation to validation."
|
CPHC | Hot Stocks09:05 EST Canterbury Park announces amphitheater development for Canterbury Commons - Canterbury Park Holding Corporation announced two new proposed development projects that will respectively elevate the entertainment experience at the property and significantly strengthen the Company's horse racing operations. One project includes the Company's agreement to sell approximately 40 acres in the northeast corner of the property to Minneapolis-based Swervo Development Corporation , which plans to build a state-of-the-art 19,000-seat amphitheater as part of the Canterbury Commons development, subject to state and local regulatory approvals. Pending approval of the amphitheater development, Canterbury also plans to invest in significant improvements to its horse stabling area. This multi-million dollar barn area redevelopment project will continue the Company's ongoing commitment to provide quality horse racing in the state of Minnesota as well as allow for future development of Canterbury's underutilized land.
|
NMTC | Hot Stocks09:04 EST NeuroOne completes testing on its platform thin film electrode technology - NeuroOne Medical Technologies announced that it successfully completed initial pre-clinical long-term testing of recording capabilities on its platform thin film electrode technology. In test procedures, the electrodes' ability to record electrical activity over a span of 5 years was measured using an accelerated aging test model. The test results demonstrated NeuroOne's thin film electrodes' reliability against environmental factors that may contribute to device failure or malfunction, which is a well-established challenge with thin film electrode technology. The Company also expects to release long-term data in the near future on electrodes that would provide therapeutic stimulation for the same applications mentioned earlier.
|
KTOS | Hot Stocks09:03 EST Kratos Defense receives $50M contract value increase - Kratos Defense & Security Solutions announced that it has recently received an approximately $50 million contract value increase for an existing Command, Control, Communications, Computing, Combat System and Intelligence, Surveillance and Reconnaissance Program. Under this Program, Kratos is providing specialized products, hardware, engineering and other services and deliverables. Kratos C5ISR business manufactures and provides specialty hardware, products and systems in support of certain of the United States and its Allies most important and Mission Critical National Security programs, including Unmanned Aerial Drone systems, Missile & Radar Systems, High Power, Directed Energy and Hypersonic Systems, Naval Combatant and Space and Satellite Communication Systems. Work under this program is being performed at secure Kratos and customer manufacturing facilities and locations. Due to customer, competitive, security related and other considerations, no additional information will be provided related to this National Security related Program.
|
NN | Hot Stocks09:03 EST NextNav partners with CRG to strengthen mapping for emergency response - NextNav announced that it has partnered with Critical Response Group, CRG, a provider of best-in-class indoor and tactical mapping solutions for public safety. By leveraging NextNav Pinnacle, CRG will strengthen its mapping capabilities. "The integration of the NextNav Pinnacle will strengthen existing and new building surveys with critical vertical location data, and help ensure that each building has the proper preparations and protocols in place to aid emergency response," the company said. "Working with CRG, we're strengthening preparedness and situational awareness at every step of the emergency response cycle," said Dan Hight, Vice President of Business Development and Partnerships at NextNav. "This partnership continues our efforts to leverage the use of NextNav Pinnacle in 3D and indoor mapping and builds on our deep legacy in helping service the public safety community. It also continues the growing adoption of vertical location capabilities by the enterprise to support use-cases in building management, lone-worker tracking, smart building initiatives, and digital twins."
|
AMIH | Hot Stocks09:03 EST American International Holdings engages RedChip to lead IR efforts - American International Holdings is pleased to announce that it has engaged RedChip Companies to lead its investor relations efforts.
|
DE | Hot Stocks09:01 EST Deere acquires majority in Kreisel Electric - Deere & Company has acquired majority ownership in Kreisel Electric, a leading pioneer in the development of immersion-cooled battery technology. The Austrian company manufactures high-density, high-durability electric battery modules and packs for high-performance and off-highway applications and has created a battery-buffered, high-powered charging infrastructure platform.
|
WKEY | Hot Stocks08:59 EST WISeKey announces latest NFTs exhibits in Times Square - WISeKey International Holding announced its latest NFTs exhibits of the artist Pedro Sandoval, The announcement of the exhibition can also be seen on the screens of the tower of the emblematic NASDAQ building, located in Times Square, this week. The exhibition marks the official USA roadshow of the WISe.ART Marketplace, which, through technology blockchain provides a secure record of digital operations without the intermediation of third parties, guarantees authenticated and signed versions of these assets, in addition to managing their sale.
|
PTON | Hot Stocks08:59 EST Peloton does not expect to rely on capital market going forward
|
PTON | Hot Stocks08:57 EST Peloton still expects to be dominant category leader going forward
|
HOG | Hot Stocks08:57 EST Harley-Davidson sees 2022 tariff rates 'relatively stable annually' - Outlook in 2022: For tariffs, duties and logistics: Rates relatively stable annually; increased frequency of expedited shipping given supply chain backlogs; expect logistics to improve in the back half of the year. For manufacturing: Expect to stabilize in the back-half of the year, as logistics and part availability improves. For materials: Continued inflation across the supply network; expect improvement in back-half driven by raw materials. Expect semi-conductor chip availability to remain challenged, with moderate improvement in latter half of year. Comments taken from investor presentation slides for Q4.
|
PTON | Hot Stocks08:53 EST Peloton now sees FY22 CapEx spend $350M
|
PTON | Hot Stocks08:52 EST Peloton sees 2H operating expense $150M lower than 1H
|
FOUN RBT | Hot Stocks08:52 EST Rubicon Technologies enters nationwide technology agreement with Odakyu - Rubicon Technologies announced that its targeted pilot with Odakyu Electric Railway has successfully transitioned into a long-term, nationwide technology licensing agreement focused on supporting the Japanese waste and recycling industry as it moves towards a more integrated circular economy. This new long-term, nationwide agreement will continue to allow Odakyu to deploy Rubicon's technology in order to promote sustainable waste solutions across Japan. In its current form, the partnership is primarily focused on helping city governments implement environmental and circular economy practices.
|
NCLH | Hot Stocks08:50 EST Norwegian Cruise Line sees net loss for Q4, FY21 - The company said, "While we cannot estimate the impact of the COVID-19 pandemic on our business, financial condition or near- or longer-term financial or operational results with certainty, we will report a net loss for the fourth quarter and full year ending December 31, 2021 and expect to report a net loss until we are able to resume regular voyages. As a result of Omicron variant-related impacts to operations in the first quarter of 2022, we now expect net cash provided by operating activities to be positive during the second quarter of 2022. Despite the impact of the Omicron variant on the booking environment, and based on our current projections and market and public health conditions, we expect to have positive Adjusted Net Income for the second half of 2022."
|
NCLH | Hot Stocks08:49 EST Norwegian Cruise Line reports Q4 monthly average cash burn $345M - The company said, "We continue to take proactive measures to enhance liquidity and financial flexibility in the current environment. As of September 30, 2021, our total debt position was $12.4 billion and our liquidity, consisting of cash and cash equivalents and short-term investments, was $1.9 billion. We have taken the following additional actions to enhance our liquidity profile and financial flexibility since September 30, 2021: In November 2021, NCL Corporation entered into a $1.0 billion commitment through August 15, 2022 that provides additional liquidity to the Company. If drawn, this commitment will convert into an unsecured note maturing in April 2024. The Company has not drawn and currently does not intend to draw under this commitment. In November 2021, NCLC issued $1.15 billion aggregate principal amount of 1.125% Exchangeable Senior Notes due 2027 which includes the full exercise of the initial purchasers' greenshoe option. The initial exchange rate per $1,000 principal amount of 2027 Exchangeable Notes is 29.6850 ordinary shares, which is equivalent to an initial exchange price of approximately $33.69 per ordinary share, subject to adjustment in certain circumstances. In November 2021, we repurchased $715.9 million aggregate principal amount of our 6.00% Exchangeable Senior Notes due 2024 for approximately $1.4 billion. In November 2021, the Company issued 46,858,854 ordinary shares to certain holders of the 2024 Exchangeable Notes in a registered direct offering. The proceeds of such offering were used to redeem $236.25 million aggregate principal amount of our 12.25% Senior Secured Notes due 2024 and $262.50 million aggregate principal amount of our 10.250% Senior Secured Notes due 2026, including any accrued but unpaid interest thereon, to pay related premiums, fees and expenses and for general corporate purposes, including the repurchase of a portion of the 2024 Exchangeable Notes. Our monthly average cash burn for the fourth quarter of 2021 was approximately $345 million, slightly lower than our prior estimate of $350 million for the fourth quarter of 2021. The cash burn rate includes ongoing ship operating expenses, administrative operating expenses, interest expense, taxes, debt deferral fees and non-newbuild capital expenditures and excludes cash refunds of customer deposits as well as cash inflows from new and existing bookings, newbuild related capital expenditures and other working capital changes."
|
NCLH | Hot Stocks08:48 EST Norwegian Cruise says cumulative booked position for 1H22 below 2019 levels - The company said, "Net booking volumes in the beginning of the fourth quarter of 2021 continued to demonstrate week-over-week sequential growth after the slowdown in booking activity caused by the Delta variant of COVID-19. Net booking volumes in the later part of the fourth quarter 2021 were negatively impacted by the Omicron variant of COVID-19, primarily for close-in voyages in the first and second quarters of 2022. In recent weeks, net booking volumes have continued to improve sequentially. As a result of the impacts from Omicron, as of February 6, 2022, the Company's cumulative booked position for the first half of 2022 is below the extraordinarily strong levels of 2019 while the second half, when the full fleet is expected to be back in operation, is in line with the comparable 2019 period. Concurrently, pricing for the first half, second half and full year 2022 are above the record levels for the same time in 2019, even when including the dilutive impact of future cruise credits. Booking trends for 2023 demonstrate continued strong demand for sailings in the medium and longer term with booked position and pricing meaningfully higher and at record levels when compared to 2019."
|
NCLH | Hot Stocks08:46 EST Norwegian Cruise expects to have 85% of berth capacity operating by end of Q1 - Norwegian Cruise Line Holdings provided a business update on the impacts of COVID-19 and its continued resumption of cruise operations. The company said, "In the third quarter of 2021, we began a phased relaunch of certain cruise voyages with ships initially operating at reduced occupancy levels. By the end of the third quarter, we operated vessels totaling approximately 40% of our berth capacity. Beginning in December 2021, the spread of the Omicron variant of COVID-19, with its increased transmissibility, caused several operational challenges and disruptions, including new travel restrictions and increased protocols in ports of call limiting port availability, which led to the cancellation of certain voyages in the fourth quarter of 2021 and first quarter of 2022, and the postponement of the restart of certain vessels. As of the date hereof, 16 of our 28 ships, or 70% of our berth capacity, are operating with guests on board. This excludes a vessel which was paused from service beginning December 2021 due to the cancellation of its South Africa and related itineraries as a result of travel restrictions and other operational challenges due to the Omicron variant. We expect to have approximately 85% of berth capacity operating by the end of the first quarter of 2022 with the full fleet expected to be back in operation during the early part of the second quarter of 2022. On January 14, 2022, we announced that our three brands have opted into the U.S. Centers for Disease Control and Prevention's COVID-19 Program for Cruise Ships Operating in U.S. Waters, the agency's voluntary COVID-19 risk mitigation program for foreign-flagged cruise ships operating in U.S. waters. The Program was announced in connection with the expiration of the Temporary Extension and Modification of Framework for Conditional Sailing Order on January 15, 2022, and we await the release of additional information about the Program from the CDC. In addition, as part of our SailSAFE health and safety program, our SailSAFE Global Health and Wellness Council, chaired by former head of the U.S. Food and Drug Administration, Dr. Scott Gottlieb, continues to advise the Company on health and safety protocols in light of advancements in medicine and technology."
|
PTON | Hot Stocks08:42 EST Peloton: Engagement levels 'very healthy'
|
CUEN | Hot Stocks08:41 EST Cuentas appoints Hugh Meadows as COO - Cuentas named Hugh Meadows as COO. He joins Cuentas after serving as COO at Great America Bank, among other key executive leadership roles.
|
AMGN | Hot Stocks08:39 EST Amgen sees 2022 share repurchases of $6B-$7B - Plans to buy back up to $6B of its shares during the first quarter of 2022.
|
UFAB | Hot Stocks08:39 EST Unique Fabricating announces Michigan facility secures Q1 certification - Unique Fabricating announced that its Auburn Hills, Michigan facility has met the requirements of Q1 certification, effective January 26, 2022. "As Unique Fabricating has always been committed to the highest customer service levels including quality and on-time delivery especially in these very challenging times, receiving Ford's Q1 certification validates our efforts," commented Doug Cain, president and CEO of Unique Fabricating. "The team at our Auburn Hills facility worked tirelessly over many months to meet these stringent requirements. We are in the process of securing Q1 certification at our facilities in Queretaro, Mexico and then LaFayette, Georgia, to further bolster our relationship with Ford and strengthen our ability to win business with various automakers."
|
VLTA | Hot Stocks08:38 EST Volta expand with new deals in Switzerland, Germany, France - Volta provided an update on its activities in key European markets, highlighting new contracts for the installation of DC Fast and AC charging stations in the region, and the inaugural installation of Volta stalls at a retail location in France. Volta has signed partnership deals with the global sporting goods chain Decathlon, starting in St. Gallen, Switzerland, and the movie theatre company Cineplex Group in Germany. Volta also recently celebrated the installation of its first charging stations in France at the popular restaurant Key West near Annecy. The company will continue to work with commercial properties and retail locations to bring charging stations to additional sites in Europe in the coming months.
|
VEV | Hot Stocks08:36 EST Vicinity Motor receives C$2.57M grant from SDTC - Vicinity Motor announced the receipt of an initial C$2.57M grant from Sustainable Development Technology Canada, or SDTC, a foundation created by the Canadian government, for the development of zero-emission transit busses. SDTC helps Canadian entrepreneurs accelerate the development and deployment of globally competitive clean technology solutions. The non-repayable grant from SDTC will help Vicinity Motor to introduce its new all-electric, true low-floor wheelchair-accessible, mid-sized, medium-duty bus.
|
STRM | Hot Stocks08:36 EST Streamline Health's Avelead announces expansion of leadership team - Avelead, a Streamline Health Company, announced the expansion of its leadership team to include Sean Sykes, Chief Technology Officer, and Michael Yzerman, Senior Vice President of Services. Prior to joining Avelead, Sean Sykes was Vice President of Technology at Hospice Source. In his previous role, Michael Yzerman acted as Executive Vice President of a national healthcare services company.
|
ITI | Hot Stocks08:35 EST Iteris picked by Kane County DOT for 'smart mobility, safety sustainability' - Iteris announced that it has been selected by the Kane County Department of Transportation, Kane County DOT, for a smart mobility, safety and sustainability program, representing continued demand for Iteris' specialized consulting services, cloud-enabled managed services and software-as-a-service solutions in a key geographic market. Under the terms of the three-year contract, Iteris will provide transportation system operations and management services that include management and operational oversight at approximately 140 signalized intersections and flashing beacon locations, 1,200 street light locations, as well as the county's growing centrally controlled advanced traffic management system network.
|
INSE GAN | Hot Stocks08:35 EST Inspired Entertainment launches igaming content with Gan Limited in Michigan - Inspired Entertainment (INSE) announced that its popular online gaming content has gone live in Michigan with GAN Limited (GAN), a full-service internet gaming software-as-a-service provider to the real money internet gaming, online sports betting, and simulated gaming industries. GAN is the latest content aggregation platform to deploy Inspired's unique online gaming content, giving Inspired access to GAN's extensive operator network in multiple U.S. states.
|
PTON | Hot Stocks08:35 EST Peloton's Foley: 'I love Peloton, role we play in connecting world to fitness' - "We have made missteps along the way," Foley said. Comments taken from Q2 earnings conference call.
|
BRFH | Hot Stocks08:33 EST Barfresh Food Group enters distribution agreement with G&J Pepsi-Cola Bottlers - Barfresh Food Group announced it has entered into a distribution arrangement with G&J Pepsi-Cola Bottlers. The arrangement is the result of a pilot program between the two companies whereby G&J Pepsi successfully tested the operational capability of its distribution network to sell and handle Barfresh product, as well as measured customer feedback to the product. Under the distribution arrangement, G&J Pepsi will purchase Barfresh's Twist & Go product and distribute it to its customers through its chilled distribution network. Riccardo Delle Coste, the Company's Chief Executive Officer, stated, "Barfresh has been able to attract top-tier distributors looking to add our excellent products to their lineup. G&J Pepsi works with over 30 of the best global beverage brands and we are excited to have successfully moved from a pilot program to a full rollout with their customers. Pepsi products are in almost every type of retail account in the United States, including schools, and we believe this arrangement will create incredible value for G&J Pepsi with the addition of Barfresh's Twist & Go product."
|
MYSZ AMZN | Hot Stocks08:33 EST My Size acquires Orgad e-commerce platform for $1M - MySize (MYSZ) announced that it has acquired Orgad, an omnichannel e-commerce platform. Orgad is headquartered in Israel and operates globally, including the U.S. and Europe. Orgad generated approximately $2.5M in revenue in 2021 with profitable operations. Its team consists of solid operators with deep understanding and knowledge in e-commerce, supply chain and technology. Orgad's focus on technology, operations and customer service to increase efficiencies and revenue growth is structured on a platform that is able to manage numerous retailers. Additionally, Orgad will integrate MySizeID into its digital offerings and platform. Incorporating MySizeID into Orgad's e-commerce solution is expected to increase its operational profit by reducing costly returns. Under the transaction terms, MySize agreed to pay to the Orgad sellers cash consideration of up to $1M in 3 installments over a period of 3 years, equity consideration of up to 2,790,049 shares of MySize common stock, and certain earn-out payments upon meeting revenue targets, subject in each case to the sellers being engaged with Orgad at the time each payment is due and subject further to post-closing adjustment. Ronen Luzon, CEO of MySize, commented, "The Orgad team has built a strong business as a direct seller of clothing and footwear globally on Amazon.com (AMZN), eBay and elsewhere. By using MySize technology Orgad will be able to increase its profitability by increasing conversion rates and reducing costly returns, which also improves their sustainability."
|
DTGI | Hot Stocks08:33 EST Digerati Technologies closes acquisition of NextLevel Internet - Digerati Technologies is pleased to announce the completion of the acquisition of San Diego-based NextLevel Internet, a leading provider of cloud communication and broadband solutions tailored for the SMB market. The acquisition of NextLevel expands the Company's growing nationwide footprint and adds a strong West Coast presence with nearly 1,000 SMB clients in California. On a consolidated basis and as a result of this acquisition, Digerati's operating subsidiaries will now serve over 4,000 business customers and approximately 45,000 users. With the acquisition of NextLevel and based upon annualized results for the quarter ending October 31, 2021, the Company expects its operating subsidiaries in the aggregate will generate approximately $31.5 million in annual revenue. In addition, the NextLevel acquisition is expected to have a positive impact on the consolidated EBITDA and operating income of the Company during FY2022. Digerati also announced that Derek M. Gietzen, current President of NextLevel, will remain in that role with the Company and join the Digerati Executive Management Team.
|
XELA | Hot Stocks08:32 EST Exela Technologies announces purchase of headquarters in Ireland - Exela Technologies announces it purchased a standalone multi-level, 25,000 square foot headquarters in Dublin, Ireland. This purchase takes advantage of the value post-Brexit opportunities have provided allowing Exela to acquire a space formerly leased. The investment is also a path to expand services in the Irish payment space. "For nearly ten years, Exela has offered a utility framework approach to the leading Irish banks by processing and clearing all domestic and cross border cheque payments. The service has grown to over 80% market share in Ireland with our close partnership with the Bank of Ireland, Allied Irish Bank, PTSB and Danske Bank and we aim to continue growing," noted Vitalie Robu, President of EMEA
|
RSI | Hot Stocks08:32 EST Rush Street's BetRivers Sportsbook is official partner of New Orleans Pelicans - Rush Street Interactive announced that its award-winning BetRivers Sportsbook is an official partner of the New Orleans Pelicans.To demonstrate RSI's support for Louisiana's NBA team, BetRivers signage appears throughout the Smoothie King Center including the front row of courtside seats. The exclusive Chairman's Club, for courtside ticket holders, has been rebranded to become the BetRivers Chairman Lounge and updated with live odds boards
|
PTON | Hot Stocks08:28 EST Blackwells urges Peloton board to initiate strategic alternatives process - Blackwells Capital LLC, an alternative investment management firm that is a significant shareholder of Peloton Interactive, yesterday sent the Peloton Board of Directors a comprehensive presentation outlining the need for immediate change in leadership and demand for the Board of Directors to initiate a strategic alternatives process to maximize value for the benefit of all shareholders. In response to this morning's reports of leadership changes at the company, Jason Aintabi, Chief Investment Officer of Blackwells, said, "Peloton CEO John Foley naming himself Executive Chairman and hiring a new CFO does not address any of Peloton investors' concerns. Mr. Foley has proven he is not suited to lead Peloton, whether as CEO or Executive Chair, and he should not be hand-picking directors, as he appears to have done today." Blackwells also disclosed that yesterday it exercised its rights to review the books and records of Peloton Interactive, Inc. in a request made to the company, pursuant to Section 220 of the Delaware General Corporation Law. Blackwells intends to determine whether the lack of effective oversight at the company was the direct result of the company's dual-class share structure, which may have precluded independent directors from exercising their fiduciary duties to the company's Class A common stockholders.
|
RAIL | Hot Stocks08:23 EST FreightCar America expects to deliver between 2,350-2,650 railcars in 2022 - Strategic Priorities for Fiscal Year 2022: Deliver between 2,350 - 2,650 railcars, an increase of over 44% compared to fiscal 2021 at the midpoint of the range; Achieve positive Adjusted EBITDA for the full fiscal year, based on the current market outlook; Complete construction of a 162,000 square foot fabrication shop and expansion of the existing wheel and axle shop by mid-year 2022 to achieve substantial additional operational efficiencies; Complete construction of additional production lines, doubling annual capacity to between 4,000 - 5,000 railcars by early 2023. "I am very proud of our team's accomplishments and hard work to transform the company," said Jim Meyer, President and Chief Executive Officer of FreightCar America. "We finished building a strong foundation in 2021 and now have a company that is positioned for growth. 2022 will be the first year for which our operations and results will not be obscured by restructuring activities. As such, we believe that our performance this year will provide more clarity on the full potential of FreightCar America. We achieved what we intended to accomplish in 2021, are excited about the near-term, and are highly confident that we have built a company poised for growth and a strong future."
|
RAIL | Hot Stocks08:23 EST FreightCar America books 1,032 new railcar orders duting Q4 - FreightCar America announced that it will host a special update call for investors later today during which management will outline the strategic direction of the business, provide a brief overview of 2021 and preview the Company's priorities and outlook for 2022. As previously reported, FreightCar America's fourth quarter and full year 2021 results will be issued on March 22, 2022. 2021 Strategic and Financial Successes: Completed the transition of the Company's railcar manufacturing operations to Castanos, Mexico, making it the only railcar manufacturer serving the North American markets with production exclusively in Mexico; In the fourth quarter 2021, achieved fifth consecutive quarter of positive gross margin, third consecutive quarter of positive manufacturing operating income, and first quarter of positive Adjusted EBITDA at the Castanos facility; Company reaffirms its ability to achieve positive Adjusted EBITDA under normal business conditions at volume levels of 2,000 units per year; Achieved annual fixed cost savings of approximately $20 million and labor cost savings of more than 60%, on average, compared to the prior U.S.-based footprint; Total railcar deliveries increased 130% versus 2020, with the large majority produced at the Castanos facility; Booked 1,032 new railcar orders during the fourth quarter 2021, supporting previously announced plans to expand the Castanos facility; Finished 2021 with total cash, cash equivalents, restricted cash equivalents, marketable securities and restricted certificates of deposit of $26.2 million, and total liquidity of over $40 million, including the new Deferred Draw Loan that closed in December 2021; Company on track to receive the majority of its Mexican value-added tax receivable in 2022, which was $31.1 million at year-end.
|
PRO MSFT | Hot Stocks08:23 EST Pros Holdings extends collaboration with Microsoft - Pros Holdings announced a five-year strategic alliances agreement with Microsoft as an extension to its existing relationship. The go-to-market agreement accelerates mass market adoption of true end-to-end digital selling technology and strategies. Additionally, Pros will also address next-generation digital selling use cases defined by Microsoft Industry Solutions, including the latest vertical cloud, Microsoft Cloud for Manufacturing.
|
PALI | Hot Stocks08:21 EST Palisade Bio to announces adhesions clinical data at SAGES 2022 meeting - Palisade Bio announced that data from a Pooled-Analysis of Studies LBS-IST-POI-101 and LBS-POI-201-CN, PROFILE-CN, has been selected for a presentation in The Next Big Thing session of the Society of American Gastrointestinal and Endoscopic Surgeons, SAGES, 2022 Annual Meeting. The title of the presentation is Incidence and Severity of Post-Surgical Intraabdominal Adhesions following Bowel Resection Surgery and Treatment with Enteral Protease Inhibitor LB1148. Studies LBS-IST-POI-101 and LBS-POI-201-CN assessed the efficacy of LB1148 to reduce the formation of adhesions in subjects undergoing abdominal surgery. Study LBS-IST-POI-101 was a Phase 1, single-center, open-label, study enrolling 11 subjects undergoing GI surgery. The PROFILE-CN study was a 120-subject Phase 2, randomized, double-blind, placebo-controlled study conducted in collaboration with co-development partner, Newsoara Biopharma to evaluate LB1148 for return of GI function in subjects undergoing elective bowel resection.
|
RAIN... | Hot Stocks08:21 EST Rain Therapeutics announces key appointments to leadership team - Rain Therapeutics (RAIN) announced the appointments of several industry veterans to the leadership team, including: Nora Ku, MD, Vice President of Clinical Development; Buenaflor Nicolas, MPH, Vice President, Head of Global Drug Safety and Pharmacovigilance; Tina Kim-Hafken, MS, Vice President and Head of Global Regulatory Affairs; Steve Flint, SHRM, MBA, Vice President of People & Culture. Additionally, Rain announced that John Maraganore, Ph.D., former founding CEO of Alnylam and biotechnology industry veteran, has served as a Special Advisor to Rain's Chief Executive Officer, Avanish Vellanki, and the leadership team since March 2021. Biographical Information for Additions to Leadership Team: Dr. Ku served as Vice President of Medical at Loxo/Lilly (LLY). Nicolas was Senior Director of Operations in Global Patient Safety at Gilead (GILD), following its acquisition of Forty Seven. Kim-Hafken was Senior Director of Regulatory Affairs at Seagen (SGEN). Flint served as Vice President of Human Resources at AltruBio. Dr. Maraganore served as founding Chief Executive Officer of Alnylam Pharmaceuticals for 20 years (ALNY).
|
GRUB | Hot Stocks08:19 EST Just Eat Takeaway to voluntarily delist ADRs from Nasdaq - Further to its previous announcements on 12 January 2021 and 15 July 2021, the company has progressed its review to determine optimal listing venues. As part of this review, the company has considered, amongst other things, the liquidity and trading volumes across its listings in Amsterdam, London and New York. Pursuant to this review, the company announces that it has formally notified The Nasdaq Stock Market of its intent to voluntarily delist its American Depositary Receipts from the Nasdaq Global Select Market. The company currently expects to file a Form 25 with the SEC of the United States of America and for the last trading day of its ADRs on Nasdaq to occur by the end of the first quarter of 2022. The company expects its ADRs to be quoted and traded on the OTC Markets via a sponsored Level I Program following the voluntary delisting. The company's main considerations for the voluntarily delisting are the low trading volumes of the company's ADRs on Nasdaq and the low proportion of the company's total share capital held via ADRs on Nasdaq (approximately 3.7%, which is expected to decrease further overtime). Considering this and subject to meeting the relevant requirements, the Company intends to apply for a deregistration of its ordinary shares under the Securities and Exchange Act of 1934 in the first half of 2023. Both the delisting and ultimately the deregistration are expected to create a substantial cost saving as well as a reduction in compliance requirements. The costs and expenses associated with being a publicly traded company in the U.S., the auditing, legal and other costs associated with continuing to make SEC filings, and the burdens placed on company management to comply with the continued listing and reporting requirements in the US are significant and are not considered to be offset by the benefits from the US listing. The company's ordinary shares will remain listed on Euronext Amsterdam and on the London Stock Exchange. The company's review of the optimal listing venues is ongoing.
|
HLGN | Hot Stocks08:19 EST Heliogen awarded exclusive right to lease land in Brenda Solar Energy Zone - Heliogen announced that the United States Bureau of Land Management has awarded the company the exclusive right to lease land in the Brenda Solar Energy Zone, or SEZ. Heliogen intends to develop a green hydrogen facility on the Brenda site, capable of producing approximately 20,000 tons of hydrogen per year. The Brenda SEZ is situated on 3,343 acres of land in La Paz County, Arizona on the California border. The site has direct access to Interstate 10 for distribution of hydrogen to nearby natural gas pipelines for blending and transport, as well as to the Phoenix metropolitan area and the Port of Los Angeles for domestic and international shipping.
|
OTLK ABC | Hot Stocks08:21 EST Outlook Therapeutics appoints Joel Prieve as SVP, commercial operations - Outlook Therapeutics announced the appointment of Joel Prieve as Senior Vice President, Commercial Operations. Prieve has nearly twenty years of experience in commercial operations, most recently in the Xcenda division of AmerisourceBergen as Vice President of Business Development and previously in the IPN Solutions division. In his new role as SVP of Commercial Operations, Mr. Prieve will report to Jeff Evanson, Chief Commercial Officer of Outlook Therapeutics, and oversee all aspects of distribution, third-party logistics, HUB services and field resources to deliver an industry-leading customer experience.
|
TWST | Hot Stocks08:18 EST C2i Genomics, Twist team to develop whole-genome cancer reference materials - C2i Genomics, a cancer intelligence company, and Twist Bioscience Corporation announced a partnership to develop whole-genome cancer reference materials. This resource will provide diagnostic labs around the globe with the ability to better validate and monitor the quality of their whole-genome cancer screening and minimal residual disease products. In addition, C2i will integrate Twist's library preparation into their MRD workflow.
|
MOXC | Hot Stocks08:16 EST Moxian announces receipt of Nasdaq notice of deficiency, regaining compliance - Moxian announces that, on February 7, 2022, the Company received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market stating that the Company no longer met the periodic filing requirement of Nasdaq Listing Rule 5250(c)(1) since the Company failed to file its Form 20-F transition report covering the transition period from October 1 to December 31, 2020, which was due to be filed with the Securities and Exchange Commission by November 16, 2021. However, based on the filing of the Company's Form 20-F on February 7, 2022, the Staff has determined that the Company complies with the Rule, and subject to the disclosure requirement of Nasdaq Listing Rule 5810(b) that the Company make a public announcement regarding the letter, this matter is now closed.
|
GSAC | Hot Stocks08:16 EST GelStat announces $5M public offering - GelStat Corporation announced the launch of a Regulation A+, Tier 2, equity financing of up to $5 million. A copy of the Company's offering circular for the Public Offering has been posted on the Company's OTC Markets profile under "Filings and Disclosure." Investors may also review the offering circular and other filings on the Securities and Exchange Commission's website. The Regulation A+ offering was qualified by the SEC on December 17, 2021. The Company expects to use the funding primarily for product marketing, research and development, and general corporate development.
|
TDY | Hot Stocks08:16 EST Teledyne FLIR Defense awarded $43.9M deal for U.S. Navy/ Coast Guard sensors - Teledyne FLIR Defense, part of Teledyne Technologies Incorporated announced that the U.S. Naval Surface Warfare Center has awarded the company an indefinite delivery, indefinite quantity contract worth up to $43.9M to service electro-optical sensor systems used for Intelligence, Surveillance and Reconnaissance. The contract will provide replacement parts and technical support for several land- and sea-based systems used by the United States Navy and Coast Guard, including the BRITE(R) Star II, the Sea Star SAFIRE III, and the Star SAFIRE 380-HD.
|
AKRO | Hot Stocks08:15 EST Akero Therapeutics completes enrollment of Phase 2b HARMONY study - Akero Therapeutics announced that it has completed enrollment of the Phase 2b HARMONY study of efruxifermin, EFX, a novel FGF21 analog, for the treatment of non-alcoholic steatohepatitis, NASH. "We believe EFX has the potential, if approved, to become a leading treatment option for patients with NASH, including those with advanced-stage fibrosis," said Kitty Yale, chief development officer for Akero. "Our confidence in EFX's potential is based on Phase 2a data that showed substantial rates of fibrosis regression after only 16 weeks of treatment. We believe the larger Phase 2b HARMONY study, with a longer 24-week treatment period, will provide further evidence of EFX's potential to reverse fibrosis as well as address the underlying metabolic disease drivers." The Phase 2b HARMONY study is a multicenter, randomized, double-blind, placebo-controlled, clinical trial in biopsy-confirmed NASH patients with fibrosis stage 2 or 3. The primary endpoint is fibrosis regression without worsening of NASH at 24 weeks. To provide long-term safety data, patients will continue on treatment with EFX or placebo for a long-term follow-up period of up to 96 weeks. Consistent with prior guidance, results from the HARMONY study remain on track to be reported in the third quarter of this year.
|
OCUP | Hot Stocks08:15 EST Ocuphire Pharma completes enrollment in MIRA-3 Phase 3 trial for Nyxol - Ocuphire Pharma announced that it has completed enrollment in MIRA-3, the second Phase 3 FDA registration trial evaluating the safety and efficacy of Nyxol eye drops to reverse pharmacologically-induced mydriasis. In addition, APX3330 and Nyxol will have data presentations at each of the Angiogenesis, Exudation, and Degeneration 2022 Meeting and the Cataract Surgery Meeting: Telling It Like It Is. Enrollment has been completed in just 11 weeks in the MIRA-3 Phase 3 clinical trial investigating the safety and efficacy of Nyxol eye drops to reverse pharmacologically-induced mydriasis. The study, a randomized, double-masked, placebo-controlled pivotal Phase 3 study recruiting healthy subjects aged 12 and older, has exceeded its target enrollment of 330 subjects. A total of 368 patients were successfully enrolled in MIRA-3 across 16 centers in the US even with the challenging circumstances related to the COVID-19 pandemic. Oculos Development Services, a clinical research organization, led the execution of the MIRA-3 trial. Top-line results are expected to read out soon in early 2022. If successful, Ocuphire anticipates submission of a New Drug Application with the U.S. Food and Drug Administration for Nyxol for RM in late 2022. Cataract Surgery: Telling It Like It Is Conference Presentation: Session: New Technology Showdowns: Presbyopia-correcting Options: Title: Nyxol for the Treatment of Presbyopia: Dr. Singh will present for the first time to the medical community recently anouncned results from the completed VEGA-1 Phase 2 trial showing that Nyxol alone and Nyxol together with low-dose pilocarpine both had statistically significant improvements in near vision with a favorable safety profile that supports Phase 3 advancement as a single-agent drop and combination drops. Having both treatment options starting with Nyxol alone as the foundation would provide patients with the ability to "tune" pupil modulation to achieve near vision improvement based on individual and lifestyle needs. Angiogenesis, Exudation, and Degeneration 2022 Conference Presentation: Session: Session IX: Diabetic Retinopathy - Treatment: Title: APX3330, a Phase 2 Oral Drug Inhibiting Novel Target Ref-1 with a Dual Anti-VEGF and Anti-inflammatory MOA for the Treatment of Diabetic Retinal Diseases: Dr. Kaiser will present for the first time to the medical community safety data on oral APX3330 from the ongoing 24-week, multi-center, randomized, double-masked, placebo-controlled ZETA-1 Phase 2b trial in diabetic patients with retinal diseases. As announced during Ocuphire's recent R&D Day, masked safety data from the study demonstrated a favorable safety profile consistent with prior studies for the first-in-class APX3330 oral drug, now with over 5,000 subject exposure days at 600 mg total daily dose across diabetic and cancer patients.
|
OVID | Hot Stocks08:14 EST Ovid Therapeutics, Healx enter strategic partnership - Ovid Therapeutics announced that Healx has secured from Ovid an exclusive option to license rights to develop and commercialize gaboxadol. Under the agreement, Healx plans to investigate the compound as part of a potential combination therapy for Fragile X syndrome, as well as a treatment for other indications. Gaboxadol has previously been tested as a monotherapy for Fragile X syndrome in a Phase 2a clinical study by Ovid. Healx will now seek to find an optimal treatment for the condition by combining gaboxadol with other compounds, including HLX-0201, that have been identified by the company's proprietary AI platform, Healnet. "Gaboxadol shows encouraging activity and a good safety profile in a range of conditions. We are keen to see its clinical value unlocked," said Jeremy Levin, D.Phil, MB BChir, Chairman and Chief Executive Officer of Ovid Therapeutics. "We're impressed by the capabilities that Healx has developed and are optimistic that they can unlock effective drug combinations that will take advantage of the unique mechanism that underlies the effects we see when patients take gaboxadol." Should Healx exercise its option, Ovid will receive milestone payments for specific clinical, regulatory, and commercial achievements associated with gaboxadol's development. Additionally, Healx will pay Ovid tiered royalties on net sales associated with marketed therapies containing gaboxadol. Ovid will retain the option to become Healx's co-development and co-commercialization partner and will share net profits and losses in lieu of the milestones and royalty payments. Ovid does not plan to conduct further trials with gaboxadol.
|
HYPR | Hot Stocks08:12 EST Hyperfine appoints Chip Truwit as senior medical director - Hyperfine announced the appointment of Dr. Chip Truwit as senior medical director. Before joining Hyperfine, Truwit served as chief medical officer of diagnostic imaging and medical officer of precision diagnosis at Philips Healthcare, where he provided medical leadership and radiology expertise.
|
SBEV | Hot Stocks08:11 EST Splash Beverage Group signs distribution agreement with Heimark Distributing - Splash Beverage announced that it has signed a distribution agreement with Heimark Distributing to distribute TapouT through the key Southern California markets. Robert Nistico, Splash Beverage Group's Chairman and CEO, commented, "This latest distribution agreement marks our sixth distribution agreement since our November agreement with AB ONE, and is another example of how the credibility that partnership brought us is helping us with other distributors. Heimark, already a distributor of our Copa di Vino and Pulpoloco product lines, has been distributing for Anheuser- Busch, a subsidiary of AB-ONE, since 1963, and we are proud to have the TapouT product line added to Heimark's amazing portfolio of brands." Nistico added, "distribution is the most difficult thing to achieve, and the most important ... if you're not in distribution you're not for sale. Our partnership with InBev's AB-ONE is invaluable and in continues to pay dividends as we build out distribution coast to coast."
|
HOG | Hot Stocks08:11 EST Harley-Davidson sees FY22 HDMC revenue growth 5%-10% - For the full year 2022, the company expects: HDMC revenue growth of 5%-10%; HDMC operating income margin of 11%-12%; HDFS operating income to decline by 20%-25%; Capital investments of $190M-$220M.
|
KTOS | Hot Stocks08:10 EST Kratos Defense announces Q4 sales of OpenSpace quantum, SpectralNet products - Kratos Defense & Security Solutions announced that its OpenSpace quantum and OpenSpace SpectralNet product lines counted sales to 25 customers in Q4 2021 supporting the satellite industry's continued evolution to dynamic, digital ground systems. Kratos' OpenSpace family of solutions help satellite operators move their network systems from traditional hardware to more dynamic, flexible and scalable architectures that are more responsive to service level agreements, mission goals and changing operating conditions. Kongsberg Satellite Services, the Norway-based satellite operator that has been a pioneer in the industry's movement to virtualized ground systems and an OpenSpace products user, added new units in Q4 to support continued customer growth. KSAT recently passed a major business milestone having supported more than 50,000 satellite passes in a single month with its virtual ground system employing both OpenSpace quantum and SpectralNet products.
|
OSPN | Hot Stocks08:10 EST OneSpan, Smart Communications partner to expand e-signature integration - Smart Communications and OneSpan announced a partnership that integrates OneSpan's e-signature product, OneSpan Sign, into the Smart Communications platform to extend the value of the total customer experience. This integration creates operational efficiencies as well as improves the customer experience. "By streamlining digital agreement processes, joint customers achieve higher customer satisfaction and increased application completions that shorten time to revenue, all while demonstrating compliance," the company said. Customers are increasingly comfortable engaging with companies across a variety of digital channels including email, SMS and in-app messages. By embedding OneSpan Sign into Smart Communications solutions, companies can collect customer information through digital forms, produce personalized, and compliant documents, and facilitate real-time signatures. "Clunky and complex forms add unnecessary friction to digital agreement processes," said OneSpan's Chief Revenue Officer, John Gunn. "Forms modernization is key to minimizing friction during any new customer acquisition experience. Our partnership with Smart Communications allows our joint customers to create faster and more intelligent forms that are easy to complete before they're e-signed."
|
WLL | Hot Stocks08:08 EST Whiting Petroleum increases accretive stake in Stanish region, declares dividend - Whiting Petroleum announced that it has entered into two separate definitive agreements to acquire non-operated oil and gas assets in the Williston Basin of North Dakota. The Company also announced its 2022 capital, operating costs and production guidance, reflecting an operating plan focused on delivering sustainable free cash flow. The board of directors declared a quarterly cash dividend of 25c per share of common stock to shareholders of record as of February 21.The assets are being acquired from two private companies for total cash consideration of $273M, before typical closing adjustments. The assets are located in Mountrail County, North Dakota and increase the average operated working interest from 61% to 74% throughout Whiting's Sanish field, impacting many of the drilling units included in the Company's current 2022 development program. The assets include 14,563 net acres, 4 gross / 0.2 net drilled and uncompleted well interests, and 277 gross / 32 net undrilled locations. The Company expects to develop the undeveloped locations near term. The assets should contribute approximately 4,500 barrels of oil equivalent per day at closing. The smaller transaction closed in the fourth quarter of 2021, and the larger acquisition is scheduled to close in the first quarter of 2022. Lynn A. Peterson, President and CEO of Whiting commented, "These transactions continue the strategy we put forth beginning in late 2020. By increasing our working interest, we are immediately recognizing substantial cash flow that is accretive for shareholders. We know and understand the Sanish field extremely well and are very comfortable with the rate of return we are achieving."
|
GANX | Hot Stocks08:07 EST Gain Therapeutics presents preclinical data from its GD program - Gain Therapeutics presented new pre-clinical data from its Gaucher Disease, GD, program. These results were highlighted in a late breaking abstract presentation at the 18th Annual WORLDSymposium on lysosomal disease research being held February 7 - 11, 2022 at the Manchester Grand Hyatt in San Diego, California. The data generated in GD-iPSC-derived dopaminergic neurons show that the tested compounds increase the levels of GCase protein, deplete phosphorylated alpha-synuclein and increase autophagic flux. "These data are further validation of our innovative proprietary drug discovery platform SEE-Tx as well as the potential of our lead compound to restore key lysosomal functions thus showing promise as a first-in-class therapy for the treatment of neuronopathic GD," said Eric Richman, Chief Executive Officer of Gain. "We remain on target to initiate IND-enabling studies for the GD program in the fourth quarter of this year." The presentation titled "Development of Structurally Targeted Allosteric Regulators for the Treatment of Neuronopathic Gaucher Disease" demonstrated the following results: Orally bioavailable and brain-penetrant lead STARs have shown promising effects in relevant in vitro models of GD; Increased total and lysosomal GCase in WT and GD dopaminergic neurons; Lowered pathogenic p-alpha-synuclein129 in WT and GD dopaminergic neurons; Induced the formation of autophagosomes and increased autophagic flux, thus improving lysosomal function in WT and GD dopaminergic neurons; Increased GCase protein levels in GD macrophages; and Effectively reduced the production of inflammatory cytokines by GD macrophages
|
LDOS | Hot Stocks08:07 EST Leidos awarded $104M contract by the U.S. Army - Leidos announced it has been awarded a prime contract by the U.S. Army's Program Executive Office for Simulation, Training, and Instrumentation to modernize the service's gunnery training simulation systems. The single-award, indefinite delivery, indefinite quantity contract has a total estimated value of $104M and a period of performance of five years. Work will be performed in Orlando, Florida.
|
NOK | Hot Stocks08:07 EST Nokia completes first of two-phase deployment of 4G FWA technology - Nokia announced it has completed the first of a two-phase deployment of 4G Fixed Wireless Access technology, along with partner AggreGateway, to provide broadband internet connectivity to underserved students in the Dos Palos Oro Lomo school district of California. The district, located in the predominantly rural San Joaquin Valley in California, comprises five campuses and serves a population of 5,000 residents. The Nokia solution will provide secure, reliable, high-performance internet access to the homes of 2400 students using Nokia Private 4.9G/LTE Digital Automation Cloud operating in the CBRS/On-Go GAA spectrum, and customer premises equipment including Nokia FastMile 4G Gateways and WiFi Beacons. The DPOL technology team will operate its new LTE network through the centrally secure Nokia DAC Cloud monitoring application. DPOL will also provision LTE / Wi-Fi hotspots to students to be used with any standard laptop or tablet to access high-speed internet.
|
IMNM | Hot Stocks08:06 EST Immunome announces IMM20253 in vitro data - Immunome announced in vitro data demonstrating effectiveness of its antibody cocktail against live versions of the SARS-CoV-2 Omicron variant when tested at two external laboratories. IMM20253 exhibits a novel mechanism of action not reported with any other Emergency Use Authorization, or EUA, antibodies by promoting a proteolytic cleavage of the portion of the spike protein needed for ACE2 binding, thus reducing the ability of the virus to infect host cells. In addition, IMM20253 induces potent non-neutralizing activity via phagocytosis. The IMM20253 epitope appears to be broadly conserved across other betacoronaviruses, including SARS-CoV-1. When tested in both laboratories, IMM20253 retained similar potency against Omicron compared to reference strains. A head-to-head test using live virus was performed at Boston University's National Emerging Infectious Diseases Laboratories to evaluate relative neutralization potency. In this assay, Immunome's IMM20253/IMM20184 combination neutralized the Omicron variant within 3.5-fold potency compared to S309, the preclinical version of sotrovimab. According to the FDA's EUA Fact Sheet for sotrovimab, less than 5-fold change in IC50 is considered no change in susceptibility. In the live virus testing conducted by Boston University and Washington University, each using a different assay, the potency of the IMM20253/IMM20184 combination was measured to be in the range of 27 nM - 100 nM. For reference, in published literature the neutralization potency of S309, the preclinical version of sotrovimab, ranged from 2.5 nM - 52 nM. As observed, significant variability exists in the measurement of neutralization potency depending on assay and test conditions. As a combination, IMM20253 and IMM20184 showed consistent neutralization across all former variants of concern in pseudovirus testing as well as all variants tested to date in live virus. The neutralization activity against Omicron was primarily driven by IMM20253, with IMM20184 making a minor contribution to the overall in vitro neutralizing activity of the cocktail. The combination is expected to maintain non-neutralization activities, including complement activation and phagocytosis, potentially contributing to viral clearance mechanisms in vivo. IMM20190, the third component of IMM-BCP-01, which is effective against other variants in preclinical testing, was excluded from live virus testing due to Immunome's prior predictive analysis suggesting a lack of binding to Omicron. Based on this positive data, Immunome plans to continue advancing the program into Phase 1b.
|
EYEN | Hot Stocks08:05 EST Eyenovia concludes Type A meeting with FDA on MydCombi NDA resubmission - Eyenovia announced that the company successfully completed a Type A meeting with the U.S. Food and Drug Administration related to the refiling of the NDA for MydCombi. On October 22, 2021, Eyenovia received a complete response letter from the FDA stating that MydCombi, the company's proprietary, first-in-class combination of tropicamide and phenylephrine for in-office pupil dilation, had been reclassified as a drug-device combination product. Following the recent Type A meeting, Eyenovia and the agency reached alignment on the path forward toward an NDA resubmission. Specifically, FDA has requested that the company conduct additional device testing related to the Optejet dispenser. Importantly, no additional clinical studies of MydCombi were requested. "We had a very constructive meeting with the FDA and confirmed the additional non-clinical items to be addressed. We are in the process of conducting these requested validation studies and plan to resubmit our NDA in Q3 2022," stated Sean Ianchulev, Chief Executive Officer and Chief Medical Officer of Eyenovia. "Of note, now that our product candidates are classified as combination drug/device products, we will be taking advantage of this requested validation work to streamline development activities for our future programs. One such potential benefit is the potential to reference this device validation work in future regulatory applications, reducing the time and expense of repeating these tests for each program. All in all, while we certainly would have preferred not to have this delay, we understand the legal necessity of the reclassification. Ultimately, we believe that our work today will lay the regulatory groundwork for future products. In parallel with these activities, our second Phase 3 VISION-2 clinical trial of MicroLine, our proprietary pilocarpine formulation for the temporary improvement in near vision in people with presbyopia, continues to enroll and we anticipate reporting results in the second quarter of this year. We believe the presbyopia market is a nearly $8 billion addressable market in the U.S. alone."
|
DRIO | Hot Stocks08:04 EST DarioHealth announces new contracts with four new employers - DarioHealth announced several new contracts to deliver its digital therapeutics solutions for four new employers. The new accounts are expected to launch during the Q1 and Q2. The new clients include a northeast regional employer contracted for Dario's diabetes solution and three employers - including two educational organizations and a regional professional services firm - launching with Dario's behavioral health solution. Dario closed 2021 with a total of 54 new contracts in its first full year of selling digital therapeutics in the business-to-business market.
|
VEC | Hot Stocks08:04 EST Vectrus awarded new five-year task order valued at $250M - Vectrus announced that it was awarded a new five-year cost-plus-fixed-fee task order valued at $250M to provide logistics support services to the U.S. Army at Fort Benning, Georgia. The task order, which was awarded under the Enhanced Army Global Logistics Enterprise contract extends through December 2026, including all option periods.
|
FOUR | Hot Stocks08:04 EST Shift4 Payments, Sporting Kansas City announce five-year partnership - Sporting Kansas City and Shift4 announced a five-year partnership through the 2026 Major League Soccer season. Shift4, a global leader in commerce technology, will integrate the company's unified commerce ecosystem into SeatGeek to optimize ticketing transactions for Sporting Kansas City, a charter member of Major League Soccer.
|
CAAP | Hot Stocks08:04 EST Corporacion America Airport expands business in Brasilia Airport region - Corporacion America Airports announced that its subsidiary Inframerica, which operates the Brasilia Airport in Brazil, will start the expansion works of the airport site, in 2022. This is the second phase of the project, which will be carried out through partnerships, and will comprise the construction of a shopping mall and both, entertainment and logistic centers. The projects begin to be delivered at the end of 2023, with the completion of the works scheduled for the first half of 2024. Inframerica estimates investments of around R$700M, with the generation of around 3,500 direct and indirect new jobs. The first development of the project, "Praca Pick Up," a mobility center that among other things includes several food options and a children's playground, opened in September 2020. "Brasilia Airport has become a successful model in Brazil, being recognized for its management and infrastructure excellence. Our goal has always been to help the city grow, be more attractive, and these projects will contribute to tourism and the local economy of this beautiful capital city. The Brasilia terminal has always had this special connection with the city, a local meeting point. The support given by the Ministry of Infrastructure, the National Civil Aviation Agency , and the Federal District Government, GDF, as well as that of our commercial partners who strongly believed in the project, were fundamental," said Jorge Arruda, CEO of Inframerica and CFO of CAAP.
|
CME | Hot Stocks08:03 EST CME Group to Launch CBL Core Global Emissions Offset futures - CME Group announced it will launch CBL Core Global Emissions Offset futures on March 7, pending all relevant regulatory reviews. CBL C-GEO futures are intended to align with the Core Carbon Principles, an emerging set of transparent and consistent standards around the supply of carbon credits to be overseen by the Integrity Council for the Voluntary Carbon Markets.
|
LMPX | Hot Stocks08:03 EST LMP subsidiary signs $4M agreement to sell Plantation, Florida property - LMP Automotive announced it signed a $4M agreement to sell its Plantation, Florida property. Richard Aldahan, LMP's Chief Operating Officer, stated, "This was our leasing and subscription site, and the sale is a profitable transaction and accretive to our financials. We expect the closing to occur on or about April of this year subject to customary closing conditions. We will discontinue operations from this facility as part of our realignment strategy, focusing on franchise dealership acquisitions and operations. This will complete the sale of certain assets related to our leasing and subscription non-core business that we began late last year, and we believe deploying capital in our dealerships will yield higher returns."
|
ABBV | Hot Stocks08:01 EST Allergan announces FDA approval of JUVEDERM VOLBELLA XC - Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVEDERM VOLBELLA XC for improvement of infraorbital hollows in adults over the age of 21.2 According to clinical trial data, 90% of subjects reported satisfaction through one year after treatment.2 With this approval, Allergan Aesthetics continues the expansion of its treatment portfolio to better address unmet patient needs. Per FDA requirement for this new indication, Allergan Aesthetics is providing a product training program for all interested providers, which includes facial anatomy and considerations for safe injection in this area, as well as identification and management of potential complications. Successful completion of this training is necessary prior to administration of JUVEDERM VOLBELLA XC for this new indication.
|
POWW | Hot Stocks08:01 EST AMMO board authorizes up to $30M share repurchase program - AMMO announced that its Board of Directors authorized a share repurchase program for up to $30M dollars of its outstanding common stock. "The repurchase authorization of up to $30 million of stock represents our commitment to increasing shareholder value and gives us flexibility to deploy some of our cash flow into our future," said Fred Wagenhals, CEO of Ammo Inc. "With a strong balance sheet and growing revenues, we believe it is appropriate to have the option to repurchase stock if it makes sense as the best investment at that time." The program is expected to commence following the public disclosure of the Company's 2022 3rd quarter financial results and filing of its report on Form 10-Q and may be suspended or discontinued at any time.
|
CRVL | Hot Stocks07:50 EST CorVel's Symbeo names Tomika Russell as President of the company - Symbeo, a CorVel company, has appointed Tomika Russell as President of the company. Russell brings over 20 years of leadership experience to Symbeo. Prior to joining Symbeo, Russell oversaw digital strategies for sales, marketing, finance and data for Daimler Trucks North America.
|
CNNEF | Hot Stocks07:50 EST Canacol Energy says gas sales averaged 170 MMscfpd for January - Canacol Energy is pleased to provide the following information concerning its January 2022 natural gas sales, the Toronja 2 development well, near term drilling plans, and the Corporation's normal course issuer bid. Realized contractual natural gas sales were approximately 170 million standard cubic feet per day for January 2022. The Toronja 2 development well was spud on January 17, 2022 and reached a total depth of 6,899 feet measured depth on January 23, 2022. The well encountered 29 feet true vertical depth of net gas pay with an average porosity of 28% within the primary Porquero sandstone reservoir target. The Toronja 2 well was tied into the Toronja production manifold and has been placed on permanent production. Drilling rig mobilizing to drill Carambolo 1 exploration well: The rig is currently mobilizing to drill the Carambolo 1 exploration well targeting gas bearing sandstones within the Cienaga de Oro sandstone reservoir. Carambolo 1 is anticipated to take approximately 4 weeks to drill, complete and test. Following the completion of Carambolo 1 the rig will be mobilized to spud the Arandala 3 development well, which the Corporation anticipates spudding in March 2022. The Arandala 3 well will also take approximately 3 weeks to drill, complete, and tie into permanent production. Normal course issuer bid: During January 2022, the Corporation repurchased 5,307,700 Common Shares for CAD$ 3.15 per share under its normal course issuer bid, relying on the block purchase exemption under the NCIB rules. The purchase was made from an arm's length third party via the TSX Exchange. Canacol's management is of the view that Canacol's shares are trading at a significant discount to their net asset value. Canacol is committed to purchasing its shares under its NCIB whenever they trade at a relevant discount to their net asset value, provided that Canacol has sufficient liquidity.
|
RVLGF | Hot Stocks07:48 EST Revival Gold releases final 2021 drill results at Haidee - Revival Gold announces results from the final seven infill drill holes completed in the Haidee target area in connection with the Company's 2021 exploration program at the Beartrack-Arnett Gold Project located in Idaho, USA. A total of 15 holes were completed for approximately 2,500 meters, with four holes drilled for geotechnical and hydrological purposes. Results are consistent with results from previous drilling and continue to support the up-dip and down-dip extensions of mineralization in the Haidee area as areas for the potential expansion of the current Mineral Resources. "Drill results released today will support an upgrade in the quality of the gold resource at Haidee and point to future resource expansion opportunities both up and down dip of the current deposit", said Hugh Agro, President and CEO. "An updated resource estimate for the entire Beartrack-Arnett project is well underway and results are expected to be released by quarter end", added Agro.
|
ATSG | Hot Stocks07:48 EST Air Transport Services expands aircraft leasing and operating pacts with DHL - Air Transport Services Group announced that it has executed agreements with DHL Network Operations under which ATSG's Cargo Aircraft Management and ABX Air subsidiaries will continue to lease aircraft to DHL and operate those aircraft within DHL's global network. Six-year extensions through April 2028 of dry leases for five Boeing 767 freighters that CAM currently leases to DHL, and of the Crew, Maintenance and Insurance agreement, CMI, under which ABX Air operates freighter aircraft for DHL. Expansion of the CMI agreement to include two more 767 freighters, bringing the total operated under that agreement to twelve. As previously announced, DHL agreed in May 2021 to lease four more 767 freighters from CAM. One was delivered in 2021 and three more will be delivered in 2022, two of which will be operated under the CMI agreement. That will increase the total CAM-leased 767 fleet at DHL to fifteen. ABX has provided and operated cargo aircraft for DHL, principally in the United States, since August 2003. "ATSG is pleased to continue and expand its long-standing support of DHL's unrivaled global logistics network," said Mike Berger, chief commercial officer of ATSG, "and we are proud of the role our airlines continue to play in delivering safe and reliable e-commerce and m-commerce satisfaction around the world."
|
OAMCF | Hot Stocks07:47 EST OverActive Media announces allotment of stock options - OverActive Media announced that the Company's board of directors has approved the grant of stock options exercisable for a total of 220,000 shares, subject to acceptance of the grantee, to an officer of the Corporation. All Options were granted pursuant to the Company's Employee Stock Ownership Plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange. The Options were granted at an exercise price of $1.19, being the closing price on February 7, 2022. The Options shall vest 33% for three consecutive years on the anniversary date of the original grant. Upon vesting, Options shall expire on the date that is ten years from the anniversary of the grant, February 7, 2032.
|
CMNDF MDGS | Hot Stocks07:46 EST Clearmind secures C$1.6M in private placement - Clearmind Medicine announced it has signed an agreement for a private placement. With gross proceeds to the Company of approximately CAD$1.6 million, the investment will be made by Medigus Ltd. (MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions. Clearmind and Medigus intend to form a joint venture in the food industry field, based on Clearmind's unique psychedelics intellectual property. The joint venture expects to focus on the product development of food supplements, on the basis of the IP, as well as obtaining the necessary regulatory approvals to enable the registration and distribution of the Products in certain targeted countries. The Company will issue Medigus 1,987,344 units at a subscription price of CAD$0.80 per Unit. Each Unit is comprised of one common share of the Company and one Common Share purchase warrant exercisable into one additional Common Share at a price per Common Share of CAD$2.00, exercisable for a period of 18 months from issuance. approximately CAD$960,000 of the gross proceeds will be paid for in cash and approximately CAD$640,000 of the gross proceeds will be satisfied through the issuance to the Company of that number of American Depository Shares of Medigus arrived at by dividing the Share Exchange Proceeds by US$1.20. Additionally, Medigus will be entitled to 10% of the initial equity of a potential venture in the area of psychedelics, based on a research project currently conducted according to an agreement between the Company and the commercialization arm of a leading Israeli academic institution.
|
MSSTF | Hot Stocks07:46 EST Mindset appoints Randall as SVP of External Alliances, Scientific Strategy - Mindset Pharma announced that it has appointed Fiona Randall, B.Sc., Ph.D., a trained neuroscientist with worldwide research and management experience, as Senior Vice President, SVP, of External Alliances and Scientific Strategy. Most recently, Dr. Randall founded FireWire Consulting which provides preclinical research and business development services to biopharmaceutical companies.
|
OSIIF | Hot Stocks07:45 EST Osino Resources announces proceeds of $9M from warrant exercise - Osino Resources announces that it has received $9,107,455 from the exercise of 8,941,047 previously issued warrants. The funds received will be used to continue to fast-track the development of its flagship Twin Hills Gold Project, to progress other Namibian exploration and project development initiatives as well as for general working capital purposes. Heye Daun, Osino's President and CEO commented: "I would like to thank our shareholders for the continued support and confidence in the Company's ability to execute on its development strategy. It's been a challenging equity market and notwithstanding the stock trading around warrant exercise price, an overwhelming majority of this series of warrants were exercised." The warrants were issued in conjunction with a private placement financing completed in January 2020. The exercise price of the warrants was $1.05 per warrant and were set to expire on January 30, 2022. The Company also announces that it has granted 150,000 stock options and 150,000 restricted share units to an eligible participant of the Company, pursuant to its Stock Option Plan and RSU Plan.
|
MDGS CMNDF | Hot Stocks07:44 EST Medigus enters investment agreement with Clearmind - Medigus Ltd. (MDGS) announced the expansion of its healthcare activities by signing an investment agreement with Clearmind Medicine Inc. (CMNDF), a psychedelic pharmaceutical biotech company. In accordance with the agreement, Medigus will invest $1.25M in exchange for approximately 2 million units, comprised of shares and warrants. The shares purchased represent 5.02% of Clearmind. Clearmind's patent portfolio consists of four utility patent families, which includes seven approved patents and 13 pending applications. Clearmind and Medigus intend to form a joint venture in the food industry, based on Clearmind's unique psychedelics intellectual property. The joint venture expects to focus on the product development of food supplements, on the basis of the IP, as well as obtaining the necessary regulatory approvals to enable the registration and distribution of the products based on such IP in certain targeted countries. As part of the agreement, Medigus will be issued approximately 2 million units, comprised of one share of common stock and one warrant, at a subscription price of CAD$0.80 per unit. Each warrant will be exercisable for a period of 18 months into one additional share of common stock at a price per share of CAD$2.00. US $750 thousands of the investment amount will be paid for in cash and US $500 thousands of the investment amount will be paid through the issuance of Medigus' American Depository Shares, at a price per ADS ofUS$1.20. In addition, Medigus will be entitled to 10% of the initial equity of a potential venture in the area of psychedelics, in connection with a research project currently conducted according to an agreement between Clearmind and the commercialization arm of a leading Israeli academic institution.
|
BSFC | Hot Stocks07:43 EST Blue Star Foods commences operations of soft-shell crab RAS division - Blue Star Foods announced that it has commenced operations of its Soft-Shell Crab Recirculatory Aquaculture Systems, RAS, division. This follows on the recent completion of the previously announced acquisition of certain assets of Gault Seafood in December 2021. The Blue Star Soft Shell Crab RAS division is focused on using its newly acquired technology to harvest the Atlantic Blue Crab during its off-season. "We'll be delivering our first product almost immediately this month, and believe that we'll be able to deliver our first off-season, fresh soft-shell crab product to consumers starting this August," said Rodrigo Mezerhane, the Senior Project Manager for the RAS Division of Blue Star. "In the meantime, we continue to search for the ideal property site, which will allow us to produce 10x what we'll be able to produce in our pilot facility in South Carolina."
|
CVGI | Hot Stocks07:42 EST Commercial Vehicle secured 11 additional customers since 2020 - CVG reports that since 2020, it has secured the development and production business for 11 additional hybrid and electric vehicle customers in Europe and North America, to deliver the electrical backbone on electric commercial and passenger vehicles. "The Electric Vehicle revolution is here, and CVG is committed to help shape the future of transportation," said Rich Tajer, SVP and CCO. "As our partnership with leaders in this space continue to grow, we expect to have an impact on reducing global emissions." In all, CVG has landed over $200M of annualized business, at planned volume, with 11 separate customers in these areas in less than two years.
|
VNT | Hot Stocks07:39 EST Vontier acquires Driivz, accelerates portfolio transformation with investment - Vontier Corporation announced its multi-year investment commitment to lead in the global low-carbon energy transition. Inclusive to the strategic pledge, Vontier also announced its first energy transition capital deployment with the acquisition of Driivz, a leading provider of EV charging and energy management software. No further transaction details were announced. Mark Morelli, President and Chief Executive Officer of Vontier, stated, "As has been widely reported, the energy landscape will change more in the next 10 years than in the previous hundred and today's announcement underscores our Net Zero goals and advances our plan to deliver solutions to help address the global emissions challenges. We are committed to tackling the energy transition in transformative ways with our commitment to invest more than $500M over the next 5 years to lead in the energy transition. "The acquisition of Driivz accelerates our portfolio diversification and e-mobility strategies toward long-term secular growth drivers and positions us well to capitalize on the global EVCI market opportunities. Driivz provides us with market leading technologies within the highest growth, most profitable network management software market segment. We are excited to offer our customers with best-in-class software that is hardware agnostic and the ability to continue to own the consumer experience."
|
CYT | Hot Stocks07:36 EST Cyteir Therapeutics announces first patient dosed in Phase 2 with CYT-0851 - Cyteir Therapeutics announced that the first patient has been dosed in a Phase 2 expansion cohort study of CYT-0851 monotherapy that is part of the Phase 1/2 trial. CYT-0851 is being evaluated for the treatment of hematologic malignancies and solid tumors. "We are excited to dose the first patient in the Phase 2 expansion cohort study with CYT-0851. This signal-seeking study in six different cancers will give us the data that may allow us to advance CYT-0851 into a clinical trial with potential registrational intent as soon as early next year," said Markus Renschler, MD, President and Chief Executive Officer of Cyteir. "I am grateful to the entire Cyteir team, our investigators and participating patients as we work together to complete these expansion cohorts."
|
ATCO | Hot Stocks07:36 EST Atlas Corp.'s APR Energy enters Brazilian market - APR Energy, a wholly-owned subsidiary of Atlas Corp., announced that it will provide Evolution Power Partners with 228 MW of gas generation capacity for a minimum of one year. APR's solution for EPP includes a full turn-key natural gas-fired power plant powered by eight GE TM2500 gas turbines in Itaguai, Rio De Janeiro with a commercial operation date of May 1, 2022.
|
REAX | Hot Stocks07:35 EST The Real Brokerage surpasses 4,000 real estate agents milestone - The Real Brokerage announced it has surpassed the milestone of 4,000 real estate agents who have joined Real in its international network. Real surpassed 3,000 agents in October 2021 and since then, the Company has launched its Instant Payment service for agents, acquired Expetitle, Inc. and broadened its brokerage operations to 40 U.S. states and the District of Columbia, with an addition of four states including Michigan, Idaho, Kentucky and Wyoming. The Company has also expanded its international dimension by commencing operations in Ontario, Canada, including the addition of Scott Benson as Canada's Growth Leader and the luxury real estate-focused Invidiata Team.
|
SHYF | Hot Stocks07:34 EST Shyft Group to launch its all-new electric delivery vehicle - The Shyft Group announced it will reveal its all-new electric delivery vehicle on their proprietary, purpose-built Class 3 EV chassis at the NTEA Work Truck Week trade show taking place in Indianapolis from March 8-10. "Unable to find a viable EV chassis option in the market, we decided to build our own," said Shyft Group CEO Daryl Adams. Using the company's proprietary Work-Driven Design process, the electric vehicle is a purpose-built walk-in delivery van that will reach a new benchmark in delivering optimal driver ergonomics and user experience. Vehicle prototypes are expected to reach customers for route testing in the coming months, with production expected to begin by mid-2023.
|
SDIG | Hot Stocks07:34 EST Stronghold Digital highlights environmental impact in response to inquiry - Stronghold Digital Mining responded to an inquiry from a group of United States Senators and members of Congress dated January 27, 2022, which details its commitment to fostering a positive environmental impact and the Company's previous and ongoing reclamation and remediation efforts. Excerpts from Stronghold's full response letter: "There are more than 840 coal refuse piles at these abandoned mine lands across Pennsylvania, which cover an aggregated area of 8,500 acres and contain a total volume of more than 200 million cubic yards." "The Facilities represent an efficient conversion of damaging waste product into power while helping achieve governmental priorities." "We convert highly polluting coal refuse into power and beneficial use ash, which consists of fly ash and bottom ash that can be beneficially reused for mine reclamation efforts and as an additive in concrete production." "Our CFB technology helps to control emissions of sulfur dioxide, nitrogen oxides, air toxins, and total particulate matter by removing ~90% of NOx emissions, ~98% of SO2 emissions, ~99.9% of particulate emissions and ~99.9% of mercury emissions." "Our Facilities are capable of diligently addressing this damaging waste product and converting over 1.25 million tons of coal refuse into energy annually."
|
KPTI | Hot Stocks07:34 EST Karyopharm says Phase 3 SIENDO study meets primary endpoint - Karyopharm Therapeutics announced positive top-line results from the Phase 3 Selinexor In ENDOmetrial Cancer study evaluating the efficacy and safety of front-line maintenance therapy using selinexor, an oral medication, in patients with advanced or recurrent endometrial cancer. The SIENDO study met its primary endpoint of a statistically significant improvement in median progression-free survival compared to placebo. Selinexor-treated patients had a median PFS of 5.7 months compared to 3.8 months for patients on placebo, representing an improvement of 50%, with a hazard ratio of 0.70, representing a 30% reduction in the risk of disease progression or death. Selinexor demonstrated a sustained and long-term improvement as seen at 12 months with a 37% increase in probability that selinexor-treated patients will be in remission compared to patients on no treatment, or today's standard of "watch and wait." In this study, selinexor was well tolerated with no new safety signals identified, and a low discontinuation rate of 10.5% due to adverse events.
|
NPIFF | Hot Stocks07:33 EST Northland Power expects to complete 366 MW of additional capacity in 2022 - Currently Northland has 366 MW of additional capacity in construction, with the expectation for completion in 2022. The Company also has almost 3 GW of gross capacity which are projects that are scheduled for financial close and commencement of construction within the next two years. Once these projects are complete, Northland's total gross capacity will nearly double to more than 6.5 GW by 2027. Longer-term, the Company continues to advance a pipeline of over 10 GW encompassing its identified projects and additional opportunities to support the sustained growth of the Company. Northland's investor day materials will provide more details on its growth ambitions including an illustration of its funding plan and specific project milestones achieved since last year that are expected to create value for shareholders over the long-term.
|
NPIFF | Hot Stocks07:33 EST Northland Power expects 2022 adjusted EBITDA $1.15B-$1.25B - For 2022, management expects Adjusted EBITDA to be in the range of $1.15 billion to $1.25 billion. Adjusted EBITDA is expected to increase relative to the 2021 guidance range, primarily due to the following factors : Higher contribution from German offshore wind facilities as a result of more normalized wind resource $50 million; Contribution from the Spain portfolio $75 million: Contribution from a one-time asset management income from a natural gas facility, as a result of financing and other optimizations $30 million; and Higher overall contribution from onshore renewables and the EBSA utility $35 million. Factors offsetting the increase in 2022 Adjusted EBITDA include: Significantly lower contributions from Iroquois Falls following the expiry of its original revenue contract at the end of 2021 $75 to $80 million; and Higher expected growth expenditures to advance Northland's projects $25 million, as well as higher G&A and other costs to support this growth $25 million. In 2022, management expects Free Cash Flow to be in the range of $1.20 to $1.40 per share, in line with the lower end of the 2021 guidance range primarily due to the following factors: Higher contribution from the offshore wind facilities as a result of more normalized wind resource and including the impact of foreign exchange hedges $60 million; Full year contribution from the Spain portfolio $15 million; Higher contribution from EBSA $40 million, including enhanced operations $5 million and net proceeds from refinancing of the EBSA debt facility $35 million based on expected growth in EBSA's EBITDA; and Contribution from a one-time asset management income from a natural gas facility, as a result of financing and other optimizations $30 million. Factors more than offsetting the aforementioned increases include: Significantly lower contributions from Iroquois Falls following the expiry of its original revenue contract at the end of 2021 $75 to $80 million; and Higher expected growth expenditures to advance Northland's projects $25 million, as well as higher G&A and other costs to support this growth $25 million. For Adjusted Free Cash Flow, which excludes growth expenditures, management expects a range of $1.65 to $1.85 per share, which compares with a range of $1.60 to $1.70 per share in 2021. The significant factors affecting Adjusted Free Cash Flow were as described above for Free Cash Flow but exclude approximately $100 million in growth expenditures.
|
ENVB | Hot Stocks07:32 EST Enveric Biosciences announces development of EV104a and EV104b - Enveric Biosciences announced the development of EV104a and EV104b, new molecular conjugates for Osteoarthritis, or OA, and other pain indications. The treatment paradigm for OA, as reflected in a recent review "Future Directions for the Management of Pain in Osteoarthritis" by Nidhi Sofat, is largely unsatisfactory and based on alleviating pain using NSAIDs and other pharmacotherapies or intra-articular injection of corticosteroids, or hyaluronic acid. Newer therapeutic alternatives, including combination treatments, are needed for optimal control of symptoms. Enveric recently licensed an Innovative Platform technology from Diverse Biotech that led to the successful synthesis of EV104a, and EV104b, two new chemical entity conjugates of cannabidiol linked to celecoxib. EV104a and EV104b are specifically designed to optimize pharmacokinetics and therapeutic synergy via improved delivery, targeting abilities, and potency to potentially be more efficacious and display fewer side effects than current treatments. Enveric has confirmed the stability of the molecules and the robustness of the manufacturing method.
|
CARS | Hot Stocks07:32 EST Cars.com to acquire Accu-Trade group for $65M in cash - Cars.com announced that it has signed an agreement to acquire 100% of the assets of Accu-Trade, Galves Market Data and MADE Logistics, which includes real-time, VIN-specific appraisal and valuation data, instant guaranteed offer capabilities, and logistics technology. Consideration for the transaction will be $65M in cash at closing. There is also the potential for additional cash and stock consideration based on achievement of certain financial thresholds. "We anticipate making a $63M earn-out payment, which may be higher or lower based on actual performance." The transaction is expected to close in approximately 30 days.
|
NESR | Hot Stocks07:31 EST National Energy Services appoints Stefan Angeli as CFO - National Energy Services announced the appointment of Stefan Angeli as CFO of NESR, effective immediately, replacing Chris Boone who is leaving the company to start another role. To ensure a transition, NESR has rescheduled its earnings conference call which will be announced separately. Angeli comes to NESR with more than 35 years of experience in corporate and operational finance, controllership, accounting, tax and mergers & acquisitions across the energy industry and public accounting. Prior to NESR, Angeli was the CFO for Stratum Reservoir.
|
NPIFF | Hot Stocks07:30 EST Northland Power intends to execute sell-down strategy on partial interests - Northland's financial position continues to be strong and the Company remains in an excellent position to fund its growth objectives. The Company manages its capital strategy with a high degree of selectivity in funding its capitalized growth projects, while maintaining an investment grade rating of BBB from two rating agencies. Northland has no material maturities over the next five years and over 95% of total debt is non-recourse to the Company. Northland also has access to a $1.0 billion corporate revolving credit facility which can be utilized to fund growth projects that have a strong probability of advancing to financial close. Borrowings under the credit facilities are revolving, such that they are ultimately repaid from project financings at financial close, corporate and/or project-level financing/re-financing optimizations and/or sell downs at or before financial close. Northland's Free Cash Flow finances growth development expenditures, corporate costs that support growth and new initiatives. With a focus on its credit rating, Northland considers it preferable to employ low-cost corporate credit to fund investments in its capitalized growth projects, most of which are targeted for financial close in either 2022 or 2023. To complement its existing sources of funding, the Company is enhancing its flexibility by considering partial sell-down of ownership interests in certain development assets on or before financial close; green financing instruments; and other financing tools. These additional sources are intended to improve Northland's financial flexibility, while supporting the capital and credit requirements for development projects. Northland intends to execute a selective sell-down strategy of partial interests of certain of its development projects on or before financial close to allow the Company to: manage jurisdictional exposures, crystalize some development profit prior to construction as a result of the de-risking of the project; enhance our free cash flow and liquidity position; and increase project returns, amongst other considerations. The Company will assess each opportunity individually and intends to remain a long-term owner in the renewable projects it develops. The Company's first notable development asset sell-down may occur as early as 2022, pending satisfactory terms to Northland.
|
LITM | Hot Stocks07:29 EST Snow Lake Resources expands resource block at Thompson Brothers Lithium Project - Snow Lake Resources advised the market of it's recent acquisition and substantial property expansion in and around it's current resource block at the Thompson Brothers Lithium Project in Manitoba, Canada. The company, with the assistance of an external consultant, has been engaged over the past several years in historic geological data analysis, diligence and "in-the-field" prospecting campaigns. The resulting efforts have culminated in the acquisition, through the staking and filing of claims with the Manitoba Mineral Resources Division, of mineral rights on an additional 33,614 acres of Crown land which the company believes is highly prospective of lithium. The total land holdings for Snow Lake Lithium now stands at 55,318 acres or 86.43 square miles. The company said, "Key factors in the acquisition were the use of historical data contained within the Manitoba Mines Branch assessments files, information contained within the provincial geological surveys report library on the "Wekusko Pegmatite Field," and guidance from Nuterra Geoscience of Saskatoon that provided Snow Lake with new insight into the location of potential pegmatites occurrences along the "Grass River" drainage system. With this analysis in hand, Snow Lake Lithium was able to acquire significant land holdings within the "Grass River" system that the Company thinks are highly prospective for lithium exploration. Four priority trends were identified i.e., Osborne, Crowduck, Dion, and Grass River. In addition, two clusters of pegmatites were also identified, aka Hat Lake and Herb Bay (Figure 1.0). All of these locations will be subject to spring and summer field exploration campaigns that may include airborne geophysical surveys, soil geochemistry, and "boot and hammer" prospecting. These procedures will then be followed by diamond drill hole testing of the anomalies."
|
RACE QCOM | Hot Stocks07:28 EST Ferrari, Qualcomm announce new technology partnership - Ferrari N.V. (RACE) announces a new partnership with Qualcomm Technologies (QCOM). As from today, the San Diego, California-based company, will be a Scuderia Ferrari Premium Partner through Snapdragon, Qualcomm's premium product and experience brand leveraged across multiple platforms and categories. The agreement with Qualcomm Technologies will have a strong technological impact aimed at accelerating the digital transformation process for Ferrari and its road cars. Benedetto Vigna, Ferrari CEO: "We believe innovation requires market leaders working together. Thanks to this agreement with Qualcomm Technologies, we expand our knowledge in digital technologies and web 3.0, areas with great potential for automotive and motorsport. We believe valuable partnerships, and a distinctive Ferrari interpretation, ultimately enhance product excellence."
|
NPIFF | Hot Stocks07:28 EST Northland Power announces 2022 strategic priorities - To further advance its strategic growth initiatives, the Company is looking to accomplish the following milestones in 2022: Further expansion of the Company's offshore wind portfolio through: Progressing the 1,044 MW Hai Long offshore wind project towards financial close, expected in the second half of 2022; Progressing the 1,200 MW Baltic Power offshore wind project towards financial close in 2023; Advancing development on the 1,333 MW Nordsee offshore wind Cluster in the German North Sea; Progressing the development on the two offshore leases secured in the recent Crown Estate Auction in Scotland with gross capacity of approximately 2,340 MW, targeted to be brought into service in late 2020's/early 2030's; Preparing bids for Taiwan's round three offshore wind auction, with two projects, CanWind and NorthWind with gross capacity of up to 1,800 MW; Securing further Electricity Business Licenses in Korea and advancing the interconnection and environmental permitting on those projects; Advancing our Japanese offshore wind projects and preparing for future auctions; and Planting low cost 'seeds' on development opportunities to extend the back-end of our pipeline beyond 2030, similar to our Scotwind development project. Successfully executing the Nordsee One main rotorshaft assembly replacement campaign. Enhancing our near-term growth objectives through: Advancing the 130 MW Suba solar development project in Colombia to financial close in 2022; Completing the construction of 366 MW of projects including the 16 MW Helios solar project, the 220 MW Ball Hill and Bluestone onshore wind projects, and along with the 130 MW La Lucha solar project, bring all the projects into commercial operations; Expanding the Company's onshore greenfield development pipeline with additional solar opportunities in the eastern United States as well as opportunities in EU Eastern Europe; and Leveraging on the recent Spanish acquisition by pursuing future growth opportunities in that market. Establishing a position in new initiatives such as storage and hydrogen to complement the existing portfolio of offshore wind and onshore renewables.
|
NPIFF | Hot Stocks07:27 EST Northland Power expects 2022 adjusted EBITDA to increase relative to 2021 - Northland Power is pleased to announce its 2022 financial outlook ahead of the previously announced annual Investor Day which will be held at 10:00 am EST today, in virtual format. Members of the executive team will provide an update on recent growth activities, Northland's long-term plans and objectives. Government de-carbonization policies and corporate net-zero plans are expected to further increase the need for additional renewable energy over the next decade. With almost 3 gigawatts of installed capacity and a 14 GW development pipeline, Northland is well positioned as a leading global offshore wind developer and operator and in addition, is establishing a strong presence in select onshore renewable power markets. The Company had success in 2021 growing its pipeline by securing long-term contracted renewable development projects in its target markets. Since last year's investor day held in February 2021, the Company has entered the Polish offshore wind market through the 1,200 megawatt Baltic Power offshore wind partnership and subsequently secured a 25-year government offtake agreement for the project; expanded its onshore renewables portfolio through the acquisition of a 551 MW portfolio of wind and solar assets in Spain; financed and commenced construction on two of its New York onshore wind projects which have a 20-year government contract with NYSERDA; exercised its 'step-in' rights on the 433 MW Nordsee Two offshore wind lease; and executed its largest ever bought deal equity financing. In terms of Financial Guidance, as detailed further herein, Northland expects Adjusted EBITDA in 2022 to increase relative to 2021, despite the expiry of a significant Power Purchase Agreement at Iroquois Falls. The Company's 2021 results reported to date have been impacted by unusually low wind in the North Sea and the 2022 guidance expects a return to more normalized wind resource, as there are no significant changes in Northland's long-term estimates of wind resource for our assets in the North Sea. Northland's focus on operational excellence and continuing to generate strong cash flows from its assets, including increased contributions from the recently acquired Spain portfolio and the EBSA utility, are also expected to contribute to Adjusted EBITDA growth in 2022. Over the next 24 months, Northland's 14 GW growth pipeline will begin entering a new phase as almost 3 GW of projects, offshore and onshore, reach financial close or commercial operations. The estimated $600 million of annual Adjusted EBITDA that these projects will deliver once in operations will, in part, help fund the continued development of earlier-stage projects in its pipeline such as the recently awarded Scottish offshore wind leases and its growing Korean offshore wind pipeline. Finally, Northland is executing on a diverse funding strategy to source capital at both the corporate and asset levels while optimizing returns and managing risk.
|
GILT | Hot Stocks07:26 EST Gilat Satellite, SES expand strategic partnership with Gilat's SkyEdge IV - Gilat Satellite Networks announced the expansion of their strategic partnership with SES. SES has selected Gilat's SkyEdge IV platform to operate with its SES-17 satellite, a very high throughput satellite, VHTS, to provide fixed services and mobility services. SES will be using SkyEdge IV simultaneously for both SES-17 and its upcoming second generation NGSO constellation, O3b mPOWER. The SkyEdge IV multi-service platform will be utilized by SES to deliver cellular-backhaul and enterprise services, in addition to previously announced maritime services. "We are excited and proud to work with our partner, SES, to support their multi-orbit network, including the O3b mPOWER constellation, SES-17, and other satellites as they are launched. The integration of SkyEdge IV with SES's ARC system ensures space and ground coordination and unified operation, forming a resilient and secure network," said Amir Yafe, VP of Mobility & Global Accounts at Gilat. "Gilat's SkyEdge IV is a multi-orbit, multi-service platform built to lead the satcom industry, supporting cloud infrastructure, an Elastix-Access Scheme, and working in harmony with next generation software-defined satellites."
|
FLGC | Hot Stocks07:26 EST Flora Growth names Vessel founder, James Choe, Chief Strategy Officer - Flora Growth announced the addition of Vessel founder and CEO, James Choe, to its executive team. Choe began his career in tech, experiencing the boom and bust of the early internet. Drawn to his life-long passion for sports, Choe pivoted and spent the better part of two decades representing athletes, building sports performance products and brands, and building out a consultancy that ultimately opened the door to new opportunities beyond athletics. Choe's varied career has given him exposure to nearly every major industry and has afforded him the opportunity to consult for over one hundred brands and launch over four hundred products into market. Through his time consulting for leading brands, cannabis producers and Fortune 500 companies, the role of people in the success of an organization was crystalized. It is through this lens that Choe takes on the role of Chief Strategy Officer of Flora where he will focus on the development of three core pillars - people, design, and community.
|
LIN | Hot Stocks07:26 EST Linde announces supply agreement with BASF for hydrogen, steam - Linde announced that it has signed a long-term agreement with BASF for the supply of hydrogen and steam. Linde will design, build, own and operate a new hydrogen production facility at Chalampe, France, effectively doubling Linde's current capacity in the Chalampe chemical park where it already has one production facility. This second plant will supply BASF's new hexamethylenediamine, or HMD, manufacturing facility and will also help meet the increasing demand from Linde's local merchant customers for hydrogen. The plant is expected onstream in the first half of 2024.
|
OBNNF | Hot Stocks07:24 EST Osisko Mining provides results from exploration program at Windfall project - Osisko Mining is pleased to provide an update from the ongoing exploration program at its 100% owned Windfall gold project located in the Abitibi greenstone belt, Urban Township, Eeyou Istchee James Bay, Quebec. New analytical results from 12.5 metre infill drilling targeting the Lynx 600 level bulk sample area are presented below. The infill program was completed in support of a revised block model for the sample, predicting approximately 5,000 tonnes with an average capped grade of 36.7 g/t Au in the planned sample area. This capped grade is 350% higher than the average grade of the recently published Windfall mineral resource estimate measured and indicated average grade of 10.5 g/t Au and demonstrates the potential for areas of the deposit to host a significant number of additional ounces. The infill intercepts are located inside defined January 2022 MRE blocks but were not included in the MRE. Results include 25 intercepts in 22 drill holes and 3 wedges. The bulk sample is situated in wireframe 3161 of the January 2022 MRE. The revised block model used the same parameters as the January 2022 MRE, including the same capping methods. The revised block model predicts 4,977 tonnes averaging 36.7 g/t Au and estimates 5,872 ounces of gold from the sample area. The planned sample is located 600 metres below surface. Access is planned via levels 0580 and 0600 which are accessible from the exploration ramp. Mining will begin with 65 metres of longitudinal development along the mineralized corridor on each level. The 20 metre high long-hole stope between levels is estimated to be 12.5 metres long x 6.5 metres wide. The proposed volume of approximately 4,977 tonnes to be mined includes the stope and the corresponding undercut segment of 12.5 metres of conventional development from level 0600. Mineralization in the sample area is characterized by a two to seven metre wide zone of alteration with trace to 10% pyrite stingers, sericite and silica +/- fuchsite, which crosscuts gabbro and felsic dykes. Grey quartz veins with pyrite veinlets, trace sphalerite and local visible gold are associated with high-grade areas.
|
BVN | Hot Stocks07:24 EST Buenaventura announces multiple transactions to enhance balance sheet - Compania de Minas Buenaventura Peru's largest publicly-traded precious metals mining company, announced multiple transactions demonstrating continued success in enhancing balance sheet strength and the expansion of available liquidity. The Company has entered into a definitive agreement to sell its total stake in Minera Yanacocha S.R.L. equal to a 43.65% participation, for net proceeds of $300M and contingent payments of up to $100M ied to future increases in metal prices. Buenaventura's interest in the Chaupiloma royalty will remain unchanged aligned with our belief that Yanacocha is a world-class asset. Concurrently, Newmont will transfer its ownership interest in the La Zanja joint venture to Buenaventura in exchange for royalties on any future production from the La Zanja operation. Newmont will also contribute $45M to Buenaventura to cover future closure costs. The acquisition is in-line with Buenaventura's consolidation strategy in an important gold-copper district. The announced transactions enable Buenaventura to further focus on the portfolio, accelerate deleveraging and support increasing shareholder returns.
|
GES | Hot Stocks07:24 EST Legion Partners urges removal of Guess co-founders and directors - Legion Partners Asset Management, together with its affiliates, is a significant shareholder of Guess. Legion Partners issued a public letter to the company's Board of Directors calling for the removal of Guess co-founders and directors Paul and Maurice Marciano. It stated, in part, "For more than a decade, a pattern of appalling sexual assault and harassment allegations have been made against Paul Marciano, while his brother Maurice Marciano appeared to turn a blind eye as a former Chairman of the Board. Now, new sexual assault and harassment allegations have surfaced against Paul Marciano. Legion Partners believes that it is the responsibility of the rest of the Board to finally take action and immediately remove Paul Marciano from his executive role and both brothers from the Board - or at the very least commit that they will not be renominated at the upcoming 2022 annual meeting of shareholders."
|
EMBK KNX | Hot Stocks07:23 EST Embark Technology, Knight-Swift announce launch of Truck Transfer Program - Embark Trucks (EMBK) and Knight-Swift Transportation (KNX) announced the launch of the Truck Transfer Program, intended to give Knight-Swift and its drivers direct access to Embark's technology. The Truck Transfer Program marks the first public initiative through which a US carrier will directly own and maintain an Embark-equipped truck, and is a major step on the path to eventual purchase and ownership of Embark-equipped trucks by carriers. The Truck Transfer Program is a testing configuration that "aims to unlock the next level of development necessary for commercialization," the company said. It marks the first time that the carrier - Knight-Swift - will own an autonomous truck, maintain and deploy the truck, and place their own driver behind the wheel. This will allow Embark and Knight-Swift to collect detailed driver feedback on the technology's performance, define how the system will improve driver jobs, and develop procedures and tools that enable Knight-Swift to maintain, inspect, dispatch, and remotely monitor Embark-equipped trucks. Currently, Knight-Swift and Embark are preparing the truck technology and carrier process flows necessary for the launch of this industry-first program. Embark plans to equip a set of Knight-Swift trucks from the carrier's slated 2022 OEM deliveries with the Embark Universal Interface. Embark plans to deliver the first Embark-equipped trucks to Knight-Swift for use in daily operations by the end of 2022. The program will help Knight-Swift determine how best to utilize its limited driver workforce to address the growing demands of the national supply chain.
|
WDOFF | Hot Stocks07:22 EST Wesdome Gold Mines announces results from Kiena Deep A Zone - Wesdome Gold Mines announces underground exploration drilling results from the Kiena Deep A Zone at the Company's 100% owned Kiena Mine Complex in Val d'Or, Quebec. Recent underground definition and exploration drilling at the Kiena Deep A Zones area has: Confirmed the A Zone continues down plunge along the basalt - ultramafic contact with drilling returning high grade from this continuous zone of mineralization; Confirmed the Footwall Zone comprises three subparallel zones and one crosscutting zone that have now been extended over 300 metres down plunge. Mineralization remains open laterally and down plunge and additional drilling platforms are being established as the A Zone ramp progresses to provide for more optimal drilling distances and angles; and Confirmed the existence of lower grade stockwork veins within the hanging wall of the A Zone within brecciated and altered basalt. These zones have the potential to be mined as access development in the hanging wall due to their proximity to the A Zones stoping area, and thereby having potential to be added to the resource base. These zones are generally located within 5 metres from the contact with the schist at a grade of 5 - 6 grams gold per tonne and an average thickness of 2 metres. Drilling is ongoing to better determine the extent of these zones. Highlights of the recent drilling are listed: Hole 6796W3: 74.6 g/t Au over 30.0 m core length A1 Zone; Hole 6752W9: 38.3 g/t Au over 37.3 m core length A Zone; Hole 6752W8: 35.9 g/t Au over 30.3 m core length A Zone. All assays capped at 90.0 g/t Au. True widths are estimated based on 3D model construction.
|
GTBIF | Hot Stocks07:20 EST Green Thumb Industries appoints Dorri McWhorter to board of directors - Green Thumb Industries announced that Dorri McWhorter has been appointed to its board of directors and will join its audit committee. In 2021, McWhorter became President and Chief Executive Officer of YMCA of Metropolitan Chicago, whose mission is to develop strong children, families and communities.
|
PFMT | Hot Stocks07:20 EST Performant Financial awarded IDIQ contract by HHS OIG - Performant Financial announced that on January 4, the U.S. Department of Health and Human Services, Office of the Inspector General, or HHS OIG, awarded Performant the indefinite delivery, indefinite quantity, or IDIQ, contract, with a base term of one year and four additional one-year options, to provide medical review and consultative services. This contract was awarded via a full-and-open competitive procurement. Under this national IDIQ contract, Performant will provide medical review and consultative services associated with the oversight activities of the OIG, primarily assessing services and claims for Medicare fee-for-service payments for Part A and Part B. OIG may also utilize Performant's services to assess services and claims for Medicaid or the Medicare Prescription Drug Plan. In addition to medical review of selected claims, Performant will provide support for auditee discussions or secondary reviews to assist HHS OIG in pursuing greater policy adherence, identifying improper payment vulnerabilities, and refining future industry communications and training.
|
PZG | Hot Stocks07:20 EST Paramount Gold reports gold intercepts from first drill program at Frost Project - Paramount Gold Nevada announced positive results from its first drill program at its Frost project located within trucking distance of the proposed Grassy Mountain Mine operation. "We are pleased with the results of this initial program. We have encountered a robust gold system which could have the potential to generate significant tonnage of economic material," said Glen Van Treek, Paramount's President and Chief Operating Officer. "There is much more drilling to be done but these results confirm the presence of a gold system as indicated by our surface work." A total of 13 reverse circulation drill holes totaling 9,010 feet were completed to test targets based upon surface geology and sampling, along with ground and helicopter borne geophysical surveys. Several drill holes intersected significant gold grades over interesting intervals including a 5-foot sample with a gold grade of 14.4 g/t and shallow intercepts up to 70 feet averaging 1.04 g/t.
|
HHC | Hot Stocks07:20 EST Howard Hughes to invest $325M in the Lakefront District in Downtown Columbia - The Howard Hughes Corporation announced that it plans to invest approximately $325M in the Lakefront District in Downtown Columbia. New development will include a state-of-the-art medical office building, housing options, retail offerings and enhanced connectivity to the natural environment, all planned to epitomize the "city in a garden" aesthetic envisioned by Columbia's founder James Rouse. Known as the grandfather of the master planned community, Rouse is responsible for some of the most successful communities and retail districts in the nation. The first project of the new investment is the $45.8M, four-story, 86,000-square-foot South Lake medical office building. It will rise along the south shore of Lake Kittamaqundi adjacent to Whole Foods Market in a walkable waterfront setting. The building is expected to achieve LEED Platinum status, the highest level of LEED certification, as well as Fitwel certification.
|
MCRB | Hot Stocks07:19 EST Seres Therapeutics appoints Paula Cloghessy as Chief People Officer - Seres Therapeutics announces that Paula Cloghessy, SPHR, SHRM-SCP, has joined Seres as Executive Vice President, Chief People Officer effective February 7 , reporting directly to Eric Shaff, President and Chief Executive Officer. "Paula joins the Seres leadership team at a pivotal time of growth. Her team-building expertise will be invaluable as we advance SER-109 toward what we expect to be the Company's first FDA drug approval, while expanding Seres' pipeline toward additional opportunities in Infection Protection and other diseases that we believe are well suited for our microbiome therapeutic approach," said Shaff. Cloghessy brings to Seres more than 20 years of human resources expertise with broad business experience leading human resources organizations in the biotechnology and pharmaceutical industries, including a successful track record of translating organizational objectives into dynamic HR programs and infrastructure. She most recently served as Chief People Officer at Translate Bio, Inc., where she led the talent architecture and people strategy. Throughout her career in biotech, Cloghessy has strived to prioritize the employee environment with an emphasis on curating talent and fostering an adaptive and inclusive culture. Prior to Translate, she served as vice president of human resources at Joule Unlimited Technologies, Inc. She has also held human resources positions at Interleukin Genetics, Inc. and NUCRYST Pharmaceuticals, Inc.
|
REFI | Hot Stocks07:19 EST FARMACEUTICALRX closes $34M in debt financing from Chicago Atlantic - FARMACEUTICALRX announced that it has closed a $34 million senior secured term loan provided by Chicago Atlantic Real Estate Finance, a commercial real estate finance company, and other institutional lenders. The Senior Term Loan proceeds will be used to complete the funding of the Company's Ohio Level 1 cultivation and post-harvest facility, repay existing debt, fund equipment purchases, and for general working capital purposes. The Company brings its cultivation and processing methods from the FARMACEUTICALRX of Pennsylvania operations to the 100,000 square foot facility in East Liverpool, Ohio. FARMACEUTICALRX of Ohio currently also operates its FRX Health dispensary in East Liverpool, Ohio.
|
AMC | Hot Stocks07:18 EST AMC Entertainment reaches lease agreements with URW, to reopen two locations - AMC Theatres announced it has reached lease agreements with Unibail-Rodamco-Westfield, or URW, global developer and operator of destinations, to acquire and open two locations, each located in a major market. In the San Diego market, AMC will reopen AMC UTC 14 at Westfield UTC, located in La Jolla, this Thursday, February 10. In the Washington D.C. market, AMC will reopen AMC Montgomery 16 at Westfield Montgomery, with an expected opening date in March. Both are former ArcLight locations. AMC remains in active discussions with other property owners regarding additional currently closed locations.
|
CLBT AMZN | Hot Stocks07:18 EST Cellebrite announces availability of Cellebrite Guardian in the UK - Cellebrite (CLBT) announced that Cellebrite Guardian, a cloud-based investigative digital evidence management solution designed specifically for investigators, examiners, and attorneys, is now available in the United Kingdom via Amazon Web Services (AMZN). Guardian is part of Cellebrite's industry-leading DI Platform that offers customers an end-to-end investigative platform covering data collection, review, analysis, and management, supporting the widest variety of digital evidence from the crime scene to the court. In addition to the United States and United Kingdom, Cellebrite also disclosed plans to deploy Guardian in AWS Data Centers in Canada, Singapore, and Australia before the end of 2022. The local data center deployments, including today's roll out in the UK, are expected to better serve local law enforcement agencies and help them maintain data sovereignty in the region. By deploying Cellebrite Guardian to manage, store, share, and review evidence, law enforcement agencies in the United Kingdom are expected to process evidence four times faster than the present rate, according to Cellebrite's estimates.
|
BCRX | Hot Stocks07:18 EST BioCryst appoints Machelle Sanders to board of directors - BioCryst Pharmaceuticals announced that the company has appointed North Carolina Secretary of Commerce, and pharmaceutical operations executive, Machelle Sanders, to its board of directors. Sanders has more than 30 years of pharmaceutical and biotechnology experience.
|
EVTL | Hot Stocks07:17 EST Leonardo and Vertical Aerospace team on on fuselage development program - Vertical Aerospace announced that it has agreed a joint development program with Leonardo for the design, testing, manufacture and supply of the carbon composite fuselage for Vertical's VX4 electric aircraft. Vertical and Leonardo will work together on optimising lightweight composite structures, modular design, systems installation, and structural testing for the co-development of the aircraft's fuselage. This is currently in place for at least six certification aircraft, up to the successful certification of the VX4. The agreement has also stated the potential to scale fuselage production to 2,000 aircraft a year to meet Vertical's existing market-leading order book demand. Vertical has what it believes is the largest conditional pre-order book in the eVTOL industry, of up to 1,350 aircraft worth $5.4B from American Airlines, Avolon, Bristow and Iberojet, including pre-order options from Virgin Atlantic and Marubeni, and through Avolon's placements, airlines JAL and Gol. Leonardo has long-established expertise in composite aerostructures development and manufacturing on civil and defense programs. The aerospace firm also has a close relationship with Vertical's strategic composite materials supplier, Solvay. Vertical and Solvay are jointly developing advanced materials and manufacturing technologies that will enable high volume manufacture of the VX4.
|
BMY | Hot Stocks07:17 EST Bristol-Myers awards $7.965M in new health equity grants - Bristol Myers Squibb announced $7.965M in new health equity grants to 24 U.S. non-profit organizations that aim to improve access and quality care to medically underserved patients and communities across oncology, cardiology, immunology and hematology therapeutic areas. These grants will bolster community outreach and education, increase patient support and care coordination services, and support diversity, cultural competency and collaboration among community health workers and patient navigators in communities across the U.S. To date, Bristol Myers Squibb's total support in addressing health disparities as part of its 2020 Commitments is just over $39M.
|
SYN | Hot Stocks07:17 EST Synthetic Biologics announces VCN-01 received Orphan Drug Designation - Synthetic Biologics announced that VCN Biosciences, S.L.'s, or VCN, VCN-01 received Orphan Drug Designation for retinoblastoma from the FDA. This announcement follows Synthetic Biologics' recent announcement that it had entered a definitive agreement to acquire VCN, which is subject to conditions that must be met prior to closing. VCN is developing a new oncolytic adenovirus, or OV, platform designed to trigger tumor cell death and promote immune cell infiltration into tumors. The FDA's Office of Orphan Products Development grants orphan status to drugs being developed to treat, diagnose or prevent a rare disease or condition affecting fewer than 200,000 people in the U.S.
|
CDNA | Hot Stocks07:17 EST CareDx submits insights from over 250 patients to CMS - CareDx announced that it has submitted insights from over 250 kidney, heart, lung, and liver transplant patients to the Centers for Medicare and Medicaid Services in response to their Request for Information on the "Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations, and End-Stage Renal Disease Facilities." For CMS's recent request, CareDx surveyed its patient community and received over 250 responses from kidney, heart, lung, and liver transplant patients. The survey identified four main areas for improvement to better support transplant patients across the continuum of care: There is a need to create greater public awareness about the need for more registered organ donors to ensure a robust transplant ecosystem in the future. More patient education is needed to prevent end-stage disease and improve post-transplant outcomes. Transplant patients are looking for ways to get on organ waitlists sooner. Patients are seeking greater financial assistance to help them manage chronic illnesses.
|
FRLN | Hot Stocks07:16 EST Freeline presents on Fabry, Gaucher disease AAV-based gene therapies - Freeline Therapeutics will present updated data from the ongoing Phase 1/2 MARVEL-1 clinical trial evaluating FLT190 for the treatment of patients with Fabry disease, and the clinical trial design for GALILEO-1, a Phase 1/2 safety and efficacy study of FLT201 in adult patients with Gaucher disease Type 1 at the 18th Annual WORLDSymposium. Highlights from the presentation titled, "Safety and efficacy of FLT190 for the treatment of patients with Fabry disease: Results from the MARVEL-1 Phase 1/2 clinical trial," include: FLT190 has been well-tolerated; a novel prophylactic immune management regimen may have prevented vector-related transaminitis in Patient 2. Results from the first dose cohort demonstrate promising efficacy. Mild, transient myocarditis was observed in both patients approximately 6-8 weeks post-dose of FLT190 which was not associated with enduring clinical sequelae on cardiac MRI. Highlights from the presentation titled "Design of GALILEO-1, a Phase 1/2 safety and efficacy study of FLT201 in adult patients with Gaucher disease Type 1," include: FLT201 consists of a rationally designed AAV capsid containing an expression cassette that encodes for a novel glucocerebrosidase variant under the control of a liver-specific promotor. GCasevar85 contains two novel amino acid substitutions that result in a 6-fold increase in half-life in human serum, and 20-fold increase in half-life at lysosomal pH conditions. Study objectives include evaluating the safety and tolerability of FLT201, investigating the relationship of FLT201 dose to production of endogenous GCase and determining the potential to improve clinical phenotype by reduction in the GCase substrate. The adaptive dose-escalation study will identify a dose of FLT201 for further development in a Phase 3 clinical trial, and will include two parts: Part 1, in patients previously treated with enzyme replacement therapy or substrate reduction therapy, and Part 2, previously untreated patients
|
EVGO | Hot Stocks07:16 EST EVgo selected as preferred EV charging partner of Subaru of America - EVgo announced the company has been selected as the preferred EV charging partner of Subaru of America. This news comes on the heels of Subaru unveiling its first ever zero-emissions vehicle, the all-new 2023 Solterra EV SUV, at the LA Auto Show in November and opening reservations this month. Subaru drivers will have access to all the benefits of EVgo's industry-leading network, with its geographic reach and 24/7 customer support.
|
TDG | Hot Stocks07:16 EST TransDigm says 2022 guidance 'remains suspended' - "The company's full fiscal 2022 guidance remains suspended at this time as a result of the continued disruption in our primary commercial end markets."
|
FTAA | Hot Stocks07:15 EST Pico launches Corvil Electronic Trading Data Warehouse - Pico continues to enhance the capabilities of its Corvil Analytics product suite, with the launch of Corvil Electronic Trading Data Warehouse. The new solution for monitoring strategy execution across the trading infrastructure helps business and operations teams make faster, more effective decisions.
|
BABYF | Hot Stocks07:14 EST Else Nutrition appoints Bo Lonnerdal to scientific advisory board - ELSE NUTRITION HOLDINGS announced that Dr. Bo Lonnerdal has joined its Scientific Advisory Board. Dr. Lonnerdal is the Distinguished Professor Emeritus of Nutrition & Internal Medicine at University of California, Davis.
|
PTON | Hot Stocks07:13 EST Peloton drops 6% in premarket trading amid restructuring, management changes
|
SPCE | Hot Stocks07:13 EST Virgin Galactic says Blair Rich appointed President and Chief Business Officer - Virgin Galactic Holdings announced that Blair Rich has been appointed President and Chief Business Officer, Commercial and Consumer Operations as the company prepares for the launch of commercial service later this year. In this newly created role, Rich will lead all aspects of the Company's commercial strategy including sales, marketing, business and product development, communications, operations, and customer experience. Rich has more than two decades of experience building some of the world's most recognizable global brands. Most recently, she served as President of Worldwide Marketing for Warner Bros.' Theatrical and Home Entertainment divisions. For the past year, she has served as a consultant and strategic advisor to Virgin Galactic. During that time, she helped the Company develop and grow its commercial strategy, including the marketing for Sir Richard Branson's inaugural spaceflight as a member of the Unity 22 crew, which was viewed by tens of millions of people around the world.
|
AGTC | Hot Stocks07:13 EST Applied Genetic announces interim data from studies of AGTC-401, AGTC-402 - Applied Genetic Technologies reported updated interim three-month pediatric results and additional adult safety results out to as long as 24 months from its ongoing Phase 1/2 dose escalation study of AGTC-401. AGTC-401 is a recombinant AAV viral vector-based gene therapy targeting mutations in the CNGB3 gene in patients with achromatopsia. Data from seven pediatric patients support previously reported findings from adults treated with AGTC-401, which demonstrated encouraging biologic activity and a favorable safety profile. There were no new Suspected Unexpected Serious Adverse Reactions, SUSARs, and for the three previously reported SUSARs, the inflammation continues to improve with steroid treatment. Based on the totality of the ACHMB3 data generated to date from 31 patients over as long as 24 months, AGTC plans to advance the clinical development of AGTC-401 subject to consultation with the U.S. Food and Drug Administration at an End-of-Phase 2 meeting in the first half of 2022. The Company also reported updated results from a parallel study of AGTC-402 targeting CNGA3 mutations in patients with achromatopsia that are consistent with previously reported results in adults, provide no indication of clinical improvements, and do not support further clinical development. AGTC will continue to follow the ACHMA3 patients for long-term safety observations.
|
LHDX... | Hot Stocks07:12 EST Lucira Health secures debt facility of up to $80M - Lucira Health (LHDX) announced that on February 4, 2022, it entered into a debt facility of up to $80 million with Hercules Capital, Inc. (HTGC) and Silicon Valley Bank (SIVB). Under the term loan, Lucira received the first tranche of $30 million at closing. A second tranche of $20 million will be available between September 1, 2022 and March 31, 2023 upon achieving certain milestones. A third tranche of $15 million will be available prior to June 15, 2023 upon achieving certain milestones. A fouth tranche of $15 million may be made available prior to March 15, 2024, as determined by Hercules and SVB.
|
PTON | Hot Stocks07:12 EST Peloton announces launch of Peloton Guide - Peloton said: "We are excited to officially announce the launch of Peloton Guide, our first connected fitness strength product, on April 5. The Peloton App already enables Members to stream great fitness workouts with world-class instructors on any screen in their home, including their TV. Priced at $495, Guide further enhances the full-body workout experience."
|
SPGI INFO | Hot Stocks07:11 EST S&P Global expects IHS Markit merger to close this quarter - "The company continues to make progress on the merger with IHS Markit as the regulatory path to closing is now clear. The UK, EU, U.S. and Canadian regulators have now announced their views on the transaction. Based on the regulatory feedback, and the previously announced divestitures, we continue to anticipate closing this quarter."
|
PTON | Hot Stocks07:11 EST Peloton: Restructuring to yield at least $800M in annual run-rate cost savings
|
PTON | Hot Stocks07:10 EST Peloton: Workforce cuts to impact nearly all operations, across all levels
|
SRE | Hot Stocks07:10 EST Sempra Energy announces Phase II of ESJ wind farm commences operations - Sempra Infrastructure, a subsidiary of Sempra, announced that Phase II of its Energia Sierra Juarez, or ESJ, wind farm in Tecate, Baja California began operations. ESJ, the first cross-border renewable energy project between Mexico and the United States, now provides 263 megawatts of zero-carbon electricity to the California electricity market.
|
PRDS | Hot Stocks07:10 EST Pardes Biosciences to present clinical data from PBI-0451 trial at CROI - Pardes Biosciences announced that a late-breaker poster presentation sharing clinical data from the ongoing PBI-0451 Phase 1 trial will be presented at the 29th Conference On Retroviruses And Opportunistic Infections, CROI, 2022, to be held virtually from February 12-16, 2022. Details of Pardes' poster presentation: Title: PBI-0451 an orally administered 3CL protease inhibitor of SARS-CoV-2 for COVID-19
|
BWEN | Hot Stocks07:10 EST Broadwind announces $16M in new tower orders - Broadwind announced that the Company has received $16 million in new tower orders from a leading global wind turbine manufacturer. Including these new orders, Broadwind has sold greater than 40% of its full-year 2022 optimal annual tower production capacity. Broadwind expects to schedule additional 2022 bookings over the coming months, as OEM customers seek to secure additional production capacity.
|
PTON | Hot Stocks07:10 EST Peloton: Roster of instructors; breadth, depth of content won't be impacted
|
PTON | Hot Stocks07:10 EST Peloton's Foley: Now is right time to introduce next phase of leadership - In a letter to shareholders, outgoing CEO John Foley said: "For several months, I have been working closely with our Board of Directors, discussing how best to ensure Peloton is built to last well into the future. Among other actions being taken, together, we have decided that now is the right time to introduce the next phase of leadership at this great company.... Our objective is clear: we are taking steps to best position Peloton for sustainable growth, while also establishing a clear path to consistent profitability. The comprehensive restructuring actions we are announcing today will streamline our teams and reporting structures, increase P&L accountability, create a more efficient and flexible supply chain, and enforce greater investment discipline to ensure our spending meets appropriate return thresholds."
|
MITC | Hot Stocks07:09 EST MeaTech 3D announces developments in stem cells to muscle fibers research - MeaTech 3D revealed significant improvement in its differentiation process from stem cells to muscle fibers. The company has succeeded in accelerating the formation of real living muscle fibers and enhancing their quality to mirror key characteristics of farm-raised meat. These results show the process in which bovine stem cells were isolated, proliferated in the lab, and differentiated into matured muscle cells with improved muscle fiber density, thickness and length. Based on these improvements, MeaTech has filed a provisional patent application with the USPTO.
|
BDX | Hot Stocks07:09 EST Becton Dickinson announces collaboration with ReturnSafe - Becton Dickinson announced a collaboration with ReturnSafe, the software solution for COVID-19 employee health, safety and compliance, to integrate the BD Veritor At-Home COVID-19 Test directly within the ReturnSafe testing management platform.
|
TLRY | Hot Stocks07:09 EST Tilray consolidates global medical offerings into Tilray Medical - Tilray Brands announced the launch of Tilray Medical, a global medical platform that unifies the Company's medical cannabis brands under one strategy, mission, and vision. Denise Faltischek, Head of International and Chief Strategy Officer, said, "Tilray is the global leader in the advancement of cannabinoid-based medicine, with a focus on providing research-backed medical cannabis products to physicians, pharmacies, and patients. By unifying the global medical divisions of Tilray and Aphria under a cohesive strategy and mission, Tilray Medical emerges as the premier global supplier of a portfolio of high-quality, effective medical cannabis brands and products for patients in need around the world." Under the Tilray Medical consolidation plan, patients in Canada will have the broadest access to our medical cannabis brands and product choices globally, including Tilray, Aphria, Broken Coast, and Symbios. Subject to local regulatory approvals, Tilray Medical's global portfolio of medical cannabis products includes high-quality and GMP-certified flower, oils, vapes, edibles, and topicals. Looking ahead, Tilray Medical will continue to expand its offering to patients worldwide.
|
LXP | Hot Stocks07:08 EST LXP Industrial Trust to review strategic alternatives - LXP Industrial Trust announced that its Board of Trustees has initiated a review of the Company's strategic alternatives. With the support of its independent financial advisors, the Board will consider a wide range of options including, among other things, a sale, merger and other business combinations. "The LXP Board and management team are committed to examining a wide range of options to maximize value for all shareholders," said T. Wilson Eglin, Chairman, Chief Executive Officer and President of LXP Industrial Trust. "Over the last five years, we have successfully transformed LXP into a leading, predominantly single-tenant industrial REIT with a much stronger and more valuable portfolio. With this transformation substantially complete, we believe now is an opportune time to launch a comprehensive process to determine the best path to drive shareholder value. As the Board conducts its review, we will remain open to all credible opportunities to unlock value, while maintaining our focus on executing our disciplined growth strategy and supporting our stakeholders." LXP has not set a timetable for the review process, nor has it made any decisions related to any potential strategic alternatives at this time. There can be no assurance that the review process will result in a transaction or other strategic change or outcome. The Company does not intend to disclose or comment on developments related to this review unless or until it determines that further disclosure is appropriate or required by law.
|
HLNE | Hot Stocks07:07 EST Hamilton Lane opens office in Switzerland - Hamilton Lane is expanding into Switzerland, establishing a formal presence in the country where it has been serving clients for more than 22 years. The opening of the new office in Zug is the latest development in the firm's commitment to strengthen and grow its presence in the region. The office will be led by EMEA Head of Client Solutions Ralph Aerni, with Vice President Rainer Kobler spearheading the firm's expansion efforts in the region.
|
BHIL | Hot Stocks07:05 EST Benson Hill appoints Dean Freeman as CFO - Benson Hill announced that Dean Freeman will become Benson Hill's next CFO. DeAnn Brunts has elected to return to retirement from her full-time executive role effective following the Company's filing with the Securities and Exchange Commission of its 2021 Annual Report on Form 10-K. Brunts will remain on the Company's Board of Directors, the original role she had when she joined Benson Hill in 2020. Freeman officially joined Benson Hill as Executive Vice President of Finance on February 2 of this year and will work closely with Brunts over the next two months to ensure an effective transition. Freeman brings nearly three decades of financial leadership and public company experience. Most recently, Freeman served as the President and CEO of First Source Capital, a commercial finance company he founded in 2019. Prior to that, he held roles as CFO at GCP Applied Technologies and interim CEO at Watts Water Technologies, each a publicly traded company on the New York Stock Exchange.
|
PTON | Hot Stocks07:05 EST Peloton confirms plans to cut approximately 2,800 global positions - Peloton Interactive announced a series of steps it is taking to position the business for long-term growth while establishing a clear path to consistent profitability and sustainable free cash flow. Once these actions are fully implemented, the company expects to achieve at least $800 million of annual run-rate cost savings through operating expense efficiencies and significant margin improvement in its Connected Fitness category. The company will also reduce its planned capital expenditures in 2022 by approximately $150 million. The restructuring program is expected to result in approximately $130 million in cash charges related to severance as well as other exit and restructuring activities and $80 million in non-cash charges. The majority of the charges will be recorded in fiscal year 2022. As a result of the initiatives announced today, the company expects to: The company is winding down the development of its Peloton Output Park manufacturing plan. This will result in $60 million in restructuring capital expenditures, which is included in the company's revised full year guidance. In addition, Peloton will optimize its logistics network by reducing its owned and operated warehousing and delivery footprint, while scaling third party relationships. The workforce reduction will occur across nearly all business operations to streamline reporting structures and create clearer lines of accountability. This will result in the reduction of approximately 2,800 global positions. Corporate positions will be reduced by approximately 20%. With regard to operations in the field, the company is reducing its owned and operated warehouses and delivery teams and expanding its commercial agreements with third party logistics providers. Peloton's roster of instructors and breadth and depth of its content will not be impacted by the initiatives announced today.
|
PTON | Hot Stocks07:05 EST Peloton winding down development of Peloton Output Park plan
|
ALKS | Hot Stocks07:05 EST Alkermes reports 'positive' results from ENLIGHTEN-Early study - Alkermes announced positive topline results from ENLIGHTEN-Early, a phase 3b study that evaluated the effect of LYBALVI compared to olanzapine on body weight in young adult patients with schizophrenia, schizophreniform disorder or bipolar I disorder who were early in their illness. The study met its pre-specified primary endpoint, as patients treated with LYBALVI experienced statistically significantly less weight gain than patients treated with olanzapine at Week 12. Consistent with the ENLIGHTEN-2 pivotal study, a numerical difference in average weight gain between treatment arms was observed early in treatment and continued to separate through the study's prespecified primary endpoint. LYBALVI is approved for the treatment of adults with schizophrenia, and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes as monotherapy or an adjunct to lithium or valproate. "We're pleased to share topline results from the ENLIGHTEN-Early study, in which LYBALVI demonstrated less mean weight gain compared to olanzapine in patients early in illness with schizophrenia, schizophreniform disorder or bipolar I disorder. These results complement the weight gain profile of LYBALVI shown in the ENLIGHTEN-2 pivotal study and reinforce the potential of LYBALVI as a new treatment option for adults living with schizophrenia or bipolar I disorder," said Craig Hopkinson, M.D., Executive Vice President of Research & Development and Chief Medical Officer at Alkermes.
|
PTON | Hot Stocks07:04 EST Peloton confirms plans to cut approximately 2,800 global positions
|
PTON | Hot Stocks07:04 EST Peloton names Angel L. Mendez, Jonathan Mildenhall to board - Peloton Interactive announced the appointment of two new directors to its Board: Angel L. Mendez and Jonathan Mildenhall. Erik Blachford, who has served as a director since 2015, will step down from his role on the Board. In addition, Barry McCarthy, Peloton's newly named CEO and President, will join the Board as a director, and John Foley has been named Executive Chair. With these changes, Peloton's Board will comprise nine directors, four of whom will have been appointed in the past three years. Nearly half of Peloton's Board seats will now be held by members of diverse communities: female, of color, and/or LGBTQIA+, Peloton said. John Foley, Co-Founder of Peloton and Executive Chair, said, "We are pleased to welcome Barry, Angel and Jonathan as new directors to the Peloton Board at this important time. We are confident they will provide valuable perspectives as we continue to execute our strategy, drive profitability, and enhance value for all Peloton shareholders."
|
PTON | Hot Stocks07:02 EST Peloton CEO John Foley to step down, Barry McCarthy named president and CEO - Peloton (PTON) announced the following leadership transitions: Barry McCarthy, who has held senior leadership roles at Spotify (SPOT) and Netflix (NFLX) and is a longtime advisor and board member at public and private technology companies, has been appointed CEO and President of Peloton, effective on February 9, 2022. He will also join Peloton's Board of Directors. Peloton Co-Founder John Foley will become Executive Chair. William Lynch transitions from President of Peloton to a non-executive director on the Board. Karen Boone, Lead Independent Director, said, "Today's leadership changes are the culmination of a succession planning process that the Board and John have worked on together over the last several months. We all agree that Barry is uniquely suited to lead Peloton into its next chapter and that this leadership transition will best position Peloton for sustainable growth, profitability, and long-term success. Barry is a proven leader, well known for his financial acumen and record of driving transformative change at iconic companies including Netflix and Spotify. In addition to his own extensive experience and expertise, Barry will also benefit from John's continued support as Executive Chair, which we view as a winning combination for all Peloton stakeholders." Foley said, "Since founding Peloton a decade ago, we've grown this brand to engage and motivate a loyal community of more than 6.6 million Members. I'm incredibly proud to have worked with such talented teammates over the years who have helped me build Peloton into what it is today, and I'm confident that Barry is the right leader to take the company into its next phase of growth. He's not only recognized as an expert in running subscription business models and helping category-leading digital streaming companies flourish, but he has also had tremendous success in partnering with founder CEOs at other brands. I'm excited to learn from him and work alongside him as Executive Chair."
|
SNAP | Hot Stocks07:02 EST Snap makes minority investment in Aleph Group - Aleph Group announced that Snap has made a minority investment in the company to support Aleph's global educational efforts in pursuit of its mission to power the digital ecosystem in emerging countries to unlock and drive economic growth. This investment will support Aleph's digital advertising education, training and certification to over 50,000 digital professionals in 90 countries, creating new digital jobs in underserved markets. The strategic investment closed in December 2021 and financial terms were not disclosed.
|
PTON | Hot Stocks07:01 EST Peloton: President William Lynch transitions to non-executive board director
|
PTON | Hot Stocks07:01 EST Peloton confirms appointment of Barry McCarthy as president and CEO
|
PTON | Hot Stocks07:01 EST Peloton confirms co-founder John Foley to become executive chair
|
WE | Hot Stocks06:56 EST WeWork, Upflex sign strategic partnership - WeWork announced a strategic and exclusive partnership with Upflex, a coworking aggregator and global flexible workplace startup.The exclusive partnership will establish a combined global network of over 5,500 locations and provide WeWork and Upflex's clients with enhanced flexibility as they adopt hybrid work strategies. WeWork will also participate in Upflex's Series A funding alongside additional investors. Through the partnership, both WeWork and its members will gain access to Upflex's fast-growing, aggregated portfolio of over 4,800 third-party spaces, provided by over 700 flexspace operators across 80 countries. WeWork will be the exclusive flex workspace operator to sell Upflex inventory to its members, allowing WeWork members to access Upflex's vast network of third-party spaces while maintaining a streamlined experience through WeWork as their single workspace provider. Additionally, this partnership will position WeWork to roll out enhanced WeWork Access membership options where members will have the ability to search, view and book space at select non-WeWork locations within the Upflex network. The expanded scale across non-core WeWork markets globally will allow members to choose from a wider array of tailored, flexible space solutions that best fit their specific real estate requirements. Reciprocally, Upflex will be the exclusive coworking aggregator to access WeWork's global inventory, allowing both Upflex's customers and employees to book workspace at WeWork locations through the Upflex platform and marking the first time WeWork has allowed workspace bookings from a third-party platform. This partnership will also enable all coworking brands on the Upflex network to leverage WeWork's community of more than 28,000 member companies around the world.
|
HOG | Hot Stocks06:55 EST Harley-Davidson sees FY22 capital expenditures $190M-$200M - The outlook assumes that supply chain challenges improve in the second half of the year.
|
STN | Hot Stocks06:54 EST Stantec selected by Southern Nevada Water Authority for Las Vegas project - The Southern Nevada Water Authority has selected Stantec to help deliver the $125M Stage II Reliability Upgrades Project to support long-term sustainable and resilient water access for the Las Vegas Valley. Stantec's role on the Stage II Reliability Upgrades Project will include the design of the new Flamingo Pumping Station and the design of approximately two miles of interconnecting pipeline from the station to the Pittman Lateral, which conveys water to the central Las Vegas Valley.
|
PFE | Hot Stocks06:51 EST Pfizer raises FY22 revenue view for Comirnaty to $32B
|
CING | Hot Stocks06:50 EST Cingulate provides update to its clinical candidate CTx-1301 - Cingulate announced updates to its 2022 clinical program for its lead candidate CTx-1301, an investigational asset for the treatment of Attention Deficit/Hyperactivity Disorder, or ADHD. This year, the Company plans to initiate its CTx-1301 Phase 3 clinical studies: a fixed-dose pediatric and adolescent safety and efficacy study, a dose-optimization study extension, and a pediatric safety and efficacy study to assess the onset and duration of efficacy. Specifically, the pivotal, fixed-dose study is slated to begin in the second quarter of 2022. These studies will be conducted in the U.S. and are instrumental for the filing of the New Drug Application to the FDA, expected in the second half of 2023.
|
MRK | Hot Stocks06:48 EST Merck provides 3.1M courses of molnupiravir to the U.S. government - Merck and Ridgeback Biotherapeutics announced that a total of approximately 3.1M courses of molnupiravir, an investigational oral antiviral COVID-19 medicine, have been provided to the U.S. government for allocation across the country. The U.S. Department of Health and Human Services, or HHS, has created a public website to help providers identify locations that have received shipments of government-procured COVID-19 therapeutics available under Emergency Use Authorization. In 2021, Merck entered a procurement agreement with the U.S. government under which the company agreed to supply approximately 3.1M courses of molnupiravir to the U.S. government upon Emergency Use Authorization or approval from the FDA. In addition to the U.S. agreement, Merck has entered into advance purchase and supply agreements for molnupiravir in more than 30 markets worldwide, including Australia, Canada, Korea, Japan, Thailand, Ukraine and United Kingdom, pending regulatory authorizations, and is currently in discussions with additional governments.
|
GHM | Hot Stocks06:47 EST Graham suspends dividend - As part of its Q3 results last night, the company announced that "the Board of Directors has suspended its dividend subject to the Company's analysis of capital allocation priorities and any requirements of a revised lending agreement." CFO Jeffrey Glajch stated: "We believe we have sufficient liquidity between our cash generated from operations and cash on hand for the foreseeable future. In fact, in the month of January 2022, we paid down nearly $4 million on our revolver with cash generated from operations. Unfortunately, the unexpected extended period of significant losses incurred at our Batavia operations impacted our ability to meet our financial covenants and required a waiver. We have been proactively working with our lender with the goal to have an amended lending agreement in place by fiscal year end."
|
BMRA | Hot Stocks06:42 EST Biomerica announces results from clinical trial of its InFoods IBS DGT - Biomerica announced positive topline results from the endpoint clinical trial of its InFoods IBS diagnostic-guided therapy, or DGT, with the trial showing statistically significant improvements in multiple endpoints in the Intent-to-Treat population. The InFoods DGT is the first of its kind therapy for Irritable Bowel Syndrome, or IBS, that uses a simple blood test designed to identify patient-specific foods that when removed from the diet may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The InFoods IBS DGT works by identifying above normal immunoreactivity to specific foods in patients. A food identified as positive is simply removed from the diet for the patient to feel better. Highlights of Topline Results from the InFoods IBS Endpoint Trial include: P-value of 0.007 for improvement in the Subject Global Assessment of Relief, or SGA, endpoint for all patient subtypes as a group; P-value of 0.040 for improvement in the Global Improvement Scale, or GIS, endpoint for all patient subtypes as a group; P-value of 0.012 for improvement in the Pain endpoint for IBS-Mixed & IBS-Constipation patients as a group. Biomerica plans to meet and work with the FDA to design a final pivotal trial focused on the endpoint that show the greatest improvement. The InFoods IBS study design has already received a non-significant risk determination from FDA, which should expedite the final approval process. Since the InFoods IBS product is a diagnostic-guided therapy, and not a drug, it has no drug type side effects which benefits patients.
|
CNTG | Hot Stocks06:37 EST Centogene CFO Rene Just resigns, Miguel Coego Rios named interim CFO - Centogene announced plans for the transition of CFO Rene Just and the appointment of Miguel Coego Rios as Executive Vice President of Finance & Legal and Interim CFO. Rene Just has resigned from the company effective March 31, after the expected filing date of Centogene's Annual Report on Form 20-F. Miguel Coego Rios will join the company on February 8, and work closely through the transition with current CFO Rene Just. The company has initiated a search for a permanent CFO; both internal and external candidates will be evaluated.
|
REDU | Hot Stocks06:34 EST Rise Education, Data Auto enter merger agreement - Rise Education and Data Auto announced that they have entered into a definitive agreement and plan of merger, pursuant to which the shareholders of NaaS will exchange all of the issued and outstanding share capital of NaaS for newly issued shares of the company on the terms and conditions set forth therein in a transaction exempt from the registration requirements under the Securities Act of 1933. Upon consummation of the Transaction, NaaS will become a wholly-owned subsidiary of the company. The transaction values NaaS at an equity value of approximately $587M and the company at an equity value of approximately $45M. Upon completion of the transaction, the existing NaaS shareholders and existing company shareholders will own approximately 92.9% and 7.1%, respectively, of the outstanding shares of the combined company. Immediately prior to the completion of the transaction, the company's ordinary shares will be divided into three classes - Class A ordinary shares, Class B ordinary shares and Class C ordinary shares - with different voting powers but equal economic rights. The company's board of directors, acting upon the unanimous recommendation of the audit committee of the board, approved the merger agreement and the transaction and resolved to recommend that the company's shareholders vote to authorize and approve the merger agreement, the other transaction documents and the transaction. The audit committee negotiated the terms of the merger agreement and the other transaction documents with the assistance of its financial and legal advisors. The audit committee received a fairness opinion from its independent financial advisor, China Renaissance Securities, attesting to the fairness of the consideration to be paid by the company in the transaction, from a financial point of view. The board of directors of NaaS has approved the merger agreement, the other transaction documents and the transaction. The company major shareholder, who holds approximately 60% of the outstanding shares of the company as of the date of this press release, has entered into a support agreement, agreeing to vote in favor of the transaction and other proposals as may be reasonably agreed to by NaaS and the company as necessary or appropriate in connection with the consummation of the transaction. BCPE Nutcracker Cayman, an affiliate of the company major shareholder, has executed agreements to become the beneficial owner of approximately 1% of NaaS, and beneficially owns approximately 15.8% of the parent company of NaaS. The company and NaaS anticipate that the transaction will be completed around mid-2022, subject to the satisfaction of closing conditions set forth in the merger agreement, including among other things, receipt of company shareholder approval and regulatory approvals, including necessary PRC regulatory approvals and the continuous listing of the company on the Nasdaq.
|
BP | Hot Stocks06:27 EST BP intends to execute further $1.5B share buyback - BP said it intends to execute a further $1.5 billion share buyback from 2021 surplus cash flow prior to announcing its first quarter 2022 results. For 2022, and subject to maintaining a strong investment grade credit rating, bp is committed to using 60% of surplus cash flow for share buybacks and intends to allocate the remaining 40% to strengthen the balance sheet. In addition, to date in 2022, bp has executed a share buyback of $500 million to offset the expected full year dilution from the vesting of awards under employee share schemes in 2022.
|
DD | Hot Stocks06:18 EST DuPont announces new $1B share buyback program - The company announced that its board of directors authorized a new $1B share buyback program which expires on March 31, 2023. This new authorization enables the company to repurchase shares following the company's expected completion of the remaining $375M in repurchases under its existing share buyback program in Q1 ahead of the program's expiration on June 30.
|
DD | Hot Stocks06:17 EST DuPont increases quarterly dividend 10% to 33c per share - The company announced that its board of directors has declared a Q1 dividend of 33c per share on its outstanding common stock, representing a 10% increase to its regular quarterly dividend, payable March 15 to holders of record at the close of business on February 28.
|
SFTBY NVDA | Hot Stocks06:12 EST Nvidia, Softbank confirm termination of deal for Arm Limited - NVIDIA (NVDA) and SoftBank Group, or SBG, (SFTBY) "confirm the termination of the previously announced transaction whereby NVIDIA would acquire Arm Limited from SBG. The parties agreed to terminate the Agreement because of significant regulatory challenges preventing the consummation of the transaction, despite good faith efforts by the parties. Arm will now start preparations for a public offering. SBG also announced that, in coordination with Arm, it will start preparations for a public offering of Arm within the fiscal year ending March 31, 2023. SBG believes Arm's technology and intellectual property will continue to be at the center of mobile computing and the development of artificial intelligence. NVIDIA and SBG had announced that they had entered into a definitive agreement, under which NVIDIA would acquire Arm from SoftBank, on September 13, 2020. In accordance with the terms of the agreement, SBG will retain the $1.25B prepaid by NVIDIA, which will be recorded as profit in the fourth quarter, and NVIDIA will retain its 20-year Arm license."
|
VIR | Hot Stocks06:08 EST Vir Biotechnology appoints Johanna Friedl-Naderer as Chief Business Officer - Vir Biotechnology announced the appointment of Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global, effective March 2. Reporting to Vir's CEO George Scangos, and joining Vir's senior leadership team, Friedl-Naderer will be responsible for shaping the company's corporate and portfolio strategy, leading the global commercial organization and driving business development efforts. Prior to joining Vir, Friedl-Naderer was President of Europe, Canada & Partner Markets for Biogen, where she served on the company's Global Leadership Team. During her more than 20-year tenure at Biogen, she held positions of increasing responsibility across a wide range of functions, building and leading teams in advancing access to groundbreaking medicines for the treatment of devastating neurological conditions, including multiple sclerosis, spinal muscular atrophy, amyotrophic lateral sclerosis and Alzheimer's disease.
|
FCFS | Hot Stocks06:04 EST FirstCash not providing FY22 guidance - Despite these near-term uncertainties, the company expects to achieve significant revenue and earnings growth in 2022.
|
INFA | Hot Stocks05:34 EST Informatica achieves FedRAMP certification - Informatica has achieved U.S. Government Federal Risk and Authorization Management Program, or FedRAMP, Moderate Level designation under the sponsorship of the Department of State for the Informatica Intelligent Cloud Services platform.
|
DIS | Hot Stocks05:32 EST Disney recommends shareholders reject Tutanota mini-tender offer - Disney has been notified of an unsolicited mini-tender offer by Tutanota to purchase up to 240,000 shares of Disney common stock at a price of $143 per share in cash. Disney recommends that shareholders not tender their shares in response to Tutanota's unsolicited offer because the offer is conditioned on the closing price per share of Disney's common stock exceeding $143 per share on the last trading day before the offer expires. This means that unless this condition is waived by Tutanota, Disney shareholders who tender their shares in the offer will receive a below-market price. Tutanota has stated it expects to extend the offer for successive periods of 45 to 180 days until the market price of the shares exceeds the offer price, in which case payment could be delayed beyond the scheduled expiration date of Friday, February 25.
|
WKSP | Hot Stocks05:29 EST Worksport delays unveiling of Terravis Energy solutions - Worksport management has decided to delay the unveiling of brand new energy solutions from its subsidiary Terravis Energy a few weeks to ensure all technical details are accurate and appropriately organized. Additionally, innovations that have transpired these past few weeks need to be featured in their best light, requiring more preparation time. "On behalf of Terravis Energy, I am deeply sorry for this delay. The Terravis Energy website will represent the work of many talented and dedicated people who have already spent countless hours making the unveiling occasion memorable. We cannot wait to release everything. Please take a few minutes to enjoy our video during this extended waiting period. The future is coming soon," said Lorenzo Rossi, CEO of Terravis Energy.
|
WPM | Hot Stocks05:26 EST Wheaton Precious Metals acquires gold stream from Sabina Goose Project for $125M - Wheaton Precious Metals announced that it has entered into a definitive precious metal purchase agreement with Sabina Gold & Silver Corp. in respect to the Goose Project, part of Sabina's 100% owned Back River Gold District located in Nunavut, Canada. The Goose Project is forecast to be a high margin mine in the lowest half of the gold cost curve with a 15-year mine life. Wheaton will pay Sabina an upfront payment of $125M in four equal installments during construction of the Goose Project, subject to customary conditions. Wheaton will be entitled to receive 4.15% of the payable gold production from the Mine dropping to 2.15% of the payable gold production from the Mine after delivery of 130,000 ounces of gold and dropping to 1.5% of the payable gold production from the Mine after delivery of 200,000 ounces of gold. With a fixed payable rate of 99.98%, attributable gold production is forecast to average 11.7 koz per year for the first five full years of production, and 10.7 koz per year for the first ten full years. Sabina is finalizing its 2022 work program and expects production to commence in the first quarter of 2025. Wheaton will make ongoing production payments for gold ounces delivered equal to 18% of the spot gold price until the value of gold delivered less the cumulative production payments is equal to the upfront consideration of $125M, at which point the production payment will increase to 22% of the spot gold price. The addition of the Goose Project will increase Wheaton's estimated Proven and Probable gold reserves by 0.14 Moz, Measured and Indicated gold resources by 0.03 Moz and Inferred gold resources by 0.04 Moz. Significant exploration upside potential exists within the Goose Project with over 4 km of untested plunge length to be explored within over 15,000 hectares of mineral claims and leases. The upfront payment will be paid over the construction of the Goose Project, coinciding with the start of construction. As at September 30, 2021, the company had approximately $372M of cash on hand, when combined with the liquidity provided by the available credit under the $2B revolving term loan and ongoing operating cash flows, positions the company to fund all outstanding commitments and known contingencies as well as providing flexibility to acquire additional accretive mineral stream interests.
|
LBTYA | Hot Stocks05:20 EST Liberty Global Ventures launches renewable energy brand - Liberty Global Ventures, the investment arm of Liberty Global, has launched a renewable energy brand, Egg, offering a range of clean technology solutions, including electric vehicle charging on a subscription basis. The subscription model - which hasn't previously been available in the UK - means that customers have ongoing maintenance and technical support, included in a monthly GBP 30 fee and without any up-front fees. Egg's launch comes ahead of the UK government ending the Electric Vehicle Homecharge Scheme at the end of March. This means that new electric vehicle owners are no longer able to access a grant of up to EUR 350 for hardware installation.
|
AXON | Hot Stocks05:16 EST Axon to open research, development office in London - Axon announced it will continue its global expansion by opening its first European research and development office in London.
|
FXLV | Hot Stocks05:15 EST F45 Training names Gunnar Peterson chief of athletics - F45 Training announced the appointment of Gunnar Peterson, personal trainer to professional athletes and Hollywood celebrities, as chief of athletics. Peterson has experience working with athletes including seven-time Super Bowl champion Tom Brady, former professional boxer Mike Tyson, and NBA champion Kevin Love, as well as personalities including the Kardashians, Rebel Wilson, and Sofia Vergara. He will join F45's team of training experts and sports scientists. To kickstart his new role, Gunnar has designed an exclusive ascending weight, pyramid-style resistance workout, which will be launching on the global F45 timetable in April.
|